UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
(Mark One)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the Fiscal Year Ended
OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM ______ TO ______
Commission File Number
(Exact Name of Registrant as Specified in its Charter)
|
|
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
(Address of principal executive offices) |
(Zip Code) |
Registrant’s telephone number, including area code: (
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Name of each exchange on which registered |
|
|
|
Securities registered pursuant to Section 12(g) of the Act:
None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15 (d) of the Act. Yes ☐
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
☒ |
|
Accelerated filer |
☐ |
Non-accelerated filer |
☐ |
|
Smaller reporting company |
|
Emerging growth company |
|
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 (a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes
The aggregate market value of the voting and non-voting common equity owned by non-affiliates of the registrant on June 30, 2019, computed by reference to the closing price for the registrant’s common stock on the New York Stock Exchange on such date was approximately $
As of February 10, 2020,
DOCUMENTS INCORPORATED BY REFERENCE
Certain portions of the registrant’s definitive proxy statement, in connection with its 2020 annual meeting of stockholders, to be filed within 120 days of December 31, 2019, are incorporated by reference into Part III, Items 10-14, of this annual report on Form 10-K.
Table of Contents
|
Page |
|||
|
|
|
||
|
1 |
|||
|
|
|
|
|
|
|
|
|
|
Item 1. |
|
|
2 |
|
Item 1A. |
|
|
12 |
|
Item 1B. |
|
|
19 |
|
Item 2. |
|
|
19 |
|
Item 3. |
|
|
19 |
|
|
|
|
|
|
|
|
|
|
|
Item 5. |
|
|
21 |
|
Item 6. |
|
|
22 |
|
Item 7. |
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
|
24 |
Item 7A. |
|
|
41 |
|
Item 8. |
|
|
42 |
|
Item 9. |
|
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure |
|
42 |
Item 9A. |
|
|
42 |
|
Item 9B. |
|
|
43 |
|
|
|
|
|
|
|
|
|
|
|
Item 10. |
|
|
45 |
|
Item 11. |
|
|
45 |
|
Item 12. |
|
Security Ownership of Certain Beneficial Owners and Management and Related StockholderMatters |
|
45 |
Item 13. |
|
Certain Relationships and Related Transactions, and Director Independence |
|
45 |
Item 14. |
|
|
45 |
|
|
|
|
|
|
|
|
|
|
|
Item 15. |
|
|
45 |
|
|
|
|
|
|
|
|
|
|
|
|
56 |
|||
|
|
|
|
|
Cautionary Statement Regarding Forward-Looking Statements
This annual report on Form 10-K includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. The “forward looking statements” include our current expectations, assumptions, estimates and projections about our business and our industry. They include statements relating to:
|
• |
future revenues, expenses and profitability; |
|
• |
the future development and expected growth of our business; |
|
• |
projected capital expenditures; |
|
• |
attendance at movies generally or in any of the markets in which we operate; |
|
• |
the number or diversity of popular movies released and our ability to successfully license and exhibit popular films; |
|
• |
national and international growth in our industry; |
|
• |
competition from other exhibitors and alternative forms of entertainment; and |
|
• |
determinations in lawsuits in which we are defendants. |
You can identify forward-looking statements by the use of words such as “may,” “should,” “could,” “estimates,” “predicts,” “potential,” “continue,” “anticipates,” “believes,” “plans,” “expects,” “future” and “intends” and similar expressions which are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. In evaluating forward-looking statements, you should carefully consider the risks and uncertainties described in the “Risk Factors” section in Item 1A of this Form 10-K and elsewhere in this Form 10-K. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements and risk factors contained in this Form 10-K. Forward-looking statements contained in this Form 10-K reflect our view only as of the date of this Form 10-K. We undertake no obligation, other than as required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Certain Definitions
Unless the context otherwise requires, all references to “we,” “our,” “us,” “the issuer”, “the Company” or “Cinemark” relate to Cinemark Holdings, Inc. and its consolidated subsidiaries. All references to Latin America are to Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay. Unless otherwise specified, all operating and other statistical data are as of and for the year ended December 31, 2019.
1
PART I
Item 1. Business
Our Company
Cinemark Holdings, Inc. and subsidiaries is a leader in the motion picture exhibition industry, with theatres in the United States, or “U.S.,” Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay.
As of December 31, 2019, we managed our business under two reportable operating segments: U.S. markets and international markets. See Note 20 to the consolidated financial statements.
Cinemark Holdings, Inc. is a Delaware corporation incorporated on August 2, 2006. Our principal executive offices are at 3900 Dallas Parkway, Plano, Texas 75093. Our telephone number is (972) 665-1000. We maintain a corporate website at www.cinemark.com. Our annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, and any amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, or the Exchange Act, are available on our website free of charge under the heading “Investor Relations – Financials - SEC Filings” as soon as practicable after such reports are filed or furnished electronically to the Securities and Exchange Commission, or the SEC. Additionally, all of our filings with the SEC can be accessed on the SEC’s website at www.sec.gov.
Description of Business
We are a leader and one of the most geographically diverse operators in the motion picture exhibition industry. As of December 31, 2019, we operated 554 theatres and 6,132 screens in the U.S. and Latin America and approximately 280 million guests attended our theatres worldwide during the year ended December 31, 2019. Our U.S. circuit had 345 theatres and 4,645 screens in 42 states and our international circuit had 209 theatres and 1,487 screens in 15 countries. Our significant and diverse presence in the U.S. and Latin America has made us an important distribution channel for movie studios and other content providers. We believe our portfolio of modern, high-quality theatres with multiple platforms provides a preferred destination for moviegoers and contributes to our consistent financial performance.
Revenues, operating income and net income attributable to Cinemark Holdings, Inc. for the year ended December 31, 2019, were $3,283.1 million, $338.3 million and $191.4 million, respectively. At December 31, 2019 we had cash and cash equivalents of $488.3 million and total long-term debt of $1,801.3 million. Approximately $196.3 million, or 11%, of our long-term debt accrues interest at variable rates and $6.6 million of our long-term debt matures in 2020.
2
Motion Picture Exhibition Industry Overview
Domestic Markets
The U.S. motion picture exhibition industry reported all-time high box office revenues of approximately $11.9 billion for 2018, a 7% increase over 2017. Industry results for 2019 are not yet available, but estimates indicate that box office revenues were approximately $11.4 billion, representing the second highest all-time box office performance. The following table represents the results of a survey by Motion Picture Association of America (“MPAA”) published during March 2019, outlining the historical trends in U.S. box office performance for the ten year period from 2009 to 2018.
|
|
U.S. Box |
|
|
|
|
|
|
|
|
|
|
|
|
Office Revenues |
|
|
Attendance |
|
|
Average Ticket |
|
|||
Year |
|
($ in billions) |
|
|
(in billions) |
|
|
Price |
|
|||
2009 |
|
$ |
10.6 |
|
|
|
1.42 |
|
|
$ |
7.50 |
|
2010 |
|
$ |
10.6 |
|
|
|
1.34 |
|
|
$ |
7.89 |
|
2011 |
|
$ |
10.2 |
|
|
|
1.28 |
|
|
$ |
7.93 |
|
2012 |
|
$ |
10.8 |
|
|
|
1.36 |
|
|
$ |
7.96 |
|
2013 |
|
$ |
10.9 |
|
|
|
1.34 |
|
|
$ |
8.13 |
|
2014 |
|
$ |
10.4 |
|
|
|
1.27 |
|
|
$ |
8.17 |
|
2015 |
|
$ |
11.1 |
|
|
|
1.32 |
|
|
$ |
8.43 |
|
2016 |
|
$ |
11.4 |
|
|
|
1.32 |
|
|
$ |
8.65 |
|
2017 |
|
$ |
11.1 |
|
|
|
1.24 |
|
|
$ |
8.97 |
|
2018 |
|
$ |
11.9 |
|
|
|
1.30 |
|
|
$ |
9.11 |
|
Over the past ten years, industry statistics have shown slight increases and decreases in attendance from one year to another, however domestic box office revenues have remained relatively stable during this period. The industry has not experienced highly volatile results, even during recessionary periods, demonstrating the stability of the industry, its continued ability to attract consumers and the fact that box office performance is primarily dependent on the quality, quantity and timing of film product rather than economic cycles. Average ticket prices can also be driven by the mix of film product and availability of films in premium formats.
Films leading the box office during the year ended December 31, 2019 included Avengers: Endgame, Star Wars: Episode IX, Frozen 2,The Lion King, Toy Story 4, Captain Marvel, SpiderMan: Far from Home, Aladdin, Joker, It: Chapter Two, Us, Fast & Furious Presents: Hobbs & Shaw, John Wick: Chapter 3 – Parabellum, and Jumanji: The Next Level, among other films.
Films scheduled for release during 2020 include Bad Boys for Life, Onward, A Quiet Place: Part 2, Mulan, No Time to Die, Black Widow, Fast & Furious 9, Wonder Woman 1984, Soul, Top Gun: Maverick, Minions: The Rise of Gru, Jungle Cruise, The King’s Man, The Eternals and Raya and the Last Dragon, among other films.
International Markets
According to MPAA, international box office revenues were approximately $29.2 billion for the year ended December 31, 2018, a slight decrease from 2017. More specifically, Latin American box office revenues were $2.7 billion for the year ended December 31, 2018, compared to $3.4 billion for the year ended December 31, 2017. Industry data for 2019 has not yet been released.
In addition to the quality, quantity and timing of Hollywood product, performance in Latin American markets is also impacted by social behaviors, growing populations, and continued retail development. In many Latin American countries, including Brazil, Argentina, Colombia, Peru and Chile, successful local film product can also contribute to box office growth.
Drivers of Continued Industry Success
We believe the following market trends will continue to drive the strength of our industry:
3
Importance of Theatrical Success in Establishing Movie Brands. Theatrical exhibition has long been the primary distribution channel for new major motion picture releases. In addition to representing a significant share of a film’s overall revenues, a successful theatrical release “brands” a film and is one of the major contributors to a film’s success in “downstream” markets, such as digital downloads, video on-demand, DVDs, pay television, network and syndicated television, and streaming video on demand, as well as branded retail merchandise.
Convenient and Affordable Form of Out-Of-Home Entertainment. Consumption of media and out-of-home experiential offerings continues to grow, and movie going is one of the most convenient and affordable forms of out-of-home entertainment. The estimated average ticket price in the U.S. was $9.11 for 2018. Average prices in 2018 for other forms of out-of-home entertainment in the U.S., including sporting events and theme parks, ranged from approximately $32.44 to $100.26 per ticket according to MPAA. (As of the date of this report, 2019 industry data was not yet available.)
Expansion of Concepts and Product Offerings that Enhance the Movie-Going Experience. The motion picture exhibition industry continues to develop new movie theatre platforms and concepts to respond to varying and changing consumer preferences as well as to differentiate the movie-going experience from other out-of-home entertainment options and from watching movies at home. Some examples include changing the overall style of and amenities of theatres, as well as expansion of concession product offerings that provide more variety to traditional popcorn, fountain drinks and candy. Many locations now offer hot foods, alcohol and/or healthier snack options for guests. Enhanced projection and sound equipment and motion seats are offered in some locations, to further enhance the movie viewing experience. New and enhanced programming alternatives expand the industry’s entertainment offerings to attract a broader customer base.
Contribution of International Markets to Box Office Performance. International markets continue to be an increasingly important component of the overall box office revenues generated by Hollywood films, accounting for $29.2 billion, or approximately 71%, of 2018 total worldwide box office revenues according to MPAA. (As of the date of this report, 2019 industry data was not yet available.) With the meaningful contribution of the international motion picture exhibition industry, we believe the relative contribution of markets outside North America will continue to be impactful. Many of the top U.S. films released during 2019 also performed exceptionally well in international markets. Avengers: End Game grossed $1,937.1 million in international markets, or 69% of its worldwide box office. The Lion King generated $1,098.7 million in international markets, or 67% of its worldwide box office. Frozen 2 generated $912.0 million in international markets, or 67% of its worldwide box office.
Our Strategy
Our primary objective is to attract and expand audiences to maximize attendance and box office, and then pursue monetization opportunities to capture additional ancillary revenue. We are focused on the following strategies to accomplish this goal:
Provide an Extraordinary Guest Experience. We differentiate our theatres by focusing on various initiatives that continuously enhance the in-theatre guest experience. We have a market-adaptive approach with our theatre amenities, including Luxury Lounger recliner seats, our exhibitor-branded premium large format, XD, and expanded food and beverage offerings. Our investment in these preferred amenities allows us to create and maintain a high-quality theatrical experience throughout our circuit. We believe our ongoing focus on providing an extraordinary in-theatre guest experience is a primary factor of our consistent industry-leading results.
Enhance Overall Guest Engagement. We offer loyalty and subscription programs that help provide a personalized experience, continued investment in our website and mobile app features and tailored custom interactions. We pursue a wide range of strategic marketing initiatives to communicate and build consumer awareness, better understand the unique preferences of our guests and enrich their movie-going experience.
Pursue Organic and Synergistic Growth Opportunities And Maintain Core Circuit. We continually utilize our cash flows from operations to invest in our circuit with a focus on new and exciting ways to attract guests. Our commitment to investing in our theatre assets is demonstrated by our level of capital expenditures for the years ended December 31, 2017, 2018 and 2019 of approximately $380.9 million, $346.1 million, and $303.6 million, respectively. In addition to our Luxury Lounger recliner seats and premium large format XD auditoriums, we have
4
incorporated other market-adaptive concepts such as full bars and dine-in options. We selectively build or acquire new theatres in markets where we can establish and maintain a strong market position. During the year ended December 31, 2019, we built eleven new theatres with 97 screens and acquired two theatres with 30 screens.
Competitive Strengths
We believe the following strengths allow us to compete effectively:
Disciplined Operating Philosophy. Our balanced and disciplined investment approach centers on building new theatres, reinvesting in our existing theatres and acquiring theatres that will complement our circuit. Our operating philosophy focuses on creating an extraordinary guest experience, maintaining favorable theatre-level economics, controlling operating costs and effectively reacting to economic and market changes.
We believe the combination of our strong balance sheet and our continued commitment to earn a solid return on our capital investments, will continue to provide us with the financial flexibility to pursue further expansion opportunities and maintain our existing locations at a high standard, while also allowing us to effectively service our debt obligations and continue to offer our stockholders a strong dividend yield.
Leading Position in Our U.S. Markets. We have a leading market share in most of the U.S. markets we serve, which includes a presence in 42 states. For the year ended December 31, 2019, we ranked either first or second, based on box office revenues, in 20 out of our top 25 U.S. markets, including the San Francisco Bay Area, Dallas, Houston, Salt Lake City, Sacramento, Cleveland, Austin and Las Vegas.
Located in Top Latin American Markets. We have successfully established a significant presence in major cities in Latin America, with theatres in 14 of the 20 largest metropolitan areas in South America. We are the largest exhibitor in Brazil and Argentina and have significant market presence in Colombia, Peru and Chile. Our geographic diversity makes us an important global distribution channel for the movie studios.
State-of-the-Art Theatre Circuit. We offer a state-of-the-art movie-going experience, which we believe makes our theatres preferred destinations for moviegoers in our markets. During 2019, we built 97 new screens. As of December 31, 2019, we had commitments to open 243 additional new screens over the next three years.
We have incorporated Luxury Lounger recliner seats in all of our recent domestic new builds and have also repositioned many of our existing domestic theatres to offer this premium seating feature. We currently feature Luxury Loungers in 2,765 domestic auditoriums, representing almost 60% of our domestic circuit. We plan to continue to add additional Luxury Loungers in certain of our domestic locations during 2020.
We offer our guests a premium large format experience through our 16 IMAX screens and our 275 XD auditoriums, which represents the largest exhibitor-branded premium large format footprint in the industry. Our XD auditoriums offer a premium experience utilizing the latest in digital projection and enhanced custom sound, including a Barco Auro 11.1 or Dolby Atmos sound system in select locations. The XD experience includes wall-to-wall screens, wrap-around sound, plush seating and a maximum comfort entertainment environment for an immersive experience. The benefits of our XD auditoriums include program flexibility, as we can show the content of our choice, and there is no additional revenue share component outside of routine film rental. We expect to continue to expand our XD footprint during 2020.
We offer enhanced food and beverages such as gourmet pizzas, burgers, and sandwiches, and a selection of beers, wines, and cocktails, all of which can be enjoyed in the comfort of the auditoriums, at approximately 59% of our worldwide theatres. We also offer market-adaptive concepts with full bars or dine-in areas in certain of our theatres and continue to expand to additional locations.
We currently have auditoriums that offer seats with immersive cinematic motion, which we refer to as motion seats, throughout our worldwide circuit. These motion seats are programmed in harmony with the audio and video content of the film and further immerse guests in the on-screen action. We offer motion seats in 235 auditoriums throughout our worldwide circuit and we plan to add motion seats to additional locations during 2020.
5
Experienced Management. Led by Chairman and founder Lee Roy Mitchell, Chief Executive Officer Mark Zoradi, Chief Operating Officer and Chief Financial Officer Sean Gamble, and President-International Valmir Fernandes, our operational management team has extensive industry experience. Similarly, each of our international offices is led by general managers that are local citizens familiar with cultural, political and economic factors impacting their country. Our global management team has successfully navigated us through many industry and economic cycles over the years.
6
Theatre Operations
As of December 31, 2019, we operated 554 theatres and 6,132 screens in 42 U.S. states and 15 Latin American countries.
We opened our first theatre in the U.S. during 1984. Our domestic circuit has expanded primarily due to organic growth and two significant acquisitions. We currently have theatres in 105 DMAs. The following table summarizes the geographic locations of our U.S. theatre circuit as of December 31, 2019.
|
|
Total |
|
Total |
|
|
State |
|
Theatres |
|
Screens |
|
|
Texas |
|
87 |
|
|
1,152 |
|
California |
|
66 |
|
|
850 |
|
Ohio |
|
29 |
|
|
364 |
|
Utah |
|
15 |
|
|
190 |
|
Nevada |
|
9 |
|
|
140 |
|
Colorado |
|
9 |
|
|
136 |
|
Illinois |
|
9 |
|
|
126 |
|
Pennsylvania |
|
9 |
|
|
125 |
|
Kentucky |
|
8 |
|
|
109 |
|
Arizona |
|
7 |
|
|
104 |
|
North Carolina |
|
7 |
|
|
83 |
|
Florida |
|
6 |
|
|
110 |
|
Oregon |
|
6 |
|
|
90 |
|
Louisiana |
|
6 |
|
|
83 |
|
Virginia |
|
6 |
|
|
82 |
|
Washington |
|
6 |
|
|
73 |
|
Oklahoma |
|
5 |
|
|
65 |
|
Iowa |
|
4 |
|
|
62 |
|
Connecticut |
|
4 |
|
|
58 |
|
New Mexico |
|
4 |
|
|
54 |
|
New Jersey |
|
4 |
|
|
50 |
|
Massachusetts |
|
3 |
|
|
46 |
|
Michigan |
|
3 |
|
|
46 |
|
Arkansas |
|
3 |
|
|
44 |
|
Mississippi |
|
3 |
|
|
41 |
|
Indiana |
|
3 |
|
|
34 |
|
South Carolina |
|
3 |
|
|
34 |
|
Maryland |
|
2 |
|
|
39 |
|
Georgia |
|
2 |
|
|
27 |
|
South Dakota |
|
2 |
|
|
26 |
|
Montana |
|
2 |
|
|
25 |
|
Delaware |
|
2 |
|
|
22 |
|
West Virginia |
|
2 |
|
|
22 |
|
Kansas |
|
1 |
|
|
20 |
|
Idaho |
|
1 |
|
|
18 |
|
New York |
|
1 |
|
|
17 |
|
Alaska |
|
1 |
|
|
16 |
|
Alabama |
|
1 |
|
|
14 |
|
Tennessee |
|
1 |
|
|
14 |
|
Wisconsin |
|
1 |
|
|
14 |
|
New Hampshire |
|
1 |
|
|
12 |
|
Minnesota |
|
1 |
|
|
8 |
|
Total |
|
345 |
|
|
4,645 |
|
7
We first entered Latin America when we opened a theatre in Chile in 1993. Since then, through our focused international growth strategy, we have developed one of the most geographically diverse theatre circuits in the region. We have balanced our risk through a diversified international portfolio, which includes theatres in 14 of the 20 largest metropolitan areas in South America. We have established significant presence in Brazil and Argentina, where we are the largest exhibitor. We also have significant market presence in Colombia, Peru and Chile. The following table summarizes the geographic locations of our international theatre circuit as of December 31, 2019.
Country |
|
Total Theatres |
|
|
Total Screens |
|
||
Brazil |
|
|
86 |
|
|
|
633 |
|
Colombia |
|
|
36 |
|
|
|
207 |
|
Argentina |
|
|
22 |
|
|
|
191 |
|
Central America(1) |
|
|
21 |
|
|
|
147 |
|
Chile |
|
|
19 |
|
|
|
127 |
|
Peru |
|
|
14 |
|
|
|
102 |
|
Ecuador |
|
|
8 |
|
|
|
51 |
|
Bolivia |
|
|
1 |
|
|
|
13 |
|
Paraguay |
|
|
1 |
|
|
|
10 |
|
Curacao |
|
|
1 |
|
|
|
6 |
|
Total |
|
|
209 |
|
|
|
1,487 |
|
|
(1) |
Includes Honduras, El Salvador, Nicaragua, Costa Rica, Panama and Guatemala. |
Content
We offer a variety of content at our theatres. We monitor upcoming films and other content and work diligently with film distributors to license content that we believe will be most successful in our theatres. We play mainstream films from many different genres, such as animated films, family films, dramas, comedies, horror and action films. We offer content in both 2-D and 3-D formats in all of our theatres, and in many locations, we offer either our exhibitor-branded premium large format, XD, or IMAX. We also offer a format that features motion seats and added sensory features.
We regularly play art and independent films at many of our U.S. theatres and offer local film product in our international markets, providing a variety of film choices to our guests. We offer a Classic Series at a majority of our U.S. theatres and some of our international theatres, which involves playing digitally re-mastered classic movies. The program covers a variety of genres of classic films that are generally exhibited during non-peak times. We also occasionally offer multi-cultural foreign language films and e-sports gaming events in our theatres.
Our joint venture, AC JV, LLC, with Regal Entertainment Group, or Regal, and AMC Entertainment, Inc., or AMC, provides marketing and distribution of live and pre-recorded entertainment programming to movie theatres to augment theatres’ feature film schedules, which includes the Metropolitan Opera, sports programs, concert events, and other special presentations, that may be live or pre-recorded. We, along with AC JV, LLC, continue to identify new ways to utilize our theatre platform to provide alternative content to consumers beyond movies.
Film Licensing
In the domestic marketplace, our corporate film department negotiates with film distributors to license films for each of our domestic theatres. In each of our international offices, our local film personnel negotiate with local offices of major film distributors, local film distributors and independent content providers to license films for our international theatres. Film distributors are responsible for determining film release dates and film marketing campaigns and the related expenditures, while we are responsible for booking the films at each of our theatres at the optimal showtimes for our guests.
In both our domestic and international locations, we pay film rental fees based on a film’s box office receipts at our theatres. Film rental rates are negotiated based on either a sliding scale formula under which the rate is based
8
on a standard rate matrix that is established prior to a film’s run; a firm terms formula, as determined prior to a film’s run, under which we pay a negotiated rate; or a rate that is negotiated after a film’s run.
Food and Beverage
Concession sales are our second largest revenue source, consistently representing approximately 35% of total revenues. We have devoted considerable management effort to expanding concession sales by enhancing our offerings and adapting to our customers’ changing preferences, as discussed below.
Concession Product Mix. Common concession products offered at all of our theatres may include various sizes and types of popcorn, soft drinks, coffees, non-carbonated drinks, candy and quickly-prepared or pre-prepared food, such as hot dogs, pizza, pretzel bites, nachos and ice cream. The food and beverage offerings vary based on consumer preferences in a particular market. We have introduced some healthier snack and beverage options for our guests, which are available at some locations, added alcohol offerings in a growing number of theatres, and also offer diverse ethnic foods based on market demographics.
In select locations, we have expanded concession product offerings to include a broader variety of food and drink options, such as gourmet pizzas, burgers, and sandwiches and a selection of beers, wines, and cocktails, all of which can be enjoyed in the comfort of the auditoriums. We also have lobby bars and VIP lounges in many domestic and international theatres.
Our proprietary point-of-sale system allows our category managers to monitor product sales and readily make adjustments to product mix on a theatre-by-theatre or market-by-market basis, when necessary. This program flexibility also allows us to efficiently activate and manage both national or regional product launches and promotional initiatives to further grow food and beverage sales.
Pricing. New products and promotions are introduced on a regular basis to increase concession purchase incidence by existing consumers as well as to attract new consumers. We offer specially-priced product combinations at our theatres. We routinely offer discounts to our guests on certain products including reusable popcorn tubs and soft drink cups that can be refilled at a discounted price. In certain international countries and in all of our domestic theatres, we offer a loyalty program that periodically offers food and beverage discounts. Our new Movie Club membership program also allows our domestic guests to sign-up for exclusive concessions discounts.
Staff Training. Employees are continually trained in proper sales techniques, food preparation and handling and maintaining concession product quality. Some of our product promotions include a motivational element that rewards theatre staff for exceptional sales of certain promotional items.
Theatre Design. Our theatres are designed to optimize the guest purchase experience at the concession stands, which includes multiple concession counters throughout a theatre to facilitate serving guests in an expedited manner. We strategically place large concession stands within theatres to heighten visibility, reduce the length of concession lines, and improve traffic flow around the concession stands. We incorporate self-serve candy cases and bottled drink coolers at our traditional crew-serve theatres to help provide convenience for our guests, drive impulse purchases and increase product availability for these two core categories. We also have self-service cafeteria-style concession areas in many of our domestic theatres, which allow customers to select their own refreshments and proceed to the cash register when they are ready. This design allows for more efficient service, and superior visibility of concession items. In select locations, we allow guests to pre-order concession items, either online or at a kiosk, and pick them up in a dedicated line at the concession counter.
Cost Control. We negotiate prices for concession supplies directly with concession vendors and manufacturers to obtain volume discounts and also negotiate volume-based and promotional-based rebates. Concession supplies are generally managed through a distribution network in which inventory is delivered to the theatres after receiving orders directly from the theatres. We conduct frequent inventory counts of concession products at every theatre to ensure proper stock levels are maintained to appropriately serve our guests.
9
Screen Advertising
In our domestic markets, our theatres are part of the in-theatre digital network operated by National CineMedia, LLC, or NCM. NCM provides advertising to our theatres through its branded “Noovie” pre-show entertainment program and also handles lobby promotions and displays for our theatres. We believe that the reach, scope and digital delivery capability of NCM’s network provides an effective platform for national, regional and local advertisers to reach our audience. We receive a monthly theatre access fee for participation in the NCM network and also earn screen rental revenue on a per patron basis or revenue share basis depending on the placement of the advertisement. As of December 31, 2019, we had an approximate 25% ownership interest in NCM. See Note 7 to the consolidated financial statements for further discussion of our investment in NCM.
Throughout our international markets, we have established our Flix Media brand that handles screen advertising functions in Brazil, Argentina, Chile, Central America, Colombia, Paraguay, Bolivia, Ecuador and Curacao. Our Flix Media marketing personnel work with local agencies and advertisers to coordinate screen advertising in our theatres as well as other theatres in our markets. In addition to screen advertising in our theatres, we will continue to expand Flix Media’s services to include, among other things, alternative content, digital media and other synergistic media opportunities. In a few of our other international markets, we outsource our screen advertising to local companies who have established relationships with local advertisers that provide similar programming benefits. The terms of our international screen advertising contracts vary by country, however, we generally earn a percentage of the screen advertising revenues for access to our screens.
Marketing and Promotions
We generally market our theatres and special events, including new theatre grand openings, remodel openings and VIP events, using email, organic and paid digital advertising, and radio and television advertising spots. We exhibit previews of coming attractions and current films as part of our on-screen pre-feature program. We offer guests access to movie times, the ability to buy their tickets and reserve their seats in advance and purchase gift cards at our website www.cinemark.com and via our smart phone and tablet applications. Customers can subscribe to our emails and push notifications to receive information about current and upcoming films at their preferred Cinemark theatre(s), including details about upcoming XD movies, advanced ticket sales, screenings, special events, concerts, live broadcasts, contests, promotions, and our latest concessions and merchandise offerings. We partner with film distributors on a regular basis to promote upcoming films through local, regional and national programs that are exclusive to our theatres.
We interact with guests every day on social media platforms, such as Instagram, Facebook, and Twitter. Through social media, we provide relevant information, quick access to advanced ticketing information and upcoming movies and events, as well as to respond to guest feedback. Guests can also utilize social media to ask us questions regarding their local Cinemark theatre offerings, movie-related information or to provide suggestions.
We launched a subscription membership program for our domestic circuit in December 2017 called Movie Club. Movie Club offers guests a 2D ticket credit, member-pricing for a companion ticket and concession and other transaction discounts for a monthly fixed price. Movie Club is a unique option to reward our loyal guests and allows us to stay informed of our frequent guests’ preferences.
We offer a free domestic loyalty program to our guests, called Movie Fan, which was launched in 2016 as Connections and renamed in 2019. Movie Fan allows our guests to earn one point for every dollar they spend. Points can then be redeemed for tickets, concession items and discounts, as well as unique and limited-edition rewards that relate to films currently playing in our theatres.
We also have loyalty programs in some of our international markets that either allow customers to pay a nominal fee for an annual membership card that provides them with certain admissions and concession discounts or that allows guests to earn loyalty points for each purchase. Similar to the Movie Fan program, our points-based international programs offer discounts on movie tickets and concessions. Our global loyalty programs put us in direct contact with our guests and provide additional opportunities for us to partner with the studios and our vendors through targeted promotions.
Our domestic and international marketing departments also focus on expanding ancillary revenue, which includes the sale of gift cards and Supersaver discount tickets. Gift cards are sold through several channels – in-theatre, online at Cinemark.com, and through third party retail channels in grocery, pharmacy and big box stores.
10
We generally market Supersaver tickets to businesses as an employee-incentive or rewards program. Our marketing departments also coordinate the use of our auditoriums, generally during off-peak times, for corporate meetings, private movie screenings, brand and product launches, education and training sessions or other private events, which contribute to our ancillary revenue.
Competition
We are one of the leaders in the motion picture exhibition industry. We compete against local, regional, national and international exhibitors with respect to attracting guests, licensing films and developing new theatre sites. Our primary U.S. competitors include Regal and AMC and our primary international competitors, which vary by country, include Cinépolis, Cine Colombia, CinePlanet, Kinoplex (GSR), Village Cines, Hoyts Chile, SuperCines and Araujo.
We are generally able to book films without regard to the film bookings of other exhibitors at many of our theatres. In certain limited situations, distributors allocate movies to only one theatre in a market generally based on demographics, the conditions, capacity and grossing potential of each theatre, and the terms of exhibition. In all theatres, our success in attracting guests can depend on customer service quality, location, theatre capacity, quality of projection and sound equipment, film showtime availability and ticket prices.
We compete for new theatre sites with other movie theatre exhibitors as well as other entertainment venues. Securing a potential site depends upon factors such as commercial terms, committed investment and resources, theatre design and capacity, revenue potential, and financial stability.
We face competition from other forms of out-of-home entertainment competing for the public’s leisure time and disposable income, such as family entertainment centers, concerts, theme parks and sporting events. We also face competition for patrons from a number of alternative film distribution channels, such as streaming services, digital downloads, video on-demand, DVDs, pay television, network and syndicated television, and streaming video on demand.
Seasonality
Our revenues have historically been seasonal, coinciding with the timing of releases of motion pictures by the major distributors. The most successful motion pictures have historically been released during summer months in the U.S., extending from May to July, and during the holiday season, extending from November through year-end. The timing of releases, however, has become less pronounced as distributors have begun releasing content more evenly throughout the year. In our Latin American markets, while Hollywood content has similar release dates as in the U.S., the local holidays and seasons can vary. The unexpected emergence of a hit film during other periods can impact this seasonality trend. The timing, quantity and quality of film releases can have a significant impact on our results of operations, and the results of one period are not necessarily indicative of results for the following period or for the same period in the following year.
Corporate Operations
Our worldwide headquarters, referred to as the Cinemark Service Center, is located in Plano, Texas. Personnel at the Cinemark Service Center provide oversight and support for our domestic and international theatres, and includes our executive team and department heads in charge of film licensing, food and beverage, theatre operations, theatre construction and maintenance, real estate, human resources, marketing, legal, finance, accounting, tax and information technology. Our U.S. operations are comprised of twenty regions, each of which is headed by a regional vice president. We have nine regional offices in Latin America responsible for the local management of theatres in fifteen countries (Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala and Curacao are managed out of one Central American regional office). Each regional office is headed by a general manager with additional personnel responsible for film licensing, marketing, human resources, information technology, operations and finance. We have divisional chief financial officers in Brazil and Argentina and a regional chief financial officer located in Chile that oversees Chile, Bolivia and Paraguay.
11
Employees
We have approximately 22,000 employees in the U.S., approximately 21% of whom are full time employees and 79% of whom are part time employees. We have approximately 10,500 employees in our international markets, approximately 77% of whom are full time employees and approximately 23% of whom are part time employees. Due to the seasonal nature of our business as discussed above, our headcount can vary throughout the year, depending on the timing and success of movie releases. Some of our international locations are subject to union regulations. We regard our relations with our employees to be satisfactory.
Regulations
The distribution of motion pictures is largely regulated by antitrust laws and has been the subject of numerous antitrust cases. The manner in which we can license films from certain major film distributors has been influenced by consent decrees resulting from these cases. Consent decrees bind certain major film distributors and require the films of such distributors to be offered and licensed to exhibitors, including Cinemark, on a theatre-by-theatre and film-by-film basis. Consequently, exhibitors cannot enter into long-term arrangements with major distributors, but must negotiate for licenses on a theatre-by-theatre and film-by-film basis.
We are subject to various general regulations applicable to our operations including the Americans with Disabilities Act of 1990, or the ADA, and regulations recently issued by the U.S. Food and Drug Administration that require nutrition labels for certain menu items. Our domestic and international theatre operations are also subject to federal, state and local laws governing such matters as wages, working conditions, citizenship, health and sanitation requirements and various business licensing and permitting.
Financial Information About Geographic Areas
We currently have operations in the U.S., Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao, and Paraguay, which are reflected in the consolidated financial statements. See Note 20 to the consolidated financial statements for segment information and financial information by geographic area.
Item 1A. Risk Factors
Our business depends on film production and performance.
Our business depends on both the availability of suitable films for exhibition in our theatres and the success of those films in our markets. Reduced volume of film releases, poor performance of films, the disruption in the production of films due to events such as a strike by directors, writers or actors, a reduction in financing options for the film distributors, or a reduction in the production and marketing efforts of the film distributors to make and promote their films could have an adverse effect on our business by resulting in fewer patrons and reduced revenues.
Our results of operations fluctuate on a seasonal basis.
Our results of operations vary from period to period based upon the quantity and quality of the motion pictures that we show in our theatres. The major film distributors generally release the films they anticipate will be most successful during the summer and holiday seasons. Consequently, we typically generate higher revenues during these periods. The timing of releases, however, has become less pronounced as distributors have begun releasing content more evenly throughout the year. In our Latin American markets, while Hollywood content has similar release dates as in the U.S., the local holidays and seasons can vary. The unexpected emergence of a successful film during other periods or the failure of an expected success at a key time could alter this seasonality trend. Due to the dependency on the success of films released from one period to the next, results of operations for one period may not be indicative of the results for the following period or the same period in the following year.
12
A deterioration in relationships with film distributors could adversely affect our ability to obtain commercially successful films.
We rely on the film distributors to supply the films shown in our theatres. The film distribution business is highly concentrated, with six major film distributors accounting for approximately 80% of U.S. box office revenues and 40 of the top 50 grossing films during 2019. Numerous antitrust cases and consent decrees resulting from the antitrust cases impact the distribution of films. Film distributors license films to exhibitors on a theatre-by-theatre and film-by-film basis. Consequently, we cannot guarantee a supply of films by entering into long-term arrangements with major distributors. We are therefore required to negotiate licenses for each film and for each theatre. A deterioration in our relationship with any of the major film distributors could adversely affect our ability to obtain commercially successful films and to negotiate favorable licensing terms for such films, both of which could adversely affect our business and operating results.
We face intense competition for patrons and films which may adversely affect our business.
The motion picture exhibition industry is highly competitive. We compete against local, regional, national and international exhibitors in many of our markets. We compete for both patrons and licensing of films. In markets where we do not face nearby competitive theatres, there is a risk of new theatres being built. The degree of competition for patrons is dependent upon such factors as location, theatre capacity, presentation quality, film showtime availability, customer service quality, products and amenities offered, and ticket prices. The principal competitive factors with respect to film licensing include the theatre’s location and its demographics, the condition, capacity and grossing potential of each theatre, and licensing terms. We also face competition from new concept theatres such as dine-in theatres and tavern style theatres that open in close proximity to our conventional theatres. If we are unable to attract patrons or to license successful films, our business may be adversely affected.
An increase in competing forms of entertainment or the use of alternative film distribution channels may reduce movie theatre attendance and limit revenue growth.
We compete with other forms of out-of-home entertainment, such as family entertainment centers, concerts, theme parks, gaming and sporting events, for our patrons’ leisure time and disposable income. We also face competition for patrons from a number of alternative film distribution channels, such as digital downloads, video on-demand, DVDs, pay television, network and syndicated television, and streaming video on demand. Some of these distribution channels have seen growth in production in recent years. A significant increase in popularity of these alternative film distribution channels, competing forms of entertainment or improvements in technologies available at home could have an adverse effect on our business and results of operations.
Our results of operations may be impacted by shrinking video and digital release windows.
The average video and digital release window, which represents the time that elapses from the date of a film’s theatrical release to the date a film is available for DVD has been approximately ninety days for the past several years. If patrons choose to wait for an in-home release rather than attend a theatre to view the film, it may adversely impact our business and results of operations, financial condition and cash flows. These release windows, which are determined by the studios, may shrink further or be eliminated altogether, which could have an adverse impact on our business and results of operations.
General political, social, health and economic conditions can adversely affect our attendance.
Our results of operations are dependent on general political, social, health and economic conditions, and the impact of such conditions on our theatre operating costs and on the willingness of consumers to spend money at movie theatres. If consumers’ discretionary income declines during a period of an economic downturn or political uncertainty, our operations could be adversely affected. If theatre operating costs, such as utility costs, increase due to political or economic changes, our results of operations could be adversely affected. Political events, such as terrorist attacks, and health-related epidemics, such as flu outbreaks, could cause people to avoid our theatres or other public places where large crowds are in attendance, which could adversely affect our results of operations. In addition, a natural disaster, such as a hurricane or an earthquake, could impact our ability to operate certain of our theatres, which could adversely affect our results of operations.
13
Our foreign operations are subject to adverse regulations, economic instability and currency exchange risk.
We have 209 theatres with 1,487 screens in fifteen countries in Latin America. Brazil represented approximately 9% of our consolidated 2019 revenues. Governmental regulation of the motion picture industry in foreign markets differs from that in the U.S. Changes in regulations affecting prices and quota systems requiring the exhibition of locally-produced films may adversely affect our international operations. Our international operations are subject to certain political, economic and other uncertainties not encountered by our domestic operations, including risks of severe economic downturns and high inflation. We also face risks of currency fluctuations, hard currency shortages and controls of foreign currency exchange and cash transfers to the U.S., all of which could have an adverse effect on the results of our operations.
We have substantial long-term lease and debt obligations, which may restrict our ability to fund current and future operations and that restrict our ability to enter into certain transactions.
We have, and will continue to have, significant long-term debt service obligations and long-term lease obligations. As of December 31, 2019, we had $1,801.3 million in long-term debt obligations, $156.4 million in finance lease obligations and $1,440.9 million in long-term operating lease obligations. Our substantial lease and debt obligations pose risk by:
|
• |
requiring us to dedicate a substantial portion of our cash flows to payments on our lease and debt obligations, thereby reducing the availability of our cash flows from operations to fund working capital, capital expenditures, acquisitions and other corporate requirements and to pay dividends; |
|
• |
impeding our ability to obtain additional financing in the future for working capital, capital expenditures, acquisitions and general corporate purposes; |
|
• |
subjecting us to the risk of increased sensitivity to interest rate increases on our variable rate debt, including our borrowings under our senior secured credit facility; |
|
• |
limiting our ability to invest in innovations in technology and implement new platforms or concepts in our theatres; and |
|
• |
making us more vulnerable to a downturn in our business and competitive pressures and limiting our flexibility to plan for, or react to, changes in our industry or the economy. |
Our ability to make scheduled payments of principal and interest with respect to our indebtedness will depend on our ability to generate positive cash flows and on our future financial results. Our ability to generate positive cash flows is subject to general economic, financial, competitive, regulatory and other factors that are beyond our control. We may not be able to continue to generate cash flows at current levels, or guarantee that future borrowings will be available under our senior secured credit facility, in an amount sufficient to enable us to pay our indebtedness. If our cash flows and capital resources are insufficient to fund our lease and debt service obligations, we may be forced to reduce or delay capital expenditures, sell assets or operations, seek additional capital or restructure or refinance our indebtedness. We may not be able to take any of these actions, and these actions may not be successful or permit us to meet our scheduled debt service obligations and these actions may be restricted under the terms of our existing or future debt agreements, including our senior secured credit facility.
If we fail to make any required payment under the agreements governing our leases and indebtedness or fail to comply with the financial and operating covenants contained in them, we would be in default, and as a result, our debt holders would have the ability to require that we immediately repay our outstanding indebtedness and the lenders under our senior secured credit facility could terminate their commitments to lend us money and foreclose against the assets securing their borrowings. We could be forced into bankruptcy or liquidation. The acceleration of our indebtedness under one agreement may permit acceleration of indebtedness under other agreements that contain cross-default and cross-acceleration provisions. If our indebtedness is accelerated, we may not be able to repay our indebtedness or borrow sufficient funds to refinance it. Even if we are able to obtain new financing, it may not be on commercially reasonable terms or on terms that are acceptable to us. If our debt holders require immediate payment, we may not have sufficient assets to satisfy our obligations under our indebtedness.
14
We are rated by nationally recognized rating agencies. The rating scales and methodologies used to derive individual ratings may vary from agency to agency. Credit ratings are issued by credit rating agencies based on evaluations of our ability to pay back our outstanding debt and the likelihood that we would default on that debt prior to its maturity. The credit ratings issued by the rating agencies represent the rating agency's evaluation of both qualitative and quantitative information for our company. The credit ratings that are issued are based on the rating agency’s judgment and experience in determining what information should be considered in giving a rating to a particular company. Ratings are always subject to change and there can be no assurance that our current ratings will continue for any given period of time. A downgrade of our debt ratings, depending on the extent, could increase the cost to borrow funds.
A failure to adapt to future technological innovations could impact our ability to compete effectively and could adversely affect our results of operations.
While we continue to invest in technological innovations, such as motion seats and satellite distribution technologies, new technological innovations continue to impact our industry. If we are unable to respond to or invest in changes in technology and the technological preferences of our customers, we may not be able to compete with other exhibitors or other entertainment venues, which could adversely affect our results of operations.
We are subject to uncertainties relating to future expansion plans, including our ability to identify suitable acquisition candidates or new theatre site locations, and to obtain financing for such activities on favorable terms or at all.
We have greatly expanded our operations over the last decade through targeted worldwide theatre development and acquisitions. We continue to pursue a strategy of expansion that will involve the development of new theatres and may involve acquisitions of existing theatres and theatre circuits both in the U.S. and internationally. There is significant competition for new site locations and for existing theatre and theatre circuit acquisition opportunities. As a result of such competition, we may not be able to acquire attractive site locations, existing theatres or theatre circuits on terms we consider acceptable. The pace of our growth may also be impacted by delays in site development caused by other parties. Acquisitions and expansion opportunities may divert a significant amount of management’s time away from the operation of our business. Growth by acquisition also involves risks relating to difficulties in integrating the operations and personnel of acquired companies and the potential loss of key employees of acquired companies. Our expansion strategy may not result in improvements to our business, financial condition, profitability, or cash flows. Further, our expansion programs may require financing above our existing borrowing capacity and operating cash flows. We may not be able to obtain such financing or ensure that such financing will be available to us on acceptable terms or at all.
If we do not comply with the ADA and the safe harbor framework included in the consent order we entered into with the Department of Justice, or the DOJ, we could be subject to further litigation.
Our theatres must comply with Title III of the ADA and analogous state and local laws. Compliance with the ADA requires among other things that public facilities “reasonably accommodate” individuals with disabilities and that new construction or alterations made to “commercial facilities” conform to accessibility guidelines unless “structurally impracticable” for new construction or technically infeasible for alterations. On November 15, 2004, Cinemark and the DOJ entered into a consent order, which was filed with the U.S. District Court for the Northern District of Ohio, Eastern Division. Under the consent order, the DOJ approved a safe harbor framework for us to construct all of our future stadium-style movie theatres. The DOJ has stipulated that all theatres built in compliance with the consent order will comply with the wheelchair seating requirements of the ADA. If we fail to comply with the ADA, remedies could include imposition of injunctive relief, fines, awards for damages to private litigants and additional capital expenditures to remedy non-compliance. Imposition of significant fines, damage awards or capital expenditures to cure non-compliance could adversely affect our business and operating results.
We may be subject to increased labor and benefits costs.
In the U.S., we are subject to United States federal and state laws governing such matters as minimum wages, working conditions and overtime. We are also subject to union regulations in certain of our international markets, which can specify wage rates as well as minimum hours to be paid to certain employees. As federal and state minimum wage rates increase, we may need to increase not only the wages of our minimum wage employees, but also the wages paid to employees at wage rates that are above minimum wage. Labor shortages, increased employee turnover and health care mandates could also increase our labor costs. This in turn could lead us to increase prices,
15
which could impact our sales. Conversely, if competitive pressures or other factors prevent us from offsetting increased labor costs by increases in prices, our results of operations may be adversely impacted.
A credit market crisis may adversely affect our ability to raise capital and may materially impact our operations.
Severe dislocations and liquidity disruptions in the credit markets could materially impact our ability to obtain debt financing on reasonable terms or at all. The inability to access debt financing on reasonable terms could materially impact our ability to make acquisitions, invest in technology innovations or significantly expand our business in the future.
Our ability to pay dividends may be limited or otherwise restricted.
Our ability to pay dividends is limited by our status as a holding company and the terms of our senior notes indentures and our senior secured credit facility, which restrict our ability to pay dividends and the ability of certain of our subsidiaries to pay dividends, directly or indirectly, to us. Under our debt instruments, we may pay a cash dividend up to a specified amount, provided we have satisfied certain financial covenants in, and are not in default under, our debt instruments. The declaration of future dividends on our common stock, par value $0.001 per share, or Common Stock, will be at the discretion of our board of directors and will depend upon many factors, including our results of operations, financial condition, earnings, capital requirements, limitations in our debt agreements and legal requirements.
Provisions in our corporate documents and certain agreements, as well as Delaware law, may hinder a change of control.
Provisions in our amended and restated certificate of incorporation and bylaws, as well as provisions of the Delaware General Corporation Law, could discourage unsolicited proposals to acquire us. These provisions include:
|
• |
authorization of our board of directors to issue shares of preferred stock without stockholder approval; |
|
• |
a board of directors classified into three classes of directors with the directors of each class having staggered, three-year terms; |
|
• |
provisions regulating the ability of our stockholders to nominate directors for election or to bring matters for action at annual meetings of our stockholders; and |
|
• |
provisions of Delaware law that restrict many business combinations and provide that directors serving on classified boards of directors, such as ours, may be removed only for cause. |
Certain provisions of our 4.875% senior notes indenture, our 5.125% senior notes indenture and our senior secured credit facility may have the effect of delaying or preventing future transactions involving a “change of control.” A “change of control” would require us to make an offer to the holders of each of our 4.875% senior notes and our 5.125% senior notes to repurchase all of the outstanding notes at a purchase price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest to the date of purchase. A “change of control” would also be an event of default under our senior secured credit facility.
Future sales of our Common Stock may adversely affect the prevailing market price.
If a large number of shares of our Common Stock is sold in the open market, or if there is a perception that such sales will occur, the trading price of our Common Stock could decrease. In addition, the sale of these shares could impair our ability to raise capital through the sale of additional Common Stock. As of December 31, 2019, we had an aggregate of 170,002,126 shares of our Common Stock authorized but unissued and not reserved for specific purposes. In general, we may issue all of these shares without any action or approval by our stockholders. We may issue shares of our Common Stock in connection with acquisitions.
As of December 31, 2019, we had 117,151,656 shares of our Common Stock outstanding. Of these shares, approximately 106,116,920 shares were freely tradable. The remaining shares of our Common Stock were “restricted securities” as that term is defined in Rule 144 under the Securities Act. Restricted securities may not be resold in a public distribution except in compliance with the registration requirements of the Securities Act or
16
pursuant to an exemption therefrom, including the exemptions provided by Regulation S and Rule 144 promulgated under the Securities Act.
We cannot predict whether substantial amounts of our Common Stock will be sold in the open market in anticipation of, or following, any divestiture by any of our large stockholders, our directors or executive officers of their shares of Common Stock.
As of December 31, 2019, there were 7,384,464 shares of our Common Stock reserved for issuance under our 2017 Omnibus Incentive Plan.
Legislative or regulatory initiatives related to global warming/climate change concerns may negatively impact our business.
Recently, there has been an increasing focus and continuous debate on global climate change including increased attention from regulatory agencies and legislative bodies. This increased focus may lead to new initiatives directed at regulating an as yet unspecified array of environmental matters. Legislative, regulatory or other efforts in the U.S. to combat climate change could result in future increases in the cost of raw materials, taxes, transportation and utilities for our vendors and for us which would result in higher operating costs for the Company. Also, compliance of our theatres and accompanying real estate with new and revised environmental, zoning, land-use or building codes, laws, rules or regulations, could have a material and adverse effect on our business. However, we are unable to predict at this time, the potential effects, if any, that any future environmental initiatives may have on our business.
We may be subject to liability under environmental laws and regulations.
We own and operate a large number of theatres and other properties within the U.S. and internationally, which may be subject to various foreign, federal, state and local laws and regulations relating to the protection of the environment or human health. Such environmental laws and regulations include those that impose liability for the investigation and remediation of spills or releases of hazardous materials. We may incur such liability, including for any currently or formerly owned, leased or operated property, or for any site, to which we may have disposed, or arranged for the disposal of, hazardous materials or wastes. Certain of these laws and regulations may impose liability, including on a joint and several liability, which can result in a liable party being obliged to pay for greater than its share, regardless of fault or the legality of the original disposal. Environmental conditions relating to our properties or operations could have an adverse effect on our business and results of operations and cash flows.
Cyber security threats and our failure to protect our electronically stored data could adversely affect our business.
We collect, use, store and maintain electronic information and data necessary to conduct our business, including confidential and proprietary information of the company, our customers, and our employees. We also rely on the availability of information technology systems to operate our business, including for communications, receiving and displaying movies, ticketing, guest services, payments, and other general operations. We rely on some of our vendors to store and process certain data and to manage, host, and/or provide some of our information technology systems. Because of the scope and complexity of our information technology systems, our reliance on vendors to provide, support and protect our systems and data, and the constantly evolving cyber-threat landscape, our information technology systems are subject to the risk of disruption, failure, unauthorized access, cyber-terrorism, human error, misuse, tampering, theft, and other cyber-attacks. These or similar events, whether accidental or intentional, could result in theft, unauthorized access or disclosure, loss, fraudulent or unlawful use of customer, employee or company data, which could harm our reputation or result in a loss of business, as well as remedial and other costs, fines, investigations, enforcement actions or lawsuits. These or similar events could also lead to an interruption in the operation of our systems resulting in business impact, including loss of business. Those same scope, complexity, reliance, and changing cyber-threat landscape factors could also affect our ability to adapt to and comply with changing regulations and contractual obligations applicable to data security and privacy, which are increasingly demanding, both in the United States and in other jurisdictions where we operate. In order to address these risks, we have adopted security measures and technology, operate a security program, and work continuously to evaluate and improve our security posture. However, the development and maintenance of these
17
systems and programs are costly and require ongoing monitoring and updating as technologies change and efforts to overcome security measures become more sophisticated. As such, there can be no assurance that these or similar events will not occur in the future or will not have an adverse effect on our business and results of operation. In addition to Company-specific cyber threats or events, our business and results of operations could also be impacted by cyber-related events affecting our peers and partners within the entertainment industry, as well as other retail companies. We maintain insurance designed to provide coverage for cyber risks related to what we believe to be adequate and collectible insurance in the event of the theft, loss, fraudulent or unlawful use of customer, employee or company data, but the foregoing events or future events could result in costs and business impacts which may not be covered or may be in excess of any available insurance that we may have procured. As a result, future events could have a material impact on our business and adversely affect our financial condition and results of operations.
Product recalls and associated costs could adversely affect our reputation and financial condition.
We may be found liable if the consumption of any of the products we sell causes illness or injury. We are also subject to recall by product manufacturers or if the food products become contaminated. Recalls could result in losses due to the cost of the recall, the destruction of the product and lost sales due to the unavailability of the product for a period of time.
Changes in privacy laws could adversely affect our ability to market our products effectively.
We rely on a variety of direct and indirect (through various third parties) marketing techniques. Any expansion on existing and/or new laws and regulations regarding marketing, solicitation or data protection could adversely affect the continuing effectiveness of our marketing techniques. This could result in changes to our marketing strategy which could adversely impact our attendance levels and revenues.
We are subject to complex taxation and could be subject to changes in our tax rates, the adoption of new U.S. or international tax legislation or exposure to additional tax liabilities.
We are subject to many different forms of taxation both in the U.S. and in the foreign jurisdictions where we operate. The tax authorities may not agree with the determinations that we made and such disagreements could result in lengthy legal disputes and, ultimately, in the payment of substantial amounts for tax, interest and penalties, which could have a material impact on our results. Additionally, current economic and political conditions make tax rates in any jurisdiction, including the U.S., subject to significant change. Our future effective tax rates could be affected by changes in the mix of earnings in countries with differing statutory tax rates, changes in the valuation of deferred tax assets and liabilities, or changes in tax laws or their interpretation. If the Company’s effective tax rates were to increase, or if the ultimate determination of the Company’s taxes owed in the U.S. or foreign jurisdictions is for an amount in excess of amounts previously accrued, the Company’s operating results, cash flows, and financial condition could be adversely affected.
We may not be able to generate additional revenues or continue to realize value from our investment in NCM.
As of December 31, 2019, we owned 39,737,700 common units of NCM, which represented an ownership interest in NCM of approximately 25%. We receive monthly theatre access and advertising fees under our Exhibitor Services Agreement with NCM and we are entitled to receive mandatory quarterly distributions of excess cash from NCM. During the years ended December 31, 2017, 2018 and 2019, the Company received approximately $11.3 million, $12.1 million and $13.8 million in other revenues from NCM, respectively, $17.4 million, $22.2 million and $25.9 million in cash distributions recorded as a reduction of our investment in NCM, respectively, and $16.4 million $15.4 million and $12.9 million in cash distributions in excess of our investment in NCM, respectively. Cinema advertising is a small component of the U.S. advertising market and therefore, NCM competes with larger, more established and well known media platforms such as broadcast radio and television, cable and satellite television, outdoor advertising and Internet portals. In-theatre advertising may not continue to attract advertisers or NCM’s in-theatre advertising format may not continue to be received favorably by theatre patrons. If NCM is unable to continue to generate consistent advertising revenues, its results of operations may be adversely affected and our investment in and distributions and revenues from NCM may be adversely impacted.
Each of our common units in NCM is convertible into one share of NCM, Inc. common stock. As of December 31, 2019, the estimated fair value of our investment in NCM was approximately $289.7 million based on
18
NCM, Inc.’s stock price as of December 31, 2019 of $7.29 per share. The market value of NCM, Inc.’s stock price may vary due to the performance of the business, industry trends, general and economic conditions and other factors. If NCM, Inc.’s stock price declines below our carrying value for an extended period of time, we may record an impairment in our investment.
We are subject to impairment losses due to potential declines in the fair value of our assets.
We have a significant amount of long-lived assets. We evaluate long-lived assets for impairment at the theatre level. Therefore, if a theatre is directly and individually impacted by increased competition, adverse changes in market demographics, or adverse changes in the development or condition of the areas surrounding the theatre, we may record impairment charges to reflect the decline in estimated fair value of that theatre.
We also have a significant amount of goodwill and tradename intangible assets. Declines in our stock price or market capitalization, declines in our attendance due to increased competition in certain regions and/or countries or economic factors that lead to a decline in attendance in any given region or country could result in impairments of goodwill and our intangible assets.
Item 1B. Unresolved Staff Comments
None.
Item 2. Properties
The following table sets forth a summary of our theatres in U.S. and international markets as of December 31, 2019:
|
|
Leased |
|
|
Owned |
|
||
Segment |
|
Theatres |
|
|
Theatres |
|
||
U.S. |
|
|
302 |
|
|
|
43 |
|
International |
|
|
209 |
|
|
|
— |
|
Total |
|
|
511 |
|
|
|
43 |
|
The Company conducts a significant part of its theatre operations in leased properties under noncancelable operating and finance leases with terms generally ranging from 10 to 25 years. In addition to fixed lease payments, some of the leases provide for variable lease payments and some require the payment of taxes, insurance and other costs applicable to the property. Variable lease payments include payments based on a percentage of retail sales over contractual levels or payments adjusted periodically for inflation or changes in attendance. The Company can renew, at its option, a substantial portion of the leases at defined or then market rental rates for various periods. Some leases also provide for escalating rent payments throughout the lease term. See Note 3 for further discussion of our property leases.
In addition to our theatre properties, we currently own an office building in Plano, Texas, which is our worldwide headquarters. We lease office space in Frisco, Texas for theatre support and a warehouse in McKinney, TX. We also lease office space in seven regions in Latin America for our local management.
Item 3. Legal Proceedings
Intertrust Technologies Corporation (“Intertrust”) v. Cinemark Holdings, Inc., Regal, AMC, et al. This case was filed against the Company on August 7, 2019 in the Eastern District of Texas – Marshall Division alleging patent infringement. The Company firmly maintains that the contentions of the Plaintiff are without merit and will vigorously defend itself against the lawsuit. Although the Company does not believe that it has infringed on any of Intertrust’s patents, it cannot predict the outcome of this litigation.
Flagship Theatres of Palm Desert, LLC d/b/a Cinemas Palme D’Or v. Century Theatres, Inc., and Cinemark USA, Inc.; Superior Court of the State of California, County of Los Angeles. Plaintiff in this case alleges that we violated California antitrust and unfair competition laws by engaging in “circuit dealing” with various motion picture distributors and tortiously interfered with Plaintiff’s business relationships. Plaintiff seeks compensatory
19
damages, trebling of those damages under California law, punitive damages, injunctive relief, attorneys’ fees, costs and interest. Plaintiff also alleges that our conduct ultimately resulted in closure of its theatre in June 2016. We denied the allegations. In 2008, we moved for summary judgment on Plaintiff’s claims, arguing primarily that clearances between the theatres at issue were lawful and that Plaintiff lacked proof sufficient to support certain technical elements of its antitrust claims. The trial court granted that motion and dismissed Plaintiff’s claims. Plaintiff appealed and, in 2011, the Court of Appeal reversed, holding, among other things, that Plaintiff’s claims were not about the illegality of clearances but were focused, instead, on “circuit dealing.” Having re-framed the claims in that manner, the Court of Appeal held that the trial court’s decision to limit discovery to the market where the theatres at issue operated was an error, as “circuit dealing” necessarily involves activities in different markets. Upon return to the trial court, the parties engaged in additional, broadened discovery related to Plaintiff’s “circuit dealing” claim. Thereafter, we moved again for summary judgment on all of Plaintiff’s claims. That new motion for summary judgment was pending when, on or about April 11, 2014, the trial court granted our motion for terminating sanctions and entered a judgment dismissing the case with prejudice. Plaintiff then appealed that second dismissal, seeking to have the judgment reversed and the case remanded to the trial court. The Court of Appeal issued a ruling on May 24, 2016, reversing the granting of terminating sanctions and instead imposed a lesser evidentiary and damages preclusion sanction. The case returned to the trial court on October 6, 2016. On May 10, 2018, after a five-week jury trial, the jury found no liability on one circuit dealing claim and awarded Plaintiff damages on the other claim, which are tripled for antitrust damage awards. Plaintiff would also be entitled to certain court costs and to seek at least some portion of its attorney’s fees. During 2018, we recorded a litigation reserve based on the jury award, court costs and attorney’s fees. The trial court denied a motion for a judgment notwithstanding the verdict and a motion for a new trial. We have appealed the judgment. Although we deny that we engaged in any form of circuit dealing, we cannot predict the outcome of our pending motions or future appeals.
Civil Investigative Demand. We received a Civil Investigative Demand (“CID”) from the Antitrust Division of the United States Department of Justice. The CID relates to an investigation under Sections 1 and 2 of the Sherman Act. The Company also received CIDs from the Antitrust Section of the Office of the Attorney General of the State of Ohio and later from other states regarding similar inquiries under state antitrust laws. The CIDs request us to answer interrogatories, and produce documents, or both, related to the investigation of matters including film clearances, potential coordination and/or communication with other major theatre circuits and related joint ventures. We to fully cooperate with all federal and state government agencies. Although we do not believe that we have violated any federal or state antitrust or competition laws, we cannot predict the ultimate scope, duration or outcome of these investigations.
From time to time, we are involved in other various legal proceedings arising from the ordinary course of business operations, such as personal injury claims, employment matters, landlord-tenant disputes, patent claims and contractual disputes, some of which are covered by insurance or by indemnification from vendors. We believe our potential liability with respect to these types of proceedings currently pending is not material, individually or in the aggregate, to our financial position, results of operations and cash flows.
20
PART II
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Market Information
Our common equity consists of common stock, which has traded on the New York Stock Exchange since April 24, 2007 under the symbol “CNK."
Holders of Common Stock
As of December 31, 2019, there were 492 holders of record of the Company’s common stock and there were no other classes of stock issued and outstanding.
Dividend Policy
We, at the discretion of the board of directors and subject to applicable law, anticipate paying regular quarterly dividends on our common stock. The amount, if any, of the dividends to be paid in the future will depend upon our then available cash, anticipated cash needs, overall financial condition, loan agreement restrictions, future prospects for earnings and cash flows, as well as other relevant factors. See Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operation – Liquidity and Capital Resources – Financing Activities for a discussion of dividend restrictions under our debt agreements.
See Note 6 to our consolidated financial statements for a detail of dividends paid during the years ended December 31, 2017, 2018 and 2019.
Performance Graph
The performance graph is incorporated by reference to the Company’s proxy statement for its annual stockholders meeting to be held on May 21, 2020 and to be filed with the SEC within 120 days after December 31, 2019.
Securities Authorized for Issuance under Equity Compensation Plans
Information regarding securities authorized for issuance under the Company’s long-term compensation plan is incorporated by reference to the Company’s proxy statement for its annual stockholders meeting to be held on May 21, 2020 and to be filed with the SEC within 120 days after December 31, 2019.
21
Item 6. Selected Financial Data
The following table provides our selected consolidated financial and operating data for the periods and at the dates indicated for each of the five most recent years ended December 31, 2019. You should read the selected consolidated financial and operating data set forth below in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our audited consolidated financial statements and related notes appearing elsewhere in this report. We adopted ASC Topic 606, Revenue Recognition, effective January 1, 2018 (see Note 4 to the consolidated financial statements for related disclosures). We adopted ASC Topic 842, Leases, effective January 1, 2019 (see Note 3 to the consolidated financial statements for a summary of the impact of adoption).
|
|
Year Ended December 31, |
|
|||||||||||||||||
|
|
2015 |
|
|
2016 |
|
|
2017 |
|
|
2018 |
|
|
2019 |
|
|||||
Statement of Income Data: |
|
(Dollars in thousands, except per share data) |
|
|||||||||||||||||
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Admissions |
|
$ |
1,765,519 |
|
|
$ |
1,789,137 |
|
|
$ |
1,794,982 |
|
|
$ |
1,834,173 |
|
|
$ |
1,805,321 |
|
Concession |
|
|
936,970 |
|
|
|
990,103 |
|
|
|
1,038,788 |
|
|
|
1,108,793 |
|
|
|
1,161,083 |
|
Other |
|
|
150,120 |
|
|
|
139,525 |
|
|
|
157,777 |
|
|
|
278,769 |
|
|
|
316,695 |
|
Total revenues |
|
|
2,852,609 |
|
|
|
2,918,765 |
|
|
|
2,991,547 |
|
|
|
3,221,735 |
|
|
|
3,283,099 |
|
Film rentals and advertising |
|
|
945,640 |
|
|
|
962,655 |
|
|
|
966,510 |
|
|
|
999,755 |
|
|
|
1,003,832 |
|
Concession supplies |
|
|
144,270 |
|
|
|
154,469 |
|
|
|
166,320 |
|
|
|
180,974 |
|
|
|
206,441 |
|
Salaries and wages |
|
|
301,099 |
|
|
|
325,765 |
|
|
|
354,510 |
|
|
|
383,860 |
|
|
|
410,086 |
|
Facility lease expense |
|
|
319,761 |
|
|
|
321,294 |
|
|
|
328,197 |
|
|
|
323,316 |
|
|
|
346,094 |
|
Utilities and other |
|
|
355,801 |
|
|
|
355,926 |
|
|
|
355,041 |
|
|
|
448,070 |
|
|
|
474,711 |
|
General and administrative expenses |
|
|
156,736 |
|
|
|
143,355 |
|
|
|
153,278 |
|
|
|
165,173 |
|
|
|
173,384 |
|
Depreciation and amortization |
|
|
189,206 |
|
|
|
209,071 |
|
|
|
237,513 |
|
|
|
261,162 |
|
|
|
261,155 |
|
Impairment of long-lived assets |
|
|
8,801 |
|
|
|
2,836 |
|
|
|
15,084 |
|
|
|
32,372 |
|
|
|
57,001 |
|
Loss on disposal of assets and other |
|
|
8,143 |
|
|
|
20,459 |
|
|
|
22,812 |
|
|
|
38,702 |
|
|
|
12,008 |
|
Total cost of operations |
|
$ |
2,429,457 |
|
|
$ |
2,495,830 |
|
|
$ |
2,599,265 |
|
|
$ |
2,833,384 |
|
|
$ |
2,944,712 |
|
Operating income |
|
$ |
423,152 |
|
|
$ |
422,935 |
|
|
$ |
392,282 |
|
|
$ |
388,351 |
|
|
$ |
338,387 |
|
Interest expense |
|
$ |
112,741 |
|
|
$ |
108,313 |
|
|
$ |
105,918 |
|
|
$ |
109,994 |
|
|
$ |
99,941 |
|
Net income |
|
$ |
218,728 |
|
|
$ |
256,827 |
|
|
$ |
266,019 |
|
|
$ |
215,305 |
|
|
$ |
193,848 |
|
Net income attributable to Cinemark Holdings, Inc. |
|
$ |
216,869 |
|
|
$ |
255,091 |
|
|
$ |
264,180 |
|
|
$ |
213,827 |
|
|
$ |
191,386 |
|
Net income attributable to Cinemark Holdings, Inc. per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
1.87 |
|
|
$ |
2.19 |
|
|
$ |
2.26 |
|
|
$ |
1.83 |
|
|
$ |
1.63 |
|
Diluted |
|
$ |
1.87 |
|
|
$ |
2.19 |
|
|
$ |
2.26 |
|
|
$ |
1.83 |
|
|
$ |
1.63 |
|
Cash dividends declared per common share |
|
$ |
1.00 |
|
|
$ |
1.08 |
|
|
$ |
1.16 |
|
|
$ |
1.28 |
|
|
$ |
1.36 |
|
|
|
Year Ended December 31, |
|
|||||||||||||||||
|
|
2015 |
|
|
2016 |
|
|
2017 |
|
|
2018 |
|
|
2019 |
|
|||||
|
|
(Dollars in thousands) |
|
|||||||||||||||||
Other Financial Data: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flow provided by (used for): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating activities |
|
$ |
455,871 |
|
|
$ |
462,910 |
|
|
$ |
528,998 |
|
|
$ |
556,915 |
|
|
$ |
561,995 |
|
Investing activities |
|
|
(328,122 |
) |
|
|
(327,769 |
) |
|
|
(410,476 |
) |
|
|
(451,370 |
) |
|
|
(310,642 |
) |
Financing activities |
|
|
(151,147 |
) |
|
|
(163,711 |
) |
|
|
(158,008 |
) |
|
|
(192,648 |
) |
|
|
(186,506 |
) |
Capital expenditures |
|
|
(331,726 |
) |
|
|
(326,908 |
) |
|
|
(380,862 |
) |
|
|
(346,073 |
) |
|
|
(303,627 |
) |
22
|
|
As of December 31, |
|
|||||||||||||||||
|
|
2015 |
|
|
2016 |
|
|
2017 |
|
|
2018 |
|
|
2019 |
|
|||||
|
|
(Dollars in thousands) |
|
|||||||||||||||||
Balance Sheet Data: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
588,539 |
|
|
$ |
561,235 |
|
|
$ |
522,547 |
|
|
$ |
426,222 |
|
|
$ |
488,313 |
|
Theatre properties and equipment, net |
|
|
1,505,069 |
|
|
|
1,704,536 |
|
|
|
1,828,054 |
|
|
|
1,833,133 |
|
|
|
1,735,247 |
|
Total assets |
|
|
4,126,497 |
|
|
|
4,306,633 |
|
|
|
4,470,893 |
|
|
|
4,481,838 |
|
|
|
5,828,017 |
|
Total long-term debt, including current portion, net of unamortized debt issue costs |
|
|
1,781,335 |
|
|
|
1,788,112 |
|
|
|
1,787,480 |
|
|
|
1,780,611 |
|
|
|
1,777,937 |
|
Equity |
|
|
1,110,813 |
|
|
|
1,272,960 |
|
|
|
1,405,688 |
|
|
|
1,408,570 |
|
|
|
1,448,322 |
|
|
|
Year Ended December 31, |
|
|||||||||||||||||
Operating Data: |
|
2015 |
|
|
2016 |
|
|
2017 |
|
|
2018 |
|
|
2019 |
|
|||||
United States |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Theatres operated (at period end) |
|
|
337 |
|
|
|
339 |
|
|
|
339 |
|
|
|
341 |
|
|
|
345 |
|
Screens operated (at period end) |
|
|
4,518 |
|
|
|
4,559 |
|
|
|
4,561 |
|
|
|
4,586 |
|
|
|
4,645 |
|
Total attendance (in 000s) |
|
|
179,601 |
|
|
|
182,660 |
|
|
|
174,432 |
|
|
|
185,268 |
|
|
|
176,162 |
|
International |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Theatres operated (at period end) |
|
|
176 |
|
|
|
187 |
|
|
|
194 |
|
|
|
205 |
|
|
|
209 |
|
Screens operated (at period end) |
|
|
1,278 |
|
|
|
1,344 |
|
|
|
1,398 |
|
|
|
1,462 |
|
|
|
1,487 |
|
Total attendance (in 000s) |
|
|
100,499 |
|
|
|
104,581 |
|
|
|
102,584 |
|
|
|
96,847 |
|
|
|
103,409 |
|
Worldwide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Theatres operated (at period end) |
|
|
513 |
|
|
|
526 |
|
|
|
533 |
|
|
|
546 |
|
|
|
554 |
|
Screens operated (at period end) |
|
|
5,796 |
|
|
|
5,903 |
|
|
|
5,959 |
|
|
|
6,048 |
|
|
|
6,132 |
|
Total attendance (in 000s) |
|
|
280,100 |
|
|
287,241 |
|
|
|
277,016 |
|
|
|
282,115 |
|
|
|
279,571 |
|
23
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis should be read in conjunction with the financial statements and accompanying notes included in this report. This discussion contains forward-looking statements. See “Cautionary Statement Regarding Forward-Looking Statements” and “Risk Factors” for a discussion of the uncertainties and risk associated with these statements. Discussion regarding our financial condition and results of operations for 2018 compared to 2017 is included in Item 7 of our 2018 Annual Report on Form 10-K filed February 28, 2019.
Overview
We are a leader in the motion picture exhibition industry, with theatres in the U.S., Brazil, Argentina, Chile, Colombia, Ecuador, Peru, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay. As of December 31, 2019, we managed our business under two reportable operating segments – U.S. markets and international markets. See Note 20 to the consolidated financial statements.
Revenues and Expenses
We generate revenues primarily from filmed entertainment box office receipts and concession sales with additional revenues from screen advertising and screen rental revenue and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals and electronic video games located in some of our theatres. We also offer alternative entertainment, such as the Metropolitan Opera, concert events, in-theatre gaming, live and pre-recorded sports programs and other special events in our theatres through Fathom Entertainment (operated by AC JV, LLC). National Cinemedia (“NCM”) provides our domestic theatres with various forms of in-theatre advertising. Our Flix Media subsidiaries provide screen advertising and alternative content for our international circuit and to other international exhibitors.
Films leading the box office during the year ended December 31, 2019 included Avengers: Endgame, Star Wars: Episode IX, Frozen 2,The Lion King, Toy Story 4, Captain Marvel, SpiderMan: Far from Home, Aladdin, Joker, It: Chapter Two, Us, Fast & Furious Presents: Hobbs & Shaw, John Wick: Chapter 3 – Parabellum, and Jumanji: The Next Level, among other films.
Films scheduled for release during 2020 include Bad Boys for Life, Onward, A Quiet Place: Part 2, Mulan, No Time to Die, Black Widow, Fast & Furious 9, Wonder Woman 1984, Soul, Top Gun: Maverick, Minions: The Rise of Gru, Jungle Cruise, The King’s Man, The Eternals and Raya and the Last Dragon, among other films.
Film rental costs are variable in nature and fluctuate with our admissions revenues. Film rental costs as a percentage of revenues are generally higher for periods in which more blockbuster films are released. The Company also receives virtual print fees from studios for certain of its international locations, which are included as a contra-expense in film rentals and advertising costs; however, these costs are expected to be fully recovered in 2020. Advertising costs, which are expensed as incurred, are primarily related to campaigns for new and remodeled theatres, loyalty and membership programs and brand advertising that vary depending on the timing of such campaigns.
Concession supplies expense is variable in nature and fluctuates with our concession revenues and product mix. We negotiate prices for concession supplies directly with concession vendors and manufacturers to obtain volume rates.
Although salaries and wages include a fixed cost component (i.e. the minimum staffing costs to operate a theatre facility during non-peak periods), salaries and wages tend to move in relation to revenues as theatre staffing is adjusted to respond to changes in attendance. In certain locations, staffing levels are also subject to local regulations.
Facility lease expense is primarily a fixed cost at the theatre level as most of our facility leases require a fixed monthly minimum rent payment. Certain leases are subject to percentage rent only, while others are subject to percentage rent in addition to their fixed monthly rent if a target annual performance level is achieved. Facility lease expense as a percentage of revenues is also affected by the number of theatres under operating leases, the number of theatres under capital and finance leases and the number of owned theatres.
24
Utilities and other costs include both fixed and variable costs and primarily consist of utilities, property taxes, janitorial costs, credit card fees, third party ticket sales commissions, repairs and maintenance expenses, security services and expenses for projection and sound equipment maintenance and monitoring.
General and administrative expenses are primarily fixed in nature and consist of the costs to support the overall management of the Company, including salaries and wages, incentive compensation and benefit costs for our corporate office personnel, facility expenses for our corporate offices, consulting fees, legal fees, audit fees, supplies and other costs that are not specifically associated with the operations of our theatres.
Critical Accounting Policies
We prepare our consolidated financial statements in conformity with generally accepted accounting principles in the U.S., or U.S. GAAP. As such, we are required to make certain estimates and assumptions that we believe are reasonable based upon the information available. These estimates and assumptions affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. The significant accounting policies, which we believe are the most critical to aid in fully understanding and evaluating our reported consolidated financial results, include the following:
Revenue and Expense Recognition
In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606), (“ASC Topic 606”), which outlines how an entity should recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. ASC Topic 606 replaced most existing revenue recognition guidance in U.S. generally accepted accounting principles. We adopted ASC Topic 606 effective January 1, 2018 under the modified retrospective method.
Our patrons have the option to purchase movie tickets well in advance of a movie showtime or right before the movie showtime, or at any point in between those two timeframes depending on seat availability. We recognize such admissions revenues when the showtime for a purchased movie ticket has passed. Concession revenues are recognized when products are sold to the consumer. Other revenues primarily consist of screen advertising and screen rental revenues, promotional income, studio trailer placements and transactional fees. We sell gift cards and discount ticket vouchers, the proceeds from which are recorded as deferred revenues. Deferred revenues for gift cards and discount ticket vouchers are recognized when they are redeemed for movie tickets or concession items. We offer a subscription program in the U.S. whereby patrons can pay a monthly fee to receive a monthly credit for use towards a future movie ticket purchase. We record the monthly subscription program fees as deferred revenues and record admissions revenues when the showtime for a movie ticket purchased with a credit has passed. We have loyalty programs in the U.S. and many of our international locations that either have a prepaid annual membership fee or award points to customers as purchases are made. For those loyalty programs that have an annual membership fee, we recognize the fee collected as other revenues on a straight-line basis over the term of the membership. For those loyalty programs that award points to customers based on their purchases, we record a portion of the original transaction proceeds as deferred revenues based on the number of reward points issued to customers and we recognize the deferred revenues when the customer redeems such points. The value of loyalty points issued is based on the estimated fair value of the rewards offered. The Company records breakage revenue on gift cards and discount ticket vouchers generally based on redemption activity and historical experience with unused balances. The Company records breakage revenue upon the expiration of loyalty points and subscription credits. Breakage revenue is recorded as other revenues on the consolidated income statements. Advances collected on concession and other contracts are deferred and recognized during the period in which we satisfy the related performance obligations, which may differ from the period in which the advances are collected. These advances are recognized on either a straight-line basis over the term of the contracts or as we meet our performance obligations in accordance with the terms of the contracts.
Film rental costs are subject to the film licensing arrangement and accrued based on the applicable box office receipts and either; 1) a sliding scale formula, which is generally established prior to the opening of the film, 2) firm terms or 3) estimates of the final settlement rate, which occurs at the conclusion of the film run. Under a sliding scale formula, we pay a percentage of box office revenues using a pre-determined matrix that is based upon box
25
office performance of the film for its full run. Under a firm terms formula, we pay the distributor a percentage of box office receipts, which reflects either an aggregate rate for the life of the film or rates that decline over the term of the run. The settlement process allows for negotiation of film rental fees upon the conclusion of the film run based upon how the film performs. Estimates are based on the expected success of a film. The success of a film can typically be determined a few weeks after a film is released when the initial box office performance of the film is known. If actual settlements are different than those estimates, film rental costs are adjusted at that time.
Our advertising costs are expensed as incurred.
Facility lease expense is primarily a fixed cost at the theatre level as most of our facility leases require a fixed monthly minimum rent payment. Certain of our leases are subject to monthly percentage rent only, which is accrued each month based on actual revenues. Certain of our other theatres require payment of percentage rent in addition to fixed monthly rent if an annual target revenue level is achieved. Percentage rent expense is estimated and recorded for these theatres on a monthly basis if the theatre’s historical performance or forecasted performance indicates that the annual target revenue level will be reached. Once annual revenues are known, which is generally at the end of the year, the percentage rent expense is adjusted at that time.
In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), (“ASC Topic 842”). The purpose of ASC Topic 842 is to provide financial statement users a better understanding of the amount, timing, and uncertainty of cash flows arising from leases. The adoption of ASU 2016-02 resulted in the recognition of a right-of-use asset and a lease liability for most operating leases. We adopted ASC Topic 842 as of January 1, 2019 under the modified retrospective approach that resulted in the recognition of a cumulative-effect adjustment to the opening balance of retained earnings and elected certain practical expedients. See Note 3 to the financial statements for additional discussion.
Theatre properties and equipment are depreciated using the straight-line method over their estimated useful lives. In estimating the useful lives of our theatre properties and equipment, we have relied upon our experience with such assets and our historical replacement period. We periodically evaluate these estimates and assumptions and adjust them as necessary. Leasehold improvements for which we pay and to which we have title are amortized over the lesser of useful life or the lease term.
Impairment of Long-Lived Assets
We review long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. We also perform a full quantitative impairment evaluation on an annual basis. We assess many factors including the following to determine whether to impair individual theatre assets:
|
• |
actual theatre level cash flows; |
|
• |
budgeted theatre level cash flows; |
|
• |
theatre property and equipment carrying values; |
|
• |
operating lease right-of-use asset carrying values; |
|
• |
amortizing intangible asset carrying values; |
|
• |
the age of a recently built theatre; |
|
• |
competitive theatres in the marketplace; |
|
• |
the impact of recent ticket price changes; |
|
• |
the impact of recent theatre remodels or other substantial improvements; |
|
• |
available lease renewal options; and |
|
• |
other factors considered relevant in our assessment of impairment of individual theatre assets. |
26
Long-lived assets are evaluated for impairment on a theatre basis, which we believe is the lowest applicable level for which there are identifiable cash flows. The impairment evaluation is based on the estimated undiscounted cash flows from continuing use through the remainder of the theatre’s useful life. The remainder of the theatre’s useful life correlates with the remaining lease period, which includes the probability of the exercise of available renewal periods for leased properties, and the lesser of twenty years or the building’s remaining useful life for owned properties. If the estimated undiscounted cash flows are not sufficient to recover a long-lived asset’s carrying value, we then compare the carrying value of the asset group (theatre) with its estimated fair value. When estimated fair value is determined to be lower than the carrying value of the asset group (theatre), the asset group (theatre) is written down to its estimated fair value. Significant judgment is involved in estimating cash flows and fair value. Fair value is determined based on a multiple of cash flows, which was six and a half times for the evaluations performed during 2017, 2018 and 2019. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on historical and projected operating performance, recent market transactions and current industry trading multiples. The long-lived asset impairment charges recorded during each of the periods presented are specific to theatres that were directly and individually impacted by increased competition, adverse changes in market demographics, or adverse changes in the development or the conditions of the areas surrounding the theatre.
Impairment of Goodwill and Intangible Assets
We evaluate goodwill for impairment annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value of the goodwill may not be fully recoverable. We evaluate goodwill for impairment at the reporting unit level and we have allocated goodwill to the reporting unit based on an estimate of its relative fair value. Management considers the reporting unit to be each of its twenty regions in the U.S. and seven of its international countries with Honduras, El Salvador, Nicaragua, Costa Rica, Panama and Guatemala considered one reporting unit (the Company does not have goodwill recorded for all of its international locations). Under ASC Topic 350, Goodwill, Intangibles and Other (“ASC Topic 350”), we may perform a qualitative impairment assessment or a quantitative impairment assessment of our goodwill.
A quantitative analysis requires us to estimate the fair value of each reporting unit and compare it with its carrying value. If the carrying value of the reporting unit exceeds its estimated fair value, goodwill would be written down such that the carrying value would equal estimated fair value. Fair value is determined based on a multiple of cash flows, which was eight times for the evaluations performed during 2017, 2018 and 2019. Significant judgment is involved in estimating cash flows and fair value. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on historical and projected operating performance, recent market transactions and current industry trading multiples. A qualitative assessment includes consideration of historical and expected future industry performance, estimated future performance of the Company, current industry trading multiples and other economic factors, and a review of current carrying values compared to estimated fair values as determined during our most recent quantitative assessment.
We performed a quantitative goodwill impairment analysis for all reporting units during the year ended December 31, 2017. For the year ended December 31, 2018, we performed a quantitative goodwill assessment for three new domestic reporting units and a qualitative assessment for all other reporting units. We performed a qualitative goodwill impairment analysis for all reporting units during the year ended December 31, 2019. As of December 31, 2019, the estimated fair value of our goodwill for each reporting unit exceeded its carrying value by more than 10%. We did not record any goodwill impairment charges as a result of the assessments performed during the years ended December 31, 2017, 2018 and 2019.
Tradename intangible assets are tested for impairment at least annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value may not be fully recoverable. Under ASC Topic 350, we can elect to perform a qualitative or quantitative impairment assessment for our tradename intangible assets. A quantitative tradename impairment assessment includes comparing the carrying values of tradename assets to an estimated fair value. Fair values are estimated by applying an estimated market royalty rate that could be charged for the use of our tradename to forecasted future revenues, with an adjustment for the present value of such royalties. If the estimated fair value is less than the carrying value, the tradename intangible asset is written down to its estimated fair value. Significant judgment is involved in estimating market royalty rates and long-term revenue
27
forecasts. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on historical and projected revenue performance and industry trends. A qualitative assessment considers our historical and forecasted revenues and changes in estimated royalty rates, and a comparison of current carrying values to estimated fair values from our most recent quantitative assessment.
During the year ended December 31, 2017, we performed quantitative tradename impairment evaluations for all tradename assets. During the years ended December 31, 2018 and 2019, we performed qualitative tradename impairment analyses. As a result of the analysis performed during each year, no impairment charges were recorded related to tradename intangible assets for the years ended December 31, 2017, 2018 and 2019.
Income Taxes
We use an asset and liability approach to financial accounting and reporting for income taxes. Deferred income taxes are provided when tax laws and financial accounting standards differ with respect to the amount of income for a year and the basis of assets and liabilities. A valuation allowance is recorded to reduce the carrying amount of deferred tax assets unless it is more likely than not that such assets will be realized. Income taxes are provided on unremitted earnings from foreign subsidiaries unless such earnings are expected to be indefinitely reinvested. Income taxes have also been provided for potential tax assessments. The evaluation of an uncertain tax position is a two-step process. The first step is recognition: We determine whether it is more likely than not that a tax position will be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. In evaluating whether a tax position has met the more-likely-than-not recognition threshold, we presume that the position would be examined by the appropriate taxing authority that would have full knowledge of all relevant information. The second step is measurement: A tax position that meets the more-likely-than-not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured at the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. Differences between tax positions taken in a tax return and amounts recognized in the financial statements result in (1) a change in a liability for income taxes payable or (2) a change in an income tax refund receivable, a deferred tax asset or a deferred tax liability or both (1) and (2). We accrue interest and penalties on uncertain tax positions. See “Impact of Recent Accounting Developments” below.
Accounting for Investment in National CineMedia, LLC and Related Agreements
We have an investment in NCM. NCM operates a digital in-theatre network in the U.S. for providing cinema advertising and non-film events. Upon joining NCM, we entered into an Exhibitor Services Agreement (“ESA”), with NCM pursuant to which NCM provides advertising, promotion and event services to our theatres. On February 13, 2007, National CineMedia, Inc., or NCM Inc., a newly formed entity that serves as a member and the sole manager of NCM, completed an initial public offering of its common stock. In connection with the NCM Inc. initial public offering, we amended our operating agreement and the Exhibitor Services Agreement, or ESA, with NCM and received proceeds related to the modification of the ESA and our sale of certain of shares in NCM. The ESA modification reflected a shift from circuit share expense under the prior Exhibitor Services Agreement, which obligated NCM to pay us a percentage of revenue, to a monthly theatre access fee, which significantly reduced the contractual amounts paid to the Company by NCM. The Company recorded the proceeds related to the ESA modification as deferred revenue. As a result of the proceeds received as part of the NCM, Inc. initial public offering, the Company had a negative basis in its original membership units in NCM (referred to herein as its Tranche 1 Investment). The Company does not recognize undistributed equity in the earnings on its Tranche 1 Investment until NCM's future net earnings, less distributions received, surpass the amount of the excess distribution. The Company recognizes equity in earnings on its Tranche 1 Investment only to the extent it receives cash distributions from NCM. The Company believes that the accounting model provided by ASC 323-10-35-22 for recognition of equity investee losses in excess of an investor's basis is analogous to the accounting for equity income subsequent to recognizing an excess distribution.
Pursuant to a Common Unit Adjustment Agreement dated as of February 13, 2007 between NCM, Inc. and Cinemark, AMC and Regal, collectively referred to as its Founding Members, annual adjustments to the common membership units are made primarily based on increases or decreases in the number of theatre screens operated and theatre attendance generated by each Founding Member. To account for the receipt of additional common units under the Common Unit Adjustment Agreement, the Company follows the guidance in ASC 323-10-35-29 (formerly EITF 02-18, Accounting for Subsequent Investments in an Investee after Suspension of Equity Loss
28
Recognition) by analogy, which also refers to AICPA Technical Practice Aid 2220.14, which indicates that if a subsequent investment is made in an equity method investee that has experienced significant losses, the investor must determine if the subsequent investment constitutes funding of prior losses. The Company concluded that the construction or acquisition of new theatres that has led to the common unit adjustments equates to making additional investments in National CineMedia. The Company evaluated the receipt of the additional common units in National CineMedia and the assets exchanged for these additional units and has determined that the right to use its incremental new screens would not be considered funding of prior losses. The Company accounts for these additional common units (referred to herein as its Tranche 2 Investment) as a separate investment than its Tranche 1 Investment. The common units received are recorded at fair value as an increase in the Company’s investment in NCM with an offset to deferred revenue. The deferred revenue is amortized over the remaining term of the ESA. The Tranche 2 Investment is accounted for following the equity method, with undistributed equity earnings related to its Tranche 2 Investment included as a component of equity in income of affiliates and distributions received related to its Tranche 2 Investment are recorded as a reduction of its investment basis.
Impact of Recent Accounting Developments
Impact of New Lease Accounting Standard
We adopted ASC Topic 842 as of January 1, 2019 under the modified retrospective approach that resulted in the recognition of a cumulative-effect adjustment to the opening balance of retained earnings. We elected the following practical expedients, as allowed by ASC Topic 842:
|
• |
We chose not to separate nonlease components from lease components, accounting for lease components and nonlease components associated with a lease as a single lease component. More specifically, for theatre leases, we elected not to separate fixed common area maintenance costs from lease costs when calculating lease liabilities and assets. |
|
• |
We did not reassess whether existing contracts in effect as of the transition date of January 1, 2019 were, or contained, a lease. |
|
• |
We did not reassess the classification of existing leases as operating or finance as of the transition date. |
|
• |
We did not reassess whether any initial direct costs were incurred for any of its existing leases. |
|
• |
We did not elect to apply the recognition requirements of ASC 842 to short-term leases. |
The adoption of ASC Topic 842 included the following primary impacts:
|
1. |
We recorded a right-of-use asset and lease liability for all of our operating leases as required by the standard. The lease liability for each lease was determined based on the present value of future minimum lease payments. The right-of-use asset was based on the lease liability value, adjusted for offsets that existed as of adoption, including deferred rent liabilities of ($39.2 million), net favorable and unfavorable lease intangibles of ($5.8 million), deferred lease incentive liabilities of ($13.0 million) and long-term prepaid rents of $7.7 million. We recorded operating lease right-of-use assets of $1,491.2 million and operating lease liabilities of $1,545.2 million upon adoption. |
|
2. |
Certain of our existing lease assets and liabilities, which were accounted for under prior sale-leaseback accounting guidance, were derecognized in accordance with ASC Topic 842 and reevaluated for classification per the new accounting guidance. Several of these leases have been reestablished as operating leases based on ASC Topic 842. |
|
a. |
For those leases that are now classified as operating leases in accordance with ASC Topic 842, approximately $110.4 million and $126.4 million of lease assets and liabilities, respectively, were recorded as an adjustment to beginning retained earnings. The related net deferred income tax asset for these accounts was also recorded as an adjustment to beginning retained earnings. See additional impact discussed in item 3 below. |
|
b. |
We recognized finance lease assets and liabilities in the amount of $57.4 million as of January 1, 2019 for the remaining leases that were determined to be finance leases under ASC Topic 842. |
29
|
3. |
For the leases noted in item 2a above, we now record the related operating lease payments as facility lease expense, compared to prior periods in which the capitalized asset was depreciated and lease payments were recorded as a reduction of a lease liability and interest expense. |
Recent Developments
On February 21, 2020, our board of directors approved a cash dividend for the fourth quarter of 2019 of $0.36 per share of common stock is payable to stockholders of record on March 6, 2020, and will be paid on March 20, 2020.
30
Results of Operations
The following table sets forth, for the periods indicated, the amounts for certain items reflected in our consolidated statements of income along with each of those items as a percentage of revenues.
|
|
Year Ended December 31, |
|
|||||||||
|
|
2017 |
|
|
2018 |
|
|
2019 |
|
|||
Operating data (in millions): |
|
|
|
|
|
|
|
|
|
|
|
|
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
Admissions |
|
$ |
1,795.0 |
|
|
$ |
1,834.2 |
|
|
$ |
1,805.3 |
|
Concession |
|
|
1,038.8 |
|
|
|
1,108.8 |
|
|
|
1,161.1 |
|
Other |
|
|
157.8 |
|
|
|
278.8 |
|
|
|
316.7 |
|
Total revenues |
|
$ |
2,991.6 |
|
|
$ |
3,221.8 |
|
|
$ |
3,283.1 |
|
Cost of operations |
|
|
|
|
|
|
|
|
|
|
|
|
Film rentals and advertising |
|
|
966.5 |
|
|
|
999.8 |
|
|
|
1,003.8 |
|
Concession supplies |
|
|
166.3 |
|
|
|
181.0 |
|
|
|
206.5 |
|
Salaries and wages |
|
|
354.5 |
|
|
|
383.9 |
|
|
|
410.1 |
|
Facility lease expense |
|
|
328.2 |
|
|
|
323.3 |
|
|
|
346.1 |
|
Utilities and other |
|
|
355.0 |
|
|
|
448.0 |
|
|
|
474.7 |
|
General and administrative expenses |
|
|
153.3 |
|
|
|
165.2 |
|
|
|
173.4 |
|
Depreciation and amortization |
|
|
237.5 |
|
|
|
261.2 |
|
|
|
261.2 |
|
Impairment of long-lived assets |
|
|
15.1 |
|
|
|
32.4 |
|
|
|
57.0 |
|
Loss on disposal of assets and other |
|
|
22.8 |
|
|
|
38.7 |
|
|
|
12.0 |
|
Total cost of operations |
|
|
2,599.2 |
|
|
|
2,833.5 |
|
|
|
2,944.8 |
|
Operating income |
|
$ |
392.4 |
|
|
$ |
388.3 |
|
|
$ |
338.3 |
|
Operating data as a percentage of total revenues: |
|
|||||||||||
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
Admissions |
|
|
60.0 |
% |
|
|
56.9 |
% |
|
|
55.0 |
% |
Concession |
|
|
34.7 |
% |
|
|
34.4 |
% |
|
|
35.4 |
% |
Other |
|
|
5.3 |
% |
|
|
8.7 |
% |
|
|
9.6 |
% |
Total revenues |
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
100.0 |
% |
Cost of operations (1) |
|
|
|
|
|
|
|
|
|
|
|
|
Film rentals and advertising |
|
|
53.8 |
% |
|
|
54.5 |
% |
|
|
55.6 |
% |
Concession supplies |
|
|
16.0 |
% |
|
|
16.3 |
% |
|
|
17.8 |
% |
Salaries and wages |
|
|
11.9 |
% |
|
|
11.9 |
% |
|
|
12.5 |
% |
Facility lease expense |
|
|
11.0 |
% |
|
|
10.0 |
% |
|
|
10.5 |
% |
Utilities and other |
|
|
11.9 |
% |
|
|
13.9 |
% |
|
|
14.5 |
% |
General and administrative expenses |
|
|
5.1 |
% |
|
|
5.1 |
% |
|
|
5.3 |
% |
Depreciation and amortization |
|
|
7.9 |
% |
|
|
8.1 |
% |
|
|
8.0 |
% |
Impairment of long-lived assets |
|
|
0.5 |
% |
|
|
1.0 |
% |
|
|
1.7 |
% |
Loss on disposal of assets and other |
|
|
0.8 |
% |
|
|
1.2 |
% |
|
|
0.4 |
% |
Total cost of operations |
|
|
86.9 |
% |
|
|
87.9 |
% |
|
|
89.7 |
% |
Operating income |
|
|
13.1 |
% |
|
|
12.1 |
% |
|
|
10.3 |
% |
Average screen count (month end average) |
|
|
5,925 |
|
|
|
5,997 |
|
|
|
6,072 |
|
Revenues per average screen (dollars) |
|
$ |
504,902 |
|
|
$ |
537,224 |
|
|
$ |
540,695 |
|
(1) |
All costs are expressed as a percentage of total revenues, except film rentals and advertising, which are expressed as a percentage of admissions revenues and concession supplies, which are expressed as a percentage of concession revenues. |
31
Comparison of Years Ended December 31, 2019 and December 31, 2018
Revenues. Total revenues increased $61.3 million to $3,283.1 million for 2019 from $3,221.8 million for 2018, representing a 1.9% increase. The table below, presented by reportable operating segment, summarizes our year-over-year revenue performance and certain key performance indicators that impact our revenues.
|
|
U.S. Operating Segment |
|
|
International Operating Segment |
|
|
Consolidated |
|
|||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Constant Currency (3) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
2019 |
|
|
2018 |
|
|
% Change |
|
|
2019 |
|
|
2018 |
|
|
% Change |
|
|
2019 |
|
|
% Change |
|
|
2019 |
|
|
2018 |
|
|
% Change |
|
|||||||||||
Admissions revenues (1) |
|
$ |
1,431.8 |
|
|
$ |
1,461.2 |
|
|
|
(2.0 |
)% |
|
$ |
373.5 |
|
|
$ |
373.0 |
|
|
|
0.1 |
% |
|
$ |
434.9 |
|
|
|
16.6 |
% |
|
$ |
1,805.3 |
|
|
$ |
1,834.2 |
|
|
|
(1.6 |
)% |
Concession revenues (1) |
|
$ |
936.2 |
|
|
$ |
892.4 |
|
|
|
4.9 |
% |
|
$ |
224.9 |
|
|
$ |
216.4 |
|
|
|
3.9 |
% |
|
$ |
258.6 |
|
|
|
19.5 |
% |
|
$ |
1,161.1 |
|
|
$ |
1,108.8 |
|
|
|
4.7 |
% |
Other revenues (1)(2) |
|
$ |
212.9 |
|
|
$ |
185.4 |
|
|
|
14.8 |
% |
|
$ |
103.8 |
|
|
$ |
93.4 |
|
|
|
11.1 |
% |
|
$ |
123.7 |
|
|
|
32.4 |
% |
|
$ |
316.7 |
|
|
$ |
278.8 |
|
|
|
13.6 |
% |
Total revenues (1)(2) |
|
$ |
2,580.9 |
|
|
$ |
2,539.0 |
|
|
|
1.7 |
% |
|
$ |
702.2 |
|
|
$ |
682.8 |
|
|
|
2.8 |
% |
|
$ |
817.2 |
|
|
|
19.7 |
% |
|
$ |
3,283.1 |
|
|
$ |
3,221.8 |
|
|
|
1.9 |
% |
Attendance (1) |
|
|
176.2 |
|
|
|
185.3 |
|
|
|
(4.9 |
)% |
|
|
103.4 |
|
|
|
96.8 |
|
|
|
6.8 |
% |
|
|
|
|
|
|
|
|
|
|
279.6 |
|
|
|
282.1 |
|
|
|
(0.9 |
)% |
Average ticket price (1) |
|
$ |
8.13 |
|
|
$ |
7.89 |
|
|
|
3.0 |
% |
|
$ |
3.61 |
|
|
$ |
3.85 |
|
|
|
(6.2 |
)% |
|
$ |
4.21 |
|
|
|
9.4 |
% |
|
$ |
6.46 |
|
|
$ |
6.50 |
|
|
|
(0.6 |
)% |
Concession revenues per patron (1) |
|
$ |
5.31 |
|
|
$ |
4.82 |
|
|
|
10.2 |
% |
|
$ |
2.18 |
|
|
$ |
2.24 |
|
|
|
(2.7 |
)% |
|
$ |
2.50 |
|
|
|
11.6 |
% |
|
$ |
4.15 |
|
|
$ |
3.93 |
|
|
|
5.6 |
% |
(1) |
Revenue and attendance amounts in millions. Average ticket price is calculated as admissions revenues divided by attendance. Concession revenues per patron is calculated as concession revenues divided by attendance. |
(2) |
U.S. operating segment revenues include eliminations of intercompany transactions with the international operating segment. See Note 20 of our consolidated financial statements. |
(3) |
Constant currency revenue amounts, which are non-GAAP measurements, were calculated using the average exchange rates for the corresponding months for 2018. We translate the results of our international operating segment from local currencies into U.S. dollars using currency rates in effect at different points in time. Significant changes in foreign exchange rates from one period to the next can result in meaningful variations in reported results. We are providing constant currency amounts for our international operating segment to present a period-to-period comparison of business performance without the impact of foreign currency fluctuations. |
• |
U.S. Admissions revenues decreased $29.4 million primarily due to a 4.9% decrease in attendance, partially offset by a 3.0% increase in average ticket price. The decrease in attendance was due to the relative consumer appeal of films during 2019 compared to 2018, partially offset by new theatres. The increase in average ticket price was primarily due to price increases, partially offset by the impact of the deferral of admissions revenues for loyalty points issued. Concession revenues increased $43.8 million primarily due to a 10.2% increase in concession revenues per patron, partially offset by the 4.9% decline in attendance. Concession revenues per patron grew primarily due to incremental sales of traditional concession products, continued expansion of concession offerings and price increases. Other revenues increased $27.5 million primarily due to increases in transactional fees and promotional activity. |
• |
International. Admissions revenues increased $0.5 million as reported (increased $61.9 million in constant currency) primarily due to a 6.8% increase in attendance, partially offset by a 6.2% decrease in average ticket price (average ticket price increased 9.4% in constant currency). Attendance increased due to the relative consumer appeal of films during 2019 compared to 2018 and new theatres. Concession revenues increased $8.5 million as reported ($42.2 million in constant currency) primarily due to the 6.8% increase in attendance, partially offset by a 2.7% decrease in concession revenues per patron (concession revenues per patron increased 11.6% in constant currency). Average ticket price and concession revenues per patron decreased, as reported, primarily due to the impact of changes in foreign currency exchange rates in certain countries in which we operate. Other revenues grew $10.4 million as reported ($30.3 million in constant currency) primarily due to increases in screen advertising, transactional fees and promotional activity, partially offset by the impact of changes in foreign currency exchange rates in certain countries in which we operate. |
32
Cost of Operations. The table below summarizes certain of our theatre operating costs by reportable operating segment (in millions) for the years ended December 31, 2018 and 2019.
|
|
U.S. Operating Segment |
|
|
International Operating Segment |
|
|
Consolidated |
|
|||||||||||||||||||
|
|
2019 |
|
|
2018 |
|
|
2019 |
|
|
2018 |
|
|
Constant Currency 2019 (1) |
|
|
2019 |
|
|
2018 |
|
|||||||
Film rentals and advertising |
|
$ |
819.6 |
|
|
$ |
822.6 |
|
|
$ |
184.2 |
|
|
$ |
177.2 |
|
|
$ |
214.5 |
|
|
$ |
1,003.8 |
|
|
$ |
999.8 |
|
Concession supplies |
|
|
156.9 |
|
|
|
134.6 |
|
|
|
49.6 |
|
|
|
46.4 |
|
|
|
57.1 |
|
|
|
206.5 |
|
|
|
181.0 |
|
Salaries and wages |
|
|
331.2 |
|
|
|
303.7 |
|
|
|
78.9 |
|
|
|
80.2 |
|
|
|
93.2 |
|
|
|
410.1 |
|
|
|
383.9 |
|
Facility lease expense |
|
|
259.8 |
|
|
|
245.1 |
|
|
|
86.3 |
|
|
|
78.2 |
|
|
|
97.4 |
|
|
|
346.1 |
|
|
|
323.3 |
|
Utilities and other |
|
|
348.2 |
|
|
|
327.0 |
|
|
|
126.5 |
|
|
|
121.0 |
|
|
|
147.6 |
|
|
|
474.7 |
|
|
|
448.0 |
|
(1) |
Constant currency expense amounts, which are non-GAAP measurements, were calculated using the average exchange rates for the corresponding months for 2018. We translate the results of our international operating segment from local currencies into U.S. dollars using currency rates in effect at different points in time. Significant changes in foreign exchange rates from one period to the next can result in meaningful variations in reported results. We are providing constant currency amounts for our international operating segment to present a period-to-period comparison of business performance without the impact of foreign currency fluctuations. |
• |
U.S. Film rentals and advertising costs were $819.6 million, or 57.2% of admissions revenues, for 2019 compared to $822.6 million, or 56.3% of admissions revenues, for 2018. The increase in the film rentals and advertising rate was primarily due to a higher concentration of blockbuster films during 2019 compared to 2018 and increased promotional expenses. Concession supplies expense was $156.9 million, or 16.8% of concession revenues, for 2019 compared to $134.6 million, or 15.1% of concession revenues, for 2018. The increase in the concessions supplies rate was primarily driven by expanded food and beverage offerings that helped drive concession per patron growth but created an adverse mix effect. |
Salaries and wages increased to $331.2 million for 2019 from $303.7 million for 2018 primarily due to increases in minimum and other wage rates across many states in which we operate, as well as staffing for new theatres and varied in-theatre consumer initiatives. Facility lease expense increased to $259.8 million for 2019 from $245.1 million for 2018 primarily due to new theatres and an increase of $11.2 million from the impact of the adoption of ASC Topic 842 (see Note 3 to the consolidated financial statements for further discussion). Utilities and other costs increased to $348.2 million for 2019 from $327.0 million for 2018 due to increased third party ticket sales commissions, property taxes, janitorial service costs, credit card fees and gift card commission expenses.
• |
International. Film rentals and advertising costs were $184.2 million ($214.5 million in constant currency), or 49.3% of admissions revenues, for 2019 compared to $177.2 million, or 47.5% of admissions revenues, for 2018. The increase in the film rentals and advertising rate was primarily due to a higher concentration of blockbuster films during 2019 compared to 2018, a decrease in virtual print fees received from distributors as the costs of digital projectors become fully reimbursed in certain countries and increased promotion expenses. Concession supplies expense was $49.6 million ($57.1 million in constant currency), or 22.1% of concession revenues, for 2019 compared to $46.4 million, or 21.4% of concession revenues, for 2018. The increase in the concession supplies rate was primarily due to promotional activities and the mix of premium concession products sold. |
Salaries and wages decreased to $78.9 million (increased to $93.2 million in constant currency) for 2019 from $80.2 million for 2018. The as reported decrease was primarily due to the impact of changes in foreign currency exchange rates in certain countries in which we operate, partially offset by increased local currency wages that were primarily driven by inflation and the impact of new theatres. Facility lease expense increased to $86.3 million (increased to $97.4 million in constant currency) for 2019 from $78.2 million for 2018. The as reported increase was due to a $10.3 million impact associated with the adoption of ASC Topic 842 (see Note 3 to the consolidated financial statements for further discussion), higher percentage rent due to an increase in revenues in local currency and incremental base rent from new theatres, partially offset by the impact of changes in foreign currency exchange rates in certain countries in which we operate. Utilities and other costs increased to $126.5 million ($147.6 million in constant currency) for 2019 from $121.0 million for 2018. The as reported increase was primarily due to increased commissions related to expanded screen advertising
33
revenues and third party ticket sales commissions and credit card fees, partially offset by the impact of changes in foreign currency exchange rates in certain countries in which we operate.
General and Administrative Expenses. General and administrative expenses increased to $173.4 million for 2019 from $165.2 million for 2018. The increase was primarily due to increases in salaries and wages, incentive compensation and increased cloud-based software costs, which were partially offset by decreased legal fees and the impact of changes in foreign currency exchange rates in certain countries in which we operate.
Depreciation and Amortization. Depreciation and amortization expense was $261.2 million for 2019 and 2018. The increase related to theatre remodels and new theatres was offset by a $13.4 million impact from the adoption of ASC Topic 842 (see Note 3 to the consolidated financial statements for further discussion).
Impairment of Long-Lived Assets. We recorded asset impairment charges on assets held and used of $57.0 million for 2019 compared to $32.4 million for 2018. Impairment charges for 2019 consisted of theatre properties in seven countries and impairment charges for 2018 consisted of theatre properties in five countries. The long-lived asset impairment charges recorded during each of the periods presented were for certain new concept theatres being developed and tested by us and other theatres that were individually impacted by increased competition, adverse changes in market demographics, or adverse changes in the development or the conditions of the areas surrounding the theatre. See Notes 1 and 10 to our consolidated financial statements.
Loss on Disposal of Assets and Other. We recorded a loss on disposal of assets and other of $12.0 million during 2019 compared to $38.7 million during 2018. Activity for 2019 was primarily due to the retirement of assets related to theatre remodels. Activity for 2018 was primarily due to the retirement of assets related to theatre remodels and the accrual of reserves for pending litigation (see Note 19 to the consolidated financial statements).
Interest Expense. Interest costs incurred, including amortization of debt issue costs, were $100.0 million for 2019 compared to $110.0 million for 2018. The decrease was primarily due to a $9.5 million impact from the adoption of ASC Topic 842 (see Note 3 to the consolidated financial statements for further discussion). See also Note 12 to our consolidated financial statements for discussion of our long-term debt and our interest rate swap agreements.
Loss on Debt Amendments and Refinancing. We recorded a loss of $1.5 million during 2018 related to amendments to our senior secured credit facility that included a reduction in the interest rates applicable to the term loan and revolving credit line, revisions to certain definitions within the agreement, and an extension of the maturity of the revolving credit line. See Note 12 to our consolidated financial statements for discussion of our long-term debt.
Foreign Currency Exchange Loss. We recorded a foreign currency exchange loss of $3.4 million during 2019 and a foreign currency exchange loss of $11.7 million during 2018 primarily related to intercompany transactions and changes in exchange rates from original transaction dates until cash settlement. See Notes 1 and 14 to our consolidated financial statements for discussion of foreign currency translation.
Distributions from NCM. We recorded distributions received from NCM of $12.9 million during 2019 and $15.4 million during 2018, which were in excess of the carrying value of our Tranche 1 Investment. See Note 7 to our consolidated financial statements.
Interest expense – NCM. We recorded non-cash interest expense of $28.6 million during 2019 compared to $19.7 million during 2018 related to the significant financing component associated with revenues collected in advance under certain of our agreements with NCM. See Note 4 to our consolidated financial statements for further discussion of ASC Topic 606 and Note 7 for a summary of all activity with NCM.
Equity in Income of Affiliates. We recorded equity in income of affiliates of $41.9 million during 2019 and $39.2 million during 2018. See Notes 7 and 8 to our consolidated financial statements for information about our equity investments.
34
Income Taxes. Income tax expense of $79.9 million was recorded for 2019 compared to $95.4 million recorded for 2018. The effective tax rate for 2019 was 29.2%. The effective tax rate for 2018 was 30.7%, which included a net charge, as a result of the Tax Act and its related guidance, of $19.2 million, all non-cash. See Note 18 to our consolidated financial statements for further information on our income tax expense.
Liquidity and Capital Resources
Operating Activities
We primarily collect our revenues in cash, mainly through box office receipts and the sale of concessions. Our revenues are generally received in cash prior to the payment of related expenses, therefore we have an operating “float” and historically have not required traditional working capital financing. Cash provided by operating activities amounted to $556.9 million and $562.0 million for the years ended December 31, 2018 and 2019, respectively.
Investing Activities
Our investing activities have been principally related to the development, remodel and acquisition of theatres. New theatre openings, remodels and acquisitions historically have been financed with internally generated cash and by debt financing, including borrowings under our senior secured credit facility. Cash used for investing activities amounted to $451.4 million and $310.6 million for the years ended December 31, 2018 and 2019, respectively. The decrease in cash used for investing activities for 2019 was primarily due to the acquisition of NCM common units (see Note 7) for $78.4 million that occurred during 2018 and a decrease in capital expenditures.
Capital expenditures for the years ended December 31, 2018 and 2019 were as follows (in millions):
Period |
|
New Theatres |
|
|
Existing Theatres |
|
|
Total |
|
|||
Year Ended December 31, 2018 |
|
$ |
80.7 |
|
|
$ |
265.4 |
|
|
$ |
346.1 |
|
Year Ended December 31, 2019 |
|
$ |
87.6 |
|
|
$ |
216.0 |
|
|
$ |
303.6 |
|
We operated 554 theatres with 6,132 screens worldwide as of December 31, 2019. Theatres and screens acquired, built and closed during the year ended December 31, 2019 were as follows:
|
|
January 1, 2019 |
|
|
Built |
|
|
Acquired |
|
|
Closed |
|
|
December 31, 2019 |
|
|||||
U.S. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Theatres |
|
|
341 |
|
|
|
5 |
|
|
|
2 |
|
|
|
(3) |
|
|
|
345 |
|
Screens |
|
|
4,586 |
|
|
|
58 |
|
|
|
30 |
|
|
|
(29) |
|
|
|
4,645 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
International |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Theatres |
|
|
205 |
|
|
|
6 |
|
|
|
— |
|
|
|
(2) |
|
|
|
209 |
|
Screens |
|
|
1,462 |
|
|
|
39 |
|
|
|
— |
|
|
|
(14) |
|
|
|
1,487 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Worldwide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Theatres |
|
|
546 |
|
|
|
11 |
|
|
|
2 |
|
|
|
(5) |
|
|
|
554 |
|
Screens |
|
|
6,048 |
|
|
|
97 |
|
|
|
30 |
|
|
|
(43) |
|
|
|
6,132 |
|
As of December 31, 2019, we had the following signed commitments (costs in millions):
35
|
|
Theatres |
|
|
Screens |
|
|
Estimated Cost |
|
|||
Expected to open during 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
U.S. |
|
|
7 |
|
|
|
84 |
|
|
$ |
59 |
|
International |
|
|
6 |
|
|
|
66 |
|
|
|
31 |
|
Total |
|
|
13 |
|
|
|
150 |
|
|
|
90 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected to open subsequent to 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
U.S. |
|
|
6 |
|
|
|
70 |
|
|
|
49 |
|
International |
|
|
4 |
|
|
|
23 |
|
|
|
11 |
|
Total |
|
|
10 |
|
|
|
93 |
|
|
|
60 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total commitments at December 31, 2019 |
|
|
23 |
|
|
|
243 |
|
|
$ |
150 |
|
Actual expenditures for continued theatre development, remodels and acquisitions are subject to change based upon the availability of attractive opportunities. We plan to fund capital expenditures for our continued development with cash flow from operations, borrowings under our senior secured credit facility, and proceeds from debt issuances, sale leaseback transactions and/or sales of excess real estate.
Financing Activities
Cash used for financing activities was $192.6 million and $186.5 million during the years ended December 31, 2018 and 2019, respectively. Cash used for financing activities primarily consists of dividends paid to our stockholders (see Note 6 to the consolidated financial statements), payments on finance leases (see Note 3 to the consolidated financial statements) and repayments on our long-term debt.
We, at the discretion of the board of directors and subject to applicable law, anticipate paying regular quarterly dividends on our common stock. The amount, if any, of the dividends to be paid in the future will depend upon our then available cash, anticipated cash needs, overall financial condition, loan agreement restrictions as discussed below, future prospects for earnings and cash flows, as well as other relevant factors.
We may from time to time, subject to compliance with our debt instruments, purchase our debt securities on the open market depending upon the availability and prices of such securities.
Long-term debt consisted of the following as of December 31, 2018 and 2019 (in millions):
|
|
As of December 31, |
|
|||||
|
|
2018 |
|
|
2019 |
|
||
Cinemark USA, Inc. term loan |
|
$ |
652.9 |
|
|
$ |
646.3 |
|
Cinemark USA, Inc. 5.125% senior notes due 2022 |
|
|
400.0 |
|
|
|
400.0 |
|
Cinemark USA, Inc. 4.875% senior notes due 2023 |
|
|
755.0 |
|
|
|
755.0 |
|
Other |
|
|
1.4 |
|
|
|
— |
|
Total long-term debt |
|
$ |
1,809.3 |
|
|
$ |
1,801.3 |
|
Less current portion |
|
|
8.0 |
|
|
|
6.6 |
|
Subtotal long-term debt, less current portion |
|
$ |
1,801.3 |
|
|
$ |
1,794.7 |
|
Less: Debt discounts and debt issuance costs, net of accumulated amortization |
|
|
28.7 |
|
|
|
23.4 |
|
Long-term debt, less current portion, net of debt issuance costs |
|
$ |
1,772.6 |
|
|
$ |
1,771.3 |
|
As of December 31, 2019, after giving effect to a letter of credit outstanding, we had $98.9 million in available borrowing capacity on our revolving credit line.
36
As of December 31, 2019, our long-term debt obligations, scheduled interest payments on long-term debt, future minimum lease obligations under non-cancelable operating and finance leases, scheduled interest payments under finance leases and other obligations for each period indicated are summarized as follows:
|
|
Payments Due by Period |
|
|||||||||||||||||
|
|
(in millions) |
|
|||||||||||||||||
|
|
|
|
|
|
Less Than |
|
|
|
|
|
|
|
|
|
|
After |
|
||
Contractual Obligations |
|
Total |
|
|
One Year |
|
|
1 - 3 Years |
|
|
3 - 5 Years |
|
|
5 Years |
|
|||||
Long-term debt (1) |
|
$ |
1,801.3 |
|
|
$ |
6.6 |
|
|
$ |
413.2 |
|
|
$ |
768.2 |
|
|
$ |
613.3 |
|
Scheduled interest payments on long-term debt (2) |
|
$ |
328.6 |
|
|
|
84.4 |
|
|
|
167.1 |
|
|
|
70.7 |
|
|
|
6.4 |
|
Operating lease obligations (3) |
|
$ |
1,731.8 |
|
|
|
280.3 |
|
|
|
499.2 |
|
|
|
371.4 |
|
|
|
580.9 |
|
Finance lease obligations (3) |
|
$ |
197.3 |
|
|
|
22.4 |
|
|
|
44.6 |
|
|
|
41.4 |
|
|
|
88.9 |
|
Purchase and other commitments (4) |
|
$ |
191.9 |
|
|
|
113.9 |
|
|
|
76.0 |
|
|
|
1.0 |
|
|
|
1.0 |
|
Current liability for uncertain tax positions (5) |
|
$ |
13.4 |
|
|
|
13.4 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Total obligations |
|
$ |
4,264.3 |
|
|
$ |
521.0 |
|
|
$ |
1,200.1 |
|
|
$ |
1,252.7 |
|
|
$ |
1,290.5 |
|
(1) |
Amounts are presented before adjusting for debt issuance costs. |
(2) |
Amounts include scheduled interest payments on fixed rate and variable rate debt agreements. Estimates for the variable rate interest payments were based on interest rates in effect on December 31, 2019. The average interest rates on our fixed rate and variable rate debt were 4.8% and 3.6%, respectively, as of December 31, 2019. |
(3) |
Amounts include both scheduled principal and interest payments on leases commenced prior to December 31, 2019. See Note 3 for discussion of lease obligations. |
(4) |
Includes estimated capital expenditures associated with the construction of new theatres to which we were committed as of December 31, 2019, obligations under employment agreements and contractual purchase commitments. |
(5) |
The contractual obligations table excludes the long-term portion of our liability for uncertain tax positions of $0.8 million because we cannot make a reliable estimate of the timing of the related cash payments. |
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements.
Senior Secured Credit Facility
Cinemark USA, Inc. has a senior secured credit facility that includes a $700.0 million term loan and a $100.0 million revolving credit line (the “Credit Agreement”).
Cinemark USA, Inc. amended its Credit Agreement during 2017 and 2018 as follows:
|
|
|
|
Debt Issue |
|
|
Loss on Debt |
|
||
Effective Date |
|
Nature of Amendment |
|
Costs Paid (1) |
|
|
Amendment (2) |
|
||
June 16, 2017 |
|
Reduced term loan interest rate by 0.25%; modified certain definitions and other provisions in the Credit Agreement |
|
$ |
0.5 |
|
|
$ |
0.2 |
|
November 28, 2017 |
|
Extended maturity of revolving credit line to December 2022; reduced the interest rate applicable to borrowings under the credit line |
|
$ |
0.3 |
|
|
$ |
0.3 |
|
March 29, 2018 |
|
Extended maturity of term loan to March 2025; reduced term loan interest rate by 0.25%; reduced real property mortgage requirements |
|
$ |
5.0 |
|
|
$ |
1.5 |
|
(1) |
Reflected as a reduction of long term debt on the consolidated balance sheet. |
(2) |
Reflected as a loss on debt amendments and refinancing on the consolidated statement of income for the year in which the amendments were effective. |
Under the amended Credit Agreement, quarterly principal payments of $1.6 million are due on the term loan through December 31, 2024, with a final principal payment of $613.4 million due on March 29, 2025.
37
Subsequent to the March 29, 2018 amendment noted above, interest on the term loan accrues at Cinemark USA, Inc.’s option at: (A) the base rate equal to the greater of (1) the US “Prime Rate” as quoted in The Wall Street Journal or if no such rate is quoted therein, in a Federal Reserve Board statistical release, (2) the federal funds effective rate plus 0.50%, and (3) a one-month Eurodollar-based rate plus 1.0%, plus, in each case, a margin of 0.75% per annum, or (B) a Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin of 1.75% per annum. Interest on the revolving credit line accrues, at our option, at: (A) a base rate equal to the greater of (1) the US “Prime Rate” as quoted in The Wall Street Journal or if no such rate is quoted therein, in a Federal Reserve Board statistical release, (2) the federal funds effective rate plus 0.50%, and (3) a one-month Eurodollar-based rate plus 1.0%, plus, in each case, a margin that ranges from 0.50% to 1.25% per annum, or (B) a Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin that ranges from 1.50% to 2.25% per annum. The margin of the revolving credit line is determined by the consolidated net senior secured leverage ratio as defined in the Credit Agreement.
At December 31, 2019, there was $646.3 million outstanding under the term loan and no borrowings outstanding under the revolving credit line. Cinemark USA, Inc. had no borrowings under the revolving credit line during the years ended December 31, 2018 and 2019. Cinemark USA, Inc. had $98.9 million in available borrowing capacity on the revolving credit line, after giving effect to a letter of credit outstanding as of December 31, 2019. The average interest rate on outstanding term loan borrowings under the Credit Agreement at December 31, 2019 was approximately 4.2% per annum.
Cinemark USA, Inc.’s obligations under the Credit Agreement are guaranteed by Cinemark Holdings, Inc. and certain of Cinemark USA, Inc.’s domestic subsidiaries and are secured by mortgages on certain fee and leasehold properties and security interests in substantially all of Cinemark USA, Inc.’s and the guarantors’ personal property, including, without limitation, pledges of all of Cinemark USA, Inc.’s capital stock, all of the capital stock of certain of Cinemark USA, Inc.’s domestic subsidiaries and 65% of the voting stock of certain of its foreign subsidiaries.
The Credit Agreement contains usual and customary negative covenants for agreements of this type, including, but not limited to, restrictions on Cinemark USA, Inc.’s ability, and in certain instances, its subsidiaries’ and our ability, to consolidate or merge or liquidate, wind up or dissolve; substantially change the nature of its business; sell, transfer or dispose of assets; create or incur indebtedness; create liens; pay dividends or repurchase stock; and make capital expenditures and investments. If Cinemark USA, Inc. has borrowings outstanding on the revolving credit line, it is required to satisfy a consolidated net senior secured leverage ratio covenant as defined in the Credit Agreement, not to exceed 5.0 to 1. As of December 31, 2019, Cinemark USA, Inc.’s actual ratio was 2.98 to 1.
The dividend restriction contained in the Credit Agreement prevents the Company and any of its subsidiaries from paying a dividend or otherwise distributing cash to its stockholders unless (1) the Company is not in default, and the distribution would not cause Cinemark USA, Inc. to be in default, under the Credit Agreement; and (2) the aggregate amount of certain dividends, distributions, investments, redemptions and capital expenditures made since December 18, 2012, including dividends declared by the board of directors, is less than the sum of (a) the aggregate amount of cash and cash equivalents received by Cinemark Holdings, Inc. or Cinemark USA, Inc. as common equity since December 18, 2012, (b) Cinemark USA, Inc.’s consolidated EBITDA minus 1.75 times its consolidated interest expense, each as defined in the Credit Agreement, and (c) certain other defined amounts. As of December 31, 2019, Cinemark USA, Inc. could have distributed up to approximately $3,196.8 million to its parent company and sole stockholder, Cinemark Holdings, Inc.
We have three interest rate swap agreements that are used to hedge a portion of the interest rate risk associated with the variable interest rates on the term loan outstanding under the Credit Agreement. See Note 12 of our consolidated financial statements for discussion of interest rate swaps. See also discussion of interest rate risk at Item 7A. Quantitative and Qualitative Disclosures About Market Risk.
4.875% Senior Notes
On May 24, 2013, Cinemark USA, Inc. issued $530.0 million aggregate principal amount of 4.875% senior notes due 2023, at par value, (the “4.875% Senior Notes”). Interest on the 4.875% Senior Notes is payable on June 1 and December 1 of each year. The 4.875% Senior Notes mature on June 1, 2023.
38
On March 21, 2016, Cinemark USA, Inc. issued an additional $225.0 million aggregate principal amount of the 4.875% Senior Notes, at 99.0% of the principal amount plus accrued and unpaid interest from December 1, 2015. These additional notes have identical terms, other than the issue date, the issue price and the first interest payment date, and constitute part of the same series as Cinemark USA, Inc.’s existing 4.875% Senior Notes. The aggregate principal amount of $755.0 million of 4.875% Senior Notes mature on June 1, 2023.
The 4.875% Senior Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of Cinemark USA, Inc.’s subsidiaries that guarantee, assume or become liable with respect to any of Cinemark USA, Inc.’s or a guarantor’s debt. The 4.875% Senior Notes and the guarantees are senior unsecured obligations and rank equally in right of payment with all of Cinemark USA, Inc.’s and its guarantor’s existing and future senior unsecured debt and senior in right of payment to all of Cinemark USA, Inc.’s and its guarantor’s existing and future senior subordinated debt. The 4.875% Senior Notes and the guarantees are effectively subordinated to all of Cinemark USA, Inc.’s and its guarantor’s existing and future secured debt to the extent of the value of the assets securing such debt, including all borrowings under Cinemark USA, Inc.’s Credit Agreement. The 4.875% Senior Notes and the guarantees are structurally subordinated to all existing and future debt and other liabilities of Cinemark USA, Inc.’s subsidiaries that do not guarantee the 4.875% Senior Notes.
The indenture to the 4.875% Senior Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. As of December 31, 2019, Cinemark USA, Inc. could have distributed up to approximately $3,353.8 million to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indenture to the 4.875% Senior Notes, subject to its available cash and other borrowing restrictions outlined in the indenture. Upon a change of control, as defined in the indenture governing the 4.875% Senior Notes, Cinemark USA, Inc. would be required to make an offer to repurchase the 4.875% Senior Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indenture governing the 4.875% Senior Notes allows Cinemark USA, Inc. to incur additional indebtedness if it satisfies the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. The required minimum coverage ratio is 2 to 1 and our actual ratio as of December 31, 2019 was approximately 6.6 to 1.
Cinemark USA, Inc. may redeem the 4.875% Senior Notes in whole or in part at redemption prices specified in the indenture.
5.125% Senior Notes
On December 18, 2012, Cinemark USA, Inc. issued $400.0 million aggregate principal amount of 5.125% senior notes due 2022, at par value (the “5.125% Senior Notes”). Interest on the 5.125% Senior Notes is payable on June 15 and December 15 of each year. The 5.125% Senior Notes mature on December 15, 2022.
The 5.125% Senior Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of Cinemark USA, Inc.’s subsidiaries that guarantee, assume or become liable with respect to any of Cinemark USA, Inc.’s or a guarantor’s debt. The 5.125% Senior Notes and the guarantees are senior unsecured obligations and rank equally in right of payment with all of Cinemark USA, Inc.’s and its guarantor’s existing and future senior unsecured debt and senior in right of payment to all of Cinemark USA, Inc.’s and its guarantor’s existing and future subordinated debt. The 5.125% Senior Notes and the guarantees are effectively subordinated to all of Cinemark USA, Inc.’s and its guarantor’s existing and future secured debt to the extent of the value of the assets securing such debt, including all borrowings under Cinemark USA, Inc.’s Credit Agreement. The 5.125% Senior Notes and the guarantees are structurally subordinated to all existing and future debt and other liabilities of Cinemark USA, Inc.’s subsidiaries that do not guarantee the 5.125% Senior Notes.
The indenture to the 5.125% Senior Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. As of
39
December 31, 2019, Cinemark USA, Inc. could have distributed up to approximately $3,347.9 million to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indenture to the 5.125% Senior Notes, subject to its available cash and other borrowing restrictions outlined in the indenture. Upon a change of control, as defined in the indenture governing the 5.125% Senior Notes, Cinemark USA, Inc. would be required to make an offer to repurchase the 5.125% Senior Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indenture governing the 5.125% Senior Notes allows Cinemark USA, Inc. to incur additional indebtedness if it satisfies the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. The required minimum coverage ratio is 2 to 1 and our actual ratio as of December 31, 2019 was approximately 6.6 to 1.
Cinemark USA, Inc. may redeem the 5.125% Senior Notes in whole or in part at redemption prices specified in the indenture.
As of December 31, 2019, we believe we were in full compliance with all agreements, including all related covenants, governing our outstanding debt.
Ratings
We are rated by nationally recognized rating agencies. The rating scales and methodologies used to derive individual ratings may vary from agency to agency. Credit ratings are issued by credit rating agencies based on evaluations of our ability to pay back our outstanding debt and the likelihood that we would default on that debt prior to its maturity. The credit ratings issued by the credit rating agencies represent the credit rating agency's evaluation of both qualitative and quantitative information for our company. The credit ratings that are issued are based on the credit rating agency’s judgment and experience in determining what information should be considered in giving a rating to a particular company. Ratings are always subject to change and there can be no assurance that our current ratings will continue for any given period of time. A downgrade of our debt ratings, depending on the extent, could increase the cost to borrow funds.
New Accounting Pronouncements
See Note 2 to our consolidated financial statements for a discussion of recently issued accounting pronouncements and their impact on our financial statements.
Seasonality
Our revenues have historically been seasonal, coinciding with the timing of releases of motion pictures by the major distributors. The most successful motion pictures have historically been released during summer months in the U.S., extending from May to July, and during the holiday season, extending from November through year-end. The timing of releases, however, has become less pronounced as distributors have begun releasing content more evenly throughout the year. In our Latin American markets, while Hollywood content has similar release dates as in the U.S., the local holidays and seasons can vary. The unexpected emergence of a hit film during other periods can alter this seasonality trend. The timing, quantity and quality of such film releases can have a significant effect on our results of operations, and the results of one quarter are not necessarily indicative of results for the next quarter or for the same period in the following year.
40
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
We have exposure to financial market risks, including changes in interest rates and foreign currency exchange rates.
Interest Rate Risk
We are currently party to variable rate debt facilities. An increase or decrease in interest rates would affect our interest expense relating to our variable rate debt facilities. At December 31, 2019, there was an aggregate of approximately $196.3 million of variable rate debt outstanding under these facilities, after giving effect to the interest rate swap agreements discussed below. Based on the interest rates in effect on the variable rate debt outstanding at December 31, 2019, a 100 basis point increase in market interest rates would increase our annual interest expense by approximately $2.0 million.
The table below provides information about our fixed rate and variable rate long-term debt agreements as of December 31, 2019:
|
|
Expected Maturity for the Twelve-Month Periods Ending December 31, |
|
|
Average |
|
||||||||||||||||||||||||||||||
|
|
(in millions) |
|
|
Interest |
|
||||||||||||||||||||||||||||||
|
|
2020 |
|
|
2021 |
|
|
2022 |
|
|
2023 |
|
|
2024 |
|
|
Thereafter |
|
|
Total |
|
|
Fair Value |
|
|
Rate |
|
|||||||||
Fixed rate |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
400.0 |
|
|
$ |
755.0 |
|
|
$ |
— |
|
|
$ |
450.0 |
|
|
$ |
1,605.0 |
|
|
$ |
1,628.2 |
|
|
|
4.8 |
% |
Variable rate |
|
|
6.6 |
|
|
|
6.6 |
|
|
|
6.6 |
|
|
|
6.6 |
|
|
|
6.6 |
|
|
|
163.3 |
|
|
|
196.3 |
|
|
|
198.3 |
|
|
|
3.6 |
% |
Total debt (1) |
|
$ |
6.6 |
|
|
$ |
6.6 |
|
|
$ |
406.6 |
|
|
$ |
761.6 |
|
|
$ |
6.6 |
|
|
$ |
613.3 |
|
|
$ |
1,801.3 |
|
|
$ |
1,826.5 |
|
|
|
|
|
(1) |
Amounts are presented before adjusting for debt issuance costs. |
Interest Rate Swap Agreements
All of our interest rate swap agreements qualify for cash flow hedge accounting. The fair values of the interest rate swaps are recorded on our consolidated balance sheet as an asset or liability with the related gains or losses reported as a component of accumulated other comprehensive loss. See Note 12 to the consolidated financial statements for further discussion of the interest rate swap agreements.
Below is a summary of our interest rate swap agreements as of December 31, 2019:
Notional |
|
|
|
|
|
|
|
|
|
|
Amount |
|
Effective Date |
|
Pay Rate |
|
|
Receive Rate |
|
Expiration Date |
|
$175.0 million |
|
December 31, 2018 |
|
2.751% |
|
|
1-Month LIBOR |
|
December 31, 2022 |
|
$137.5 million |
|
December 31, 2018 |
|
2.765% |
|
|
1-Month LIBOR |
|
December 31, 2022 |
|
$137.5 million |
|
December 31, 2018 |
|
2.746% |
|
|
1-Month LIBOR |
|
December 31, 2022 |
|
$450.0 million |
|
|
|
|
|
|
|
|
|
|
Foreign Currency Exchange Rate Risk
We are also exposed to market risk arising from changes in foreign currency exchange rates as a result of our international operations. Generally, we export from the U.S. certain of the equipment and interior finish items and other operating supplies used by our international subsidiaries. A majority of the revenues and operating expenses of our international subsidiaries are transacted in the country’s local currency. U.S. GAAP requires that our subsidiaries use the currency of the primary economic environment in which they operate as their functional currency. If our subsidiaries operate in a highly inflationary economy, U.S. GAAP requires that the U.S. dollar be used as the functional currency for the subsidiary, which could impact future results of operations as reported. Currency fluctuations in the countries in which we operate result in us reporting exchange gains (losses) or foreign currency translation adjustments. Based upon our equity ownership in our international subsidiaries as of December 31, 2019, holding everything else constant, a 10% immediate, simultaneous, unfavorable change in all of the foreign currency exchange rates to which we are exposed, would decrease the aggregate net book value of our investments in our international subsidiaries by approximately $46.0 million and would decrease the aggregate net income of our international subsidiaries for the year ended December 31, 2019 by $5.9 million, respectively.
41
We deemed Argentina to be highly inflationary beginning July 1, 2018. A highly inflationary economy is defined as an economy with a cumulative inflation rate of approximately 100 percent or more over a three-year period. If a country’s economy is classified as highly inflationary, the financial statements of the foreign entity operating in that country must be remeasured to the functional currency of the reporting entity. The financial statements of the Company’s Argentina subsidiaries has been remeasured in U.S. dollars in accordance with ASC Topic 830, Foreign Currency Matters, effective beginning July 1, 2018.
Item 8. Financial Statements and Supplementary Data
The financial statements and supplementary data are listed on the Index on page F-1 of this Form 10-K. Such financial statements and supplementary data are included herein beginning on page F-3.
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
None.
Item 9A. Controls and Procedures
Evaluation of the Effectiveness of Disclosure Controls and Procedures
As of December 31, 2019, under the supervision and with the participation of our principal executive officer and principal financial officer, we carried out an evaluation required by the Exchange Act of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rule 13a-15(e) of the Exchange Act. Based on this evaluation, our principal executive officer and principal financial officer concluded that, as of December 31, 2019, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and were effective to provide reasonable assurance that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosures.
Changes in Internal Control over Financial Reporting
There have been no changes in our internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 that occurred during the quarter ended December 31, 2019 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Management’s Report on Internal Control over Financial Reporting
Management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) of the Exchange Act. The Company’s internal control framework and processes are designed to provide reasonable assurance to management and the board of directors regarding the reliability of financial reporting and the preparation of the Company’s consolidated financial statements in accordance with the accounting principles generally accepted in the U.S. Management has assessed the effectiveness of our internal control over financial reporting as of December 31, 2019 based on criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission, or COSO, in Internal Control—Integrated Framework (2013). As a result of this assessment, management concluded that, as of December 31, 2019, our internal control over financial reporting was effective.
Certifications of our Chief Executive Officer and our Chief Financial Officer, which are required in accordance with Rule 13a-14 of the Exchange Act, are attached as exhibits to this Annual Report. This "Controls and Procedures" section includes the information concerning the controls evaluation referred to in the certifications, and it should be read in conjunction with the certifications for a more complete understanding of the topics presented.
42
The Company’s independent registered public accounting firm, Deloitte & Touche LLP, which has direct access to the Company’s board of directors through its Audit Committee, have audited the consolidated financial statements prepared by the Company. Their report on the consolidated financial statements is included in Part II, Item 8, Financial Statements and Supplementary Data. Deloitte & Touche LLP has issued an attestation report on the Company’s internal control over financial reporting.
Limitations on Controls
Management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all errors or fraud. Any control system, no matter how well designed and operated, is based upon certain assumptions and can provide only reasonable, not absolute, assurance that its objectives will be met. Further, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the Company have been detected.
Item 9B. Other Information
None.
43
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the stockholders and the Board of Directors of Cinemark Holdings, Inc.
Opinion on Internal Control over Financial Reporting
We have audited the internal control over financial reporting of Cinemark Holdings, Inc. and subsidiaries (the “Company”) as of December 31, 2019, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2019, based on criteria established in Internal Control — Integrated Framework (2013) issued by COSO.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements and financial statement schedule as of and for the year ended December 31, 2019, of the Company and our report dated February 21, 2020, expressed an unqualified opinion on those financial statements and financial statement schedule.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
/s/ Deloitte & Touche LLP |
Dallas, Texas |
February 21, 2020 |
44
PART III
Item 10. Directors, Executive Officers and Corporate Governance
Incorporated by reference to the Company’s proxy statement for its annual stockholders meeting (under the headings “Election of Directors”, “Section 16(a) Beneficial Ownership Reporting Compliance”, “Corporate Governance” and “Executive Officers”) to be held on May 21, 2020 and to be filed with the SEC within 120 days after December 31, 2019.
Item 11. Executive Compensation
Incorporated by reference to the Company’s proxy statement for its annual stockholders meeting (under the heading “Executive Compensation”) to be held on May 21, 2020 and to be filed with the SEC within 120 days after December 31, 2019.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Incorporated by reference to the Company’s proxy statement for its annual stockholders meeting (under the headings “Security Ownership of Certain Beneficial Owners and Management”) to be held on May 21, 2020 and to be filed with the SEC within 120 days after December 31, 2019.
Item 13. Certain Relationships and Related Transactions, and Director Independence
Incorporated by reference to the Company’s proxy statement for its annual stockholders meeting (under the heading “Certain Relationships and Related Party Transactions” and “Corporate Governance”) to be held on May 21, 2020 and to be filed with the SEC within 120 days after December 31, 2019.
Item 14. Principal Accounting Fees and Services
Incorporated by reference to the Company’s proxy statement for its annual stockholders meeting (under the heading “Board Committees – Audit Committee – Fees Paid to Independent Registered Public Accounting Firm”) to be held on May 21, 2020 and to be filed with the SEC within 120 days after December 31, 2019.
PART IV
Item 15. Exhibits, Financial Statement Schedules
(a) Documents Filed as Part of this Report
|
1. |
The financial statement schedules and related data listed in the accompanying Index beginning on page F-1 are filed as a part of this report. |
|
2. |
The exhibits listed in the accompanying Index beginning on page 46 are filed as a part of this report. |
(b) Exhibits
See the accompanying Index beginning on page 46.
(c) Financial Statement Schedules
Schedule I – Condensed Financial Information of Registrant beginning on page S-1.
All Schedules not identified above have been omitted because they are not required, are not applicable or the information is included in the consolidated financial statements or notes contained in this report.
45
EXHIBIT INDEX
Number |
|
Exhibit Title |
|
|
|
3.1 |
|
|
3.2(a) |
|
|
3.2(b) |
|
|
3.2(c) |
|
|
*4.1 |
|
|
4.2 |
|
|
4.3(a) |
|
|
4.3(b) |
|
|
4.4(a) |
|
|
4.4(b) |
|
|
4.5 |
|
|
10.1(a) |
|
Management Agreement, dated December 10, 1993, between Laredo Theatre, Ltd. and Cinemark USA, Inc. (incorporated by reference to Exhibit 10.14(b) to Cinemark USA, Inc.’s Annual Report on Form 10-K, File No. 033-47040, filed March 31, 1994). (P) |
10.1(b) |
|
|
10.1(c) |
|
|
10.1(d) |
|
|
10.2 |
|
License Agreement, dated December 10, 1993, between Laredo Joint Venture and Cinemark USA, Inc. (incorporated by reference to Exhibit 10.14(c) to Cinemark USA, Inc.’s Annual Report on Form 10-K, File No. 033-47040, filed March 31, 1994). (P) |
10.3(a) |
|
|
10.3(b) |
|
|
10.3 (c) |
|
46
Number |
|
Exhibit Title |
|
|
|
10.3 (d) |
|
|
10.3 (e) |
|
|
10.3 (f) |
|
|
10.3 (g) |
|
|
10.3(h) |
|
|
10.3(i) |
|
|
+10.4(a) |
|
|
+10.4(b) |
|
|
+10.4(c) |
|
|
+10.4(d) |
|
|
+10.4(e) |
|
|
+10.4(f) |
|
|
+10.4(g) |
|
|
+10.5(a) |
|
|
+10.5(b) |
|
|
+10.5(c) |
|
|
+10.5(d) |
|
|
+10.5(e) |
|
|
+10.5(f) |
|
47
Number |
|
Exhibit Title |
|
|
|
+10.5(g) |
|
|
+10.6(a) |
|
|
+10.6(b) |
|
|
+10.6(c) |
|
|
+10.6(d) |
|
|
+10.6(e) |
|
|
+10.6(f) |
|
|
+10.6(g) |
|
|
10.7(a) |
|
|
10.7(b) |
|
|
10.8 |
|
|
10.9(a) |
|
|
10.9(b) |
|
|
10.9(c) |
|
|
10.9(d) |
|
|
10.9(e) |
|
|
10.10(a) |
|
|
10.10(b) |
|
48
Number |
|
Exhibit Title |
|
|
|
10.10(c) |
|
|
10.10(d) |
|
|
10.10(e) |
|
|
10.10(f) |
|
|
10.11(a) |
|
|
10.11(b) |
|
|
10.11(c) |
|
|
10.11(d) |
|
|
10.11(e) |
|
|
10.11(f) |
|
|
10.12(a) |
|
|
10.12(b) |
|
|
10.12(c) |
|
|
10.12(d) |
|
|
10.12(e) |
|
49
Number |
|
Exhibit Title |
|
|
|
10.12(f) |
|
|
10.12(g) |
|
|
10.13(a) |
|
|
10.13(b) |
|
|
10.13(c) |
|
|
10.13(d) |
|
|
10.13(e) |
|
|
10.13(f) |
|
|
10.13(g) |
|
|
10.13(h) |
|
|
10.14(a) |
|
|
10.14(b) |
|
|
10.14(c) |
|
|
10.14(d) |
|
|
10.14(e) |
|
|
10.14(f) |
|
50
Number |
|
Exhibit Title |
|
|
|
10.15(a) |
|
|
10.15(b) |
|
|
10.15(c) |
|
|
10.15(d) |
|
|
10.16(a) |
|
|
10.16(b) |
|
|
10.16(c) |
|
|
10.16(d) |
|
|
10.16(e) |
|
|
10.16(f) |
|
|
10.17(a) |
|
|
10.17(b) |
|
|
10.17(c) |
|
|
10.17(d) |
|
|
10.17(e) |
|
|
10.18(a) |
|
51
Number |
|
Exhibit Title |
|
|
|
10.18(b) |
|
|
10.18(c) |
|
|
10.18(d) |
|
|
10.18(e) |
|
|
10.19(a) |
|
|
10.19(b) |
|
|
10.19(c) |
|
|
10.19(d) |
|
|
10.19(e) |
|
|
10.19(f) |
|
|
10.19(g) |
|
|
10.20(a) |
|
|
10.20(b) |
|
|
10.20(c) |
|
|
10.20(d) |
|
|
10.20(e) |
|
|
10.20(f) |
|
52
Number |
|
Exhibit Title |
|
|
|
10.21(a) |
|
|
10.21(b) |
|
|
10.21(c) |
|
|
10.21(d) |
|
|
10.21(e) |
|
|
10.21(f) |
|
|
10.22(a) |
|
|
10.22(b) |
|
|
10.22(c) |
|
|
10.22(d) |
|
|
10.22(e) |
|
|
10.22(f) |
|
|
10.23(a) |
|
|
10.23(b) |
|
|
10.23(c) |
|
|
10.23(d) |
|
53
Number |
|
Exhibit Title |
|
|
|
10.23(e) |
|
|
10.23(f) |
|
|
10.24(a) |
|
|
10.24(b) |
|
|
10.24(c) |
|
|
10.24(d) |
|
|
10.24(e) |
|
|
10.24(f) |
|
|
10.24(g) |
|
|
10.25(a) |
|
|
10.25(b) |
|
|
10.26 |
|
|
+10.27 |
|
|
10.28 |
|
|
10.29 |
|
|
10.30 |
|
|
10.31 |
|
|
*21 |
|
|
*23.1 |
|
|
*31.1 |
|
54
Number |
|
Exhibit Title |
|
|
|
*31.2 |
|
|
*32.1 |
|
|
*32.2 |
|
|
*101 |
|
The following financial information from Cinemark Holdings, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2019 filed with the SEC on February 21, 2020, formatted in iXBRL (Inline eXtensible Business Reporting Language), filed herewith: (i) Consolidated Balance Sheets (ii) Consolidated Statements of Income, (iii) Consolidated Statements of Comprehensive Income, (iv) Consolidated Statements of Equity, (v) Consolidated Statements of Cash Flows and (vi) the Notes to Consolidated Financial Statements tagged as detailed text. |
*104 |
|
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101). |
* |
Filed herewith. |
+ |
Any management contract, compensatory plan or arrangement. |
(P) |
Paper filing. |
55
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: February 21, 2020 |
|
CINEMARK HOLDINGS, INC |
||
|
|
|
||
|
|
BY: |
|
/s/ Mark Zoradi |
|
|
|
|
Mark Zoradi |
|
|
|
|
Chief Executive Officer |
|
|
BY: |
|
/s/ Sean Gamble |
|
|
|
|
Sean Gamble |
|
|
|
|
Chief Financial Officer and |
|
|
|
|
Principal Accounting Officer |
POWER OF ATTORNEY
Each person whose signature appears below hereby severally constitutes and appoints Mark Zoradi and Sean Gamble his true and lawful attorney-in-fact and agent, each with the power of substitution and resubstitution, for him in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K and to file the same, with accompanying exhibits and other related documents, with the Securities and Exchange Commission, and ratify and confirm all that said attorney-in-fact and agent, or his substitute or substitutes, may lawfully do or cause to be done by virtue of said appointment.
Pursuant to the requirements of the Exchange Act, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
Name |
|
Title |
|
Date |
/s/ Lee Roy Mitchell |
|
Chairman of the Board of Directors and Director |
|
February 21, 2020 |
Lee Roy Mitchell |
|
|
|
|
|
|
|
|
|
/s/ Mark Zoradi |
|
Chief Executive Officer and Director |
|
February 21, 2020 |
Mark Zoradi |
|
(principal executive officer) |
|
|
|
|
|
|
|
/s/ Sean Gamble |
|
Chief Financial Officer |
|
February 21, 2020 |
Sean Gamble |
|
(principal financial and accounting officer) |
|
|
|
|
|
|
|
/s/ Benjamin D. Chereskin |
|
Director |
|
February 21, 2020 |
Benjamin D. Chereskin |
|
|
|
|
|
|
|
|
|
/s/ Enrique F. Senior |
|
Director |
|
February 21, 2020 |
Enrique F. Senior |
|
|
|
|
|
|
|
|
|
/s/ Raymond W. Syufy |
|
Director |
|
February 21, 2020 |
Raymond W. Syufy |
|
|
|
|
|
|
|
|
|
/s/ Carlos M. Sepulveda |
|
Director |
|
February 21, 2020 |
Carlos M. Sepulveda |
|
|
|
|
|
|
|
|
|
/s/ Steven Rosenberg |
|
Director |
|
February 21, 2020 |
Steven Rosenberg |
|
|
|
|
|
|
|
|
|
/s/ Nina Vaca |
|
Director |
|
February 21, 2020 |
Nina Vaca |
|
|
|
|
|
|
|
|
|
/s/ Darcy Antonellis |
|
Director |
|
February 21, 2020 |
Darcy Antonellis |
|
|
|
|
|
|
|
|
|
/s/ Nancy Loewe |
|
Director |
|
February 21, 2020 |
Nancy Loewe |
|
|
|
|
56
SUPPLEMENTAL INFORMATION TO BE FURNISHED WITH REPORTS FILED PURSUANT TO
SECTION 15(d) OF THE ACT BY REGISTRANTS WHICH HAVE NOT REGISTERED
SECURITIES PURSUANT TO SECTION 12 OF THE ACT.
No annual report or proxy material has been sent to our stockholders. An annual report and proxy material may be sent to our stockholders subsequent to the filing of this Form 10-K. We shall furnish to the SEC copies of any annual report or proxy material that is sent to our stockholders.
57
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
|
|
Page |
|
|
|
CINEMARK HOLDINGS, INC. AND SUBSIDIARIES CONSOLIDATED FINANCIAL STATEMENTS: |
|
|
|
|
|
|
F-2 |
|
|
|
|
|
F-4 |
|
|
|
|
Consolidated Statements of Income for the Years Ended December 31, 2017, 2018 and 2019 |
|
F-5 |
|
|
|
Consolidated Statements of Comprehensive Income for the Years Ended December 31, 2017, 2018 and 2019 |
|
F-6 |
|
|
|
Consolidated Statements of Equity for the Years Ended December 31, 2017, 2018 and 2019 |
|
F-7 |
|
|
|
Consolidated Statements of Cash Flows for the Years Ended December 31, 2017, 2018 and 2019 |
|
F-8 |
|
|
|
|
F-9 |
F-1
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the stockholders and the Board of Directors of Cinemark Holdings, Inc.
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of Cinemark Holdings, Inc. and subsidiaries (the "Company") as of December 31, 2019 and 2018, the related consolidated statements of income, comprehensive income, equity, and cash flows, for each of the three years in the period ended December 31, 2019, and the related notes and the schedule listed in the Index at Item 15 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2019 and 2018, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2019, in conformity with accounting principles generally accepted in the United States of America.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2019, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 21, 2020, expressed an unqualified opinion on the Company's internal control over financial reporting.
Change in Accounting Principle
As discussed in Note 3 to the financial statements, effective January 1, 2019, the Company adopted Financial Accounting Standards Board Accounting Standards Update 2016-02, Leases (Topic 842) using the modified retrospective approach.
Basis for Opinion
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Impairment of Long-Lived Assets — Refer to Notes 1 and 10 to the consolidated financial statements
Critical Audit Matter Description
The impairment evaluation of long-lived assets is an assessment that begins with the Company’s monitoring of indicators of impairment on a theatre basis, which the Company believes is the lowest applicable level for which
F-2
there are identifiable cash flows. Due to the high number of asset groups (i.e., theatres), the Company reviews long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. The Company also performs a full quantitative impairment evaluation on an annual basis. If the estimated undiscounted cash flows are not sufficient to recover a long-lived asset’s carrying value, the Company then compares the carrying value of the asset group (theatre) with its estimated fair value. The Company applies significant judgment in estimating the fair value of theatres, based on historical and projected operating performance, recent market transactions and current industry trading multiples. When the estimated fair value is determined to be lower than the carrying value of the asset group, the asset group is written down to its estimated fair value.
We identified the impairment of long-lived assets as a critical audit matter because of the significant judgment required by management to determine estimated undiscounted cash flows. This required a high degree of auditor judgment and an increased extent of effort when performing audit procedures to evaluate the reasonableness of management’s undiscounted cash flow analysis. Although the carrying value of an individual theatre asset group typically isn’t material, changes in these assumptions, including available renewal options and the likelihood of exercising those renewal options and expected future performance of newly opened or recently remodeled theatres across several asset groups could have a significant impact on the amount of any long-lived asset impairment charge.
How the Critical Audit Matter Was Addressed in the Audit
Our audit procedures related to management’s undiscounted cash flow analysis, including available renewal options and the likelihood of exercising those renewal options and expected future performance of newly opened or recently remodeled theatres include the following, among others:
|
• |
We tested the effectiveness of the Company’s controls over long-lived assets and long-lived asset impairment evaluation, including those over the undiscounted cash flows. |
|
• |
We evaluated management’s ability to accurately forecast future theatre cash flows by: |
|
|
Comparing actual cash flows to management’s historical forecasts and historical results. |
|
|
Testing the reasonableness of available renewal options and the likelihood of exercising those renewal options through inspection of underlying lease agreements and theatre projections used by management in evaluating the renewal option. |
|
|
Testing the reasonableness of management’s estimate of expected future performance of newly opened or recently remodeled theatres, based on the historical performance of theatres recently opened or remodeled. |
|
• |
We researched competitor data and industry trends that might impact film product or other disruptive industry trends (e.g., video on demand, changes to distribution of film product) and compared the applicability of these trends to management’s assumptions used to develop their forecasts. |
|
• |
We tested the underlying source information and mathematical accuracy of the calculations. |
/s/ Deloitte & Touche LLP
Dallas, Texas
February 21, 2020
We have served as the Company's auditor since 1988.
F-3
PART IV - FINANCIAL INFORMATION
Item 15. Financial Statement
CINEMARK HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share data)
|
|
December 31, |
|
|
December 31, |
|
||
|
|
2018 |
|
|
2019 |
|
||
Assets |
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
|
|
|
$ |
|
|
Inventories |
|
|
|
|
|
|
|
|
Accounts receivable |
|
|
|
|
|
|
|
|
Current income tax receivable |
|
|
|
|
|
|
|
|
Prepaid expenses and other |
|
|
|
|
|
|
|
|
Total current assets |
|
|
|
|
|
|
|
|
Theatre properties and equipment |
|
|
|
|
|
|
|
|
Land |
|
|
|
|
|
|
|
|
Buildings |
|
|
|
|
|
|
|
|
Property under capital and finance lease |
|
|
|
|
|
|
|
|
Theatre furniture and equipment |
|
|
|
|
|
|
|
|
Leasehold interests and improvements |
|
|
|
|
|
|
|
|
Total |
|
|
|
|
|
|
|
|
Less: accumulated depreciation and amortization |
|
|
|
|
|
|
|
|
Theatre properties and equipment, net |
|
|
|
|
|
|
|
|
Operating Lease right-of-use assets |
|
|
|
|
|
|
|
|
Other assets |
|
|
|
|
|
|
|
|
Goodwill |
|
|
|
|
|
|
|
|
Intangible assets - net |
|
|
|
|
|
|
|
|
Investment in NCM |
|
|
|
|
|
|
|
|
Investments in and advances to affiliates |
|
|
|
|
|
|
|
|
Long-term deferred tax asset |
|
|
|
|
|
|
|
|
Deferred charges and other assets - net |
|
|
|
|
|
|
|
|
Total other assets |
|
|
|
|
|
|
|
|
Total assets |
|
$ |
|
|
|
$ |
|
|
Liabilities and equity |
|
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
|
Current portion of long-term debt |
|
$ |
|
|
|
$ |
|
|
Current portion of operating lease obligations |
|
|
|
|
|
|
|
|
Current portion of capital and finance lease obligations |
|
|
|
|
|
|
|
|
Current income tax payable |
|
|
|
|
|
|
|
|
Current liability for uncertain tax positions |
|
|
|
|
|
|
|
|
Accounts payable |
|
|
|
|
|
|
|
|
Accrued film rentals |
|
|
|
|
|
|
|
|
Accrued payroll |
|
|
|
|
|
|
|
|
Accrued property taxes |
|
|
|
|
|
|
|
|
Accrued other current liabilities |
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
|
|
|
|
|
|
Long-term liabilities |
|
|
|
|
|
|
|
|
Long-term debt, less current portion |
|
|
|
|
|
|
|
|
Operating lease obligations, less current portion |
|
|
|
|
|
|
|
|
Capital and finance lease obligations, less current portion |
|
|
|
|
|
|
|
|
Long-term deferred tax liability |
|
|
|
|
|
|
|
|
Long-term liability for uncertain tax positions |
|
|
|
|
|
|
|
|
Deferred lease expenses |
|
|
|
|
|
|
|
|
NCM screen advertising advances |
|
|
|
|
|
|
|
|
Other long-term liabilities |
|
|
|
|
|
|
|
|
Total long-term liabilities |
|
|
|
|
|
|
|
|
Commitments and contingencies (see Note 19) |
|
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
|
|
|
Cinemark Holdings, Inc.'s stockholders' equity: |
|
|
|
|
|
|
|
|
Common stock, $ |
|
|
|
|
|
|
|
|
Additional paid-in-capital |
|
|
|
|
|
|
|
|
Treasury stock, |
|
|
( |
) |
|
|
( |
) |
Retained earnings |
|
|
|
|
|
|
|
|
Accumulated other comprehensive loss |
|
|
( |
) |
|
|
( |
) |
Total Cinemark Holdings, Inc.'s stockholders' equity |
|
|
|
|
|
|
|
|
Noncontrolling interests |
|
|
|
|
|
|
|
|
Total equity |
|
|
|
|
|
|
|
|
Total liabilities and equity |
|
$ |
|
|
|
$ |
|
|
The accompanying notes are an integral part of the consolidated financial statements.
F-4
CINEMARK HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
YEARS ENDED DECEMBER 31, 2017, 2018 AND 2019
(in thousands, except per share data)
|
|
2017 |
|
|
2018 |
|
|
2019 |
|
|||
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
Admissions |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Concession |
|
|
|
|
|
|
|
|
|
|
|
|
Other |
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
|
|
|
|
|
|
|
|
|
|
|
Cost of operations |
|
|
|
|
|
|
|
|
|
|
|
|
Film rentals and advertising |
|
|
|
|
|
|
|
|
|
|
|
|
Concession supplies |
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and wages |
|
|
|
|
|
|
|
|
|
|
|
|
Facility lease expense |
|
|
|
|
|
|
|
|
|
|
|
|
Utilities and other |
|
|
|
|
|
|
|
|
|
|
|
|
General and administrative expenses |
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
|
|
Impairment of long-lived assets |
|
|
|
|
|
|
|
|
|
|
|
|
Loss on disposal of assets and other |
|
|
|
|
|
|
|
|
|
|
|
|
Total cost of operations |
|
|
|
|
|
|
|
|
|
|
|
|
Operating income |
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense) |
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Loss on debt amendments and refinancing |
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
Interest income |
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency exchange gain (loss) |
|
|
|
|
|
|
( |
) |
|
|
( |
) |
Distributions from NCM |
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense - NCM |
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
Equity in income of affiliates |
|
|
|
|
|
|
|
|
|
|
|
|
Total other expense |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Income before income taxes |
|
|
|
|
|
|
|
|
|
|
|
|
Income taxes |
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Less: Net income attributable to noncontrolling interests |
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to Cinemark Holdings, Inc. |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Weighted average shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
|
|
|
|
|
|
|
|
|
|
Diluted |
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share attributable to Cinemark Holdings, Inc.'s common stockholders |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Diluted |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
The accompanying notes are an integral part of the consolidated financial statements.
F-5
CINEMARK HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
YEARS ENDED DECEMBER 31, 2017, 2018 AND 2019
(In thousands)
|
|
2017 |
|
|
2018 |
|
|
2019 |
|
|||
Net income |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Other comprehensive income (loss), net of tax |
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $ |
|
|
|
|
|
|
( |
) |
|
|
( |
) |
Other comprehensive income (loss) in equity method investments |
|
|
|
|
|
|
( |
) |
|
|
( |
) |
Foreign currency translation adjustments |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Total other comprehensive loss, net of tax |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Total comprehensive income, net of tax |
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income attributable to noncontrolling interests |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Comprehensive income attributable to Cinemark Holdings, Inc. |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
The accompanying notes are an integral part of the consolidated financial statements.
F-6
CINEMARK HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF EQUITY
YEARS ENDED DECEMBER 31, 2017, 2018 AND 2019
(in thousands, except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated |
|
|
Cinemark |
|
|
|
|
|
|
|
|
|
|||||||
|
|
Common Stock |
|
|
Treasury Stock |
|
|
Additional |
|
|
|
|
|
|
Other |
|
|
Holdings, Inc.'s |
|
|
|
|
|
|
|
|
|
|||||||||||||
|
|
Shares |
|
|
|
|
|
|
Shares |
|
|
|
|
|
|
Paid-in- |
|
|
Retained |
|
|
Comprehensive |
|
|
Stockholders' |
|
|
Noncontrolling |
|
|
Total |
|
||||||||
|
|
Issued |
|
|
Amount |
|
|
Acquired |
|
|
Amount |
|
|
Capital |
|
|
Earnings |
|
|
Loss |
|
|
Equity |
|
|
Interests |
|
|
Equity |
|
||||||||||
Balance at January 1, 2017 |
|
|
|
|
|
$ |
|
|
|
|
( |
) |
|
$ |
( |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
( |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Issuance of restricted stock |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Issuance of stock upon vesting of restricted stock units |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Restricted stock forfeitures and stock withholdings related to share based awards that vested during the year ended December 31, 2017 |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Share based awards compensation expense |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
— |
|
|
|
|
|
Tax expense related to share based award vestings |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Dividends paid to stockholders, $ |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Dividends accrued on unvested restricted stock unit awards |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Dividends paid to noncontrolling interests |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
Net income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
Reclassification of cumulative translation adjustments |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Other comprehensive loss |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Balance at December 31, 2017 |
|
|
|
|
|
$ |
|
|
|
|
( |
) |
|
$ |
( |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
( |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Cumulative effect of change in accounting principle, net of taxes of $ |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Issuance of restricted stock |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Issuance of stock upon vesting of restricted stock units |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Restricted stock forfeitures and stock withholdings related to share based awards that vested during the year ended December 31, 2018 |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Share based awards compensation expense |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
— |
|
|
|
|
|
Dividends paid to stockholders, $ |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Dividends accrued on unvested restricted stock unit awards |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Dividends paid to noncontrolling interests |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
Net income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
Reclassification of cumulative translation adjustments |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
|
|
Other comprehensive loss |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Balance at December 31, 2018 |
|
|
|
|
|
$ |
|
|
|
|
( |
) |
|
$ |
( |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
( |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Cumulative effect of change in accounting principle, net of taxes of $ |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
— |
|
|
|
|
|
|
|
— |
|
|
|
|
|
Issuance of restricted stock |
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
— |
|
|
|
|
|
Issuance of stock upon vesting of restricted stock units |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Restricted stock forfeitures and stock withholdings related to share based awards that vested during the year ended December 31, 2019 |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Share based awards compensation expense |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
— |
|
|
|
|
|
Dividends paid to stockholders, $ |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Dividends accrued on unvested restricted stock unit awards |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Dividends paid to noncontrolling interests |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
Net income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive loss |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Balance at December 31, 2019 |
|
|
|
|
|
$ |
|
|
|
|
( |
) |
|
$ |
( |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
( |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
The accompanying notes are an integral part of the consolidated financial statements.
F-7
CINEMARK HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
YEARS ENDED DECEMBER 31, 2017, 2018 AND 2019
(In thousands)
|
|
2017 |
|
|
2018 |
|
|
2019 |
|
|||
Operating activities |
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Adjustments to reconcile net income to cash provided by operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation |
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of intangible and other assets and favorable/unfavorable leases |
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of long-term prepaid rents |
|
|
|
|
|
|
|
|
|
|
— |
|
Amortization of debt issue costs |
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of deferred revenues, deferred lease incentives and other |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Impairment of long-lived assets |
|
|
|
|
|
|
|
|
|
|
|
|
Share based awards compensation expense |
|
|
|
|
|
|
|
|
|
|
|
|
Loss on disposal of assets and other |
|
|
|
|
|
|
|
|
|
|
|
|
Loss on debt amendments and refinancing |
|
|
|
|
|
|
|
|
|
|
— |
|
Non-cash rent expense |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
Deferred lease expenses |
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
Reclassification of cumulative translation adjustments |
|
|
( |
) |
|
|
|
|
|
|
— |
|
Equity in income of affiliates |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Deferred income tax expenses |
|
|
( |
) |
|
|
|
|
|
|
( |
) |
Distributions from equity investees |
|
|
|
|
|
|
|
|
|
|
|
|
Changes in other assets and liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
Inventories |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Accounts receivable |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
Income tax receivable |
|
|
( |
) |
|
|
|
|
|
|
( |
) |
Prepaid expenses and other |
|
|
( |
) |
|
|
|
|
|
|
( |
) |
Deferred charges and other assets - net |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Accounts payable and accrued expenses |
|
|
|
|
|
|
( |
) |
|
|
|
|
Income tax payable |
|
|
|
|
|
|
|
|
|
|
( |
) |
Liabilities for uncertain tax positions |
|
|
|
|
|
|
( |
) |
|
|
|
|
Other long-term liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities |
|
|
|
|
|
|
|
|
|
|
|
|
Investing activities |
|
|
|
|
|
|
|
|
|
|
|
|
Additions to theatre properties and equipment and other |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Proceeds from sale of theatre properties and equipment and other |
|
|
|
|
|
|
|
|
|
|
|
|
Acquisitions of theatres in the U.S. and international markets, net of cash acquired |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Acquisition of NCM common units |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
Investment in joint ventures and other, net |
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
Net cash used for investing activities |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Financing activities |
|
|
|
|
|
|
|
|
|
|
|
|
Dividends paid to stockholders |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Payroll taxes paid as a result of restricted stock withholdings |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Repayments of long-term debt |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Payment of debt issue costs |
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
Fees paid related to debt amendments |
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
Payments on capital and finance leases |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Proceeds from financing lease |
|
|
|
|
|
|
— |
|
|
|
— |
|
Other |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Net cash used for financing activities |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Effect of exchange rate changes on cash and cash equivalents |
|
|
|
|
|
|
( |
) |
|
|
( |
) |
Increase (decrease) in cash and cash equivalents |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
Cash and cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Beginning of period |
|
|
|
|
|
|
|
|
|
|
|
|
End of period |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Supplemental information (see Note 17)
The accompanying notes are an integral part of the consolidated financial statements.
F-8
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
1. |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
Business — Cinemark Holdings, Inc. and subsidiaries (the “Company”) operates in the motion picture exhibition industry, with theatres in the United States (“U.S.”), Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curaçao and Paraguay.
Principles of Consolidation — The consolidated financial statements include the accounts of Cinemark Holdings, Inc. and its subsidiaries. Majority-owned subsidiaries that the Company has control of are consolidated while those affiliates of which the Company owns between
Cash and Cash Equivalents — Cash and cash equivalents consist of operating funds held in financial institutions, petty cash held by the theatres and highly liquid investments with original maturities of three months or less when purchased. Cash investments are primarily in money market funds, certificates of deposit, commercial paper or other similar funds.
Accounts Receivable – Accounts receivable, which are recorded at net realizable value, consist primarily of receivables related to screen advertising, screen rental, receivables related to discounted tickets and gift cards sold to third party retail locations, receivables from landlords related to theatre construction and remodels, rebates earned from the Company’s concession vendors and value-added and other non-income tax receivables.
Inventories — Concession and theatre supplies inventories are stated at the lower of cost (first-in, first-out method) or market.
Theatre Properties and Equipment — Theatre properties and equipment are stated at cost less accumulated depreciation and amortization.
Category |
Useful Life |
Buildings on owned land |
|
Buildings on leased land |
|
Land and buildings under capital and finance leases (1) |
|
Theatre furniture and equipment |
|
Leasehold improvements |
|
(1) |
|
The Company reviews long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. The Company also performs a full quantitative impairment evaluation on an annual basis. The Company considers actual theatre level cash flows, budgeted theatre level cash flows, theatre property and equipment carrying values, operating lease right-of-use asset carrying values, amortizing intangible asset carrying values, the age of a recently built theatre, competitive theatres in the marketplace, the impact of recent ticket price changes, the impact of recent theatre remodels or other substantial improvements, available lease renewal options and other factors considered relevant in its impairment assessment. Long-lived assets are evaluated for impairment on a theatre basis, which the Company
F-9
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
believes is the lowest applicable level for which there are identifiable cash flows. The impairment evaluation is based on the estimated undiscounted cash flows from continuing use through the remainder of the theatre’s useful life. The remainder of the theatre’s useful life correlates with the remaining lease period, which includes the probability of the exercise of available renewal periods or extensions, for leased properties and the lesser of
Goodwill and Other Intangible Assets — The Company evaluates goodwill for impairment annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value of the goodwill may not be fully recoverable. The Company evaluates goodwill for impairment at the reporting unit level and we have allocated goodwill to the reporting unit based on an estimate of its relative fair value. Management considers the reporting unit to be each of its
A quantitative analysis requires the Company to estimate the fair value of each reporting unit and compare it with its carrying value. If the carrying value of the reporting unit exceeds its estimated fair value, goodwill would be written down such that the carrying value would equal estimated fair value. Fair value is determined based on a multiple of cash flows, which was
The Company performed a quantitative goodwill impairment analysis for all reporting units during the year ended December 31, 2017. For the year ended December 31, 2018, the Company performed a quantitative goodwill assessment for three new domestic reporting units and a qualitative assessment for all other reporting units. For the year ended December 31, 2019 the Company performed a qualitative analysis for all reporting units. The Company did
Tradename intangible assets are tested for impairment at least annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value may not be fully recoverable. Under ASC Topic 350, the Company can elect to perform a qualitative or quantitative impairment assessment for our tradename intangible assets. A quantitative tradename impairment assessment includes comparing the carrying values of tradename assets to an estimated fair value. Fair values are estimated by applying an estimated market royalty rate that could be charged for the use of our tradename to forecasted future revenues, with an adjustment for the present value of such royalties. If the estimated fair value is less than the carrying value, the tradename intangible asset is written down to its estimated fair value. Significant judgment is involved in estimating market royalty rates and long-term revenue forecasts. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on historical and projected revenue performance and industry trends. A
F-10
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
qualitative assessment considers our historical and forecasted revenues and changes in estimated royalty rates, and a comparison of current carrying values to estimated fair values from our most recent quantitative assessment.
During the year ended December 31, 2017, the Company performed a quantitative tradename impairment assessment for its tradename in Ecuador and performed a qualitative tradename impairment analysis for all other tradename intangible assets. During the year ended December 31, 2018, the Company performed a quantitative tradename impairment evaluation for all of its tradename assets. During the year ended December 31, 2019, the Company performed a qualitative tradename impairment analysis for all of its tradename assets. As a result of the analysis performed during each year,
The table below summarizes the Company’s intangible assets and the amortization method used for each type of intangible asset:
Intangible Asset |
Amortization Method |
Goodwill |
|
Tradename |
Indefinite-lived and definite-lived. Definite-lived tradename assets have a remaining useful life of approximately |
Vendor contracts |
Straight-line method over the terms of the underlying contracts. The remaining term of the underlying contract is |
Favorable/unfavorable leases |
|
Other intangible assets |
Straight-line method over the terms of the underlying agreement or the expected useful life of the intangible asset. The remaining useful lives of these intangible assets range from |
Deferred Charges — Deferred charges and other assets consist of construction and other deposits, equipment to be placed in service, and other assets of a long-term nature.
Revenue and Expense Recognition — See Note 4 for discussion of revenue recognition and deferred revenues.
Film rental costs are subject to the film licensing arrangement and accrued based on the applicable box office receipts and either; 1) a sliding scale formula, which is generally established prior to the opening of the film, 2) firm terms or 3) estimates of the final settlement rate, which occurs at the conclusion of the film run. Under a sliding scale formula, we pay a percentage of box office revenues using a pre-determined matrix that is based upon box office performance of the film for its full run. Under a firm terms formula, we pay the distributor a percentage of box office receipts, which reflects either an aggregate rate for the life of the film or rates that decline over the term of the run. The settlement process allows for negotiation of film rental fees upon the conclusion of the film run
F-11
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
based upon how the film performs. Estimates are based on the expected success of a film. The success of a film can typically be determined a few weeks after a film is released when the initial box office performance of the film is known. If actual settlements are different than those estimates, film rental costs are adjusted at that time.
Accounting for Share Based Awards — The Company measures the cost of employee services received in exchange for an equity award based on the fair value of the award on the date of the grant. The grant date fair value is estimated using a market observed price. Such costs are recognized over the period during which an employee is required to provide service in exchange for the award (which is usually the vesting period). At the time of the grant, the Company also estimates the number of awards that will ultimately be forfeited. See Note 16 for discussion of the Company’s share based awards and related compensation expense.
Income Taxes — The Company uses an asset and liability approach to financial accounting and reporting for income taxes. Deferred income taxes are provided when tax laws and financial accounting standards differ with respect to the amount of income for a year and the basis of assets and liabilities. A valuation allowance is recorded to reduce the carrying amount of deferred tax assets unless it is more likely than not that such assets will be realized. Income taxes are provided on unremitted earnings from foreign subsidiaries unless such earnings are expected to be indefinitely reinvested. Income taxes have also been provided for potential tax assessments. The evaluation of an uncertain tax position is a two-step process. The first step is recognition: The Company determines whether it is more likely than not that a tax position will be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. In evaluating whether a tax position has met the more-likely-than-not recognition threshold, the Company should presume that the position would be examined by the appropriate taxing authority that would have full knowledge of all relevant information. The second step is measurement: A tax position that meets the more-likely-than-not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is greater than
Segments — For the years ended December 31, 2017, 2018 and 2019, the Company managed its business under
Use of Estimates — The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. The Company’s consolidated financial statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates.
Foreign Currency Translations — The assets and liabilities of the Company’s foreign subsidiaries are translated into U.S. dollars at current exchange rates as of the balance sheet date, and revenues and expenses are translated at average monthly exchange rates. The resulting translation adjustments are recorded in the consolidated balance sheets in accumulated other comprehensive loss. See Note 14 for a summary of the translation adjustments recorded in accumulated other comprehensive loss for the years ended December 31, 2017, 2018 and 2019. The Company recognizes foreign currency transaction gains and losses when changes in exchange rates impact transactions, other than intercompany transactions of a long-term investment nature, that have been denominated in a currency other than the functional currency.
F-12
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
Fair Value Measurements — According to authoritative guidance, inputs used in fair value measurements fall into three different categories; Level 1, Level 2 and Level 3. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for the asset or liability. See Note 13 for a discussion of our fair value measurements for the years ended December 31, 2018 and 2019.
Acquisitions — The Company accounts for acquisitions under the acquisition method of accounting. The acquisition method requires that the acquired assets and liabilities, including contingencies, be recorded at fair value determined on the acquisition date and changes thereafter reflected in income. For certain acquisitions, the Company obtains independent third party valuation studies for certain of the assets acquired and liabilities assumed to assist the Company in determining fair value. The estimation of the fair values of the assets acquired and liabilities assumed involves a number of estimates and assumptions that could differ materially from the actual amounts realized. The Company provides assumptions, including both quantitative and qualitative information, about the specified asset or liability to the third party valuation firms. The Company primarily utilizes the third parties to accumulate comparative data from multiple sources and assemble a report that summarizes the information obtained. The Company then uses the information to record estimated fair value. The third party valuation firms are supervised by Company personnel who are knowledgeable about valuations and fair value. The Company evaluates the appropriateness of the assumptions and valuation methodologies utilized by the third party valuation firm.
2. |
NEW ACCOUNTING PRONOUNCEMENTS |
Impact of New Lease Accounting Standard
The Company adopted ASC Topic 842 effective January 1, 2019. See Note 3 for further discussion.
Other Accounting Pronouncements
ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement, (“ASU 2018-13”). The purpose of ASU 2018-13 is to improve the disclosures related to fair value measurements in the financial statements. The improvements in ASU 2018-13 include the removal, modification and addition of certain disclosure requirements primarily related to Level 3 fair value measurements. ASU 2018-13 is effective for fiscal years beginning after December 15, 2019, including interim periods within that year. The amendments in ASU 2018-13 should be applied prospectively. The Company does not expect ASU 2018-13 to have a significant impact on the consolidated financial statements.
ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, (“ASU 2019-12”). The purpose of ASU 2019-12 is to improve the disclosures related to fair value measurements in the financial statements. The improvements in ASU 2019-12 include removing certain exceptions for recognizing deferred taxes for investments, performing intraperiod allocation and calculating income taxes in interim periods. ASU 2019-12 also adds guidance to reduce complexity in certain areas, including recognizing deferred taxes for tax goodwill and allocating taxes to members of a consolidated group. ASU 2019-12 is effective for fiscal years beginning after December 15, 2020, including interim periods within that year. The amendments in ASU 2019-12 should be applied prospectively. The Company is evaluating the impact of ASU 2019-12 on the consolidated financial statements.
3. |
ADOPTION OF ASC TOPIC 842 – LEASE ACCOUNTING |
The Company adopted ASC Topic 842 as of January 1, 2019 under the modified retrospective approach that resulted in the recognition of a cumulative-effect adjustment to the opening balance of retained earnings and elected certain practical expedients. The Company elected the following practical expedients, as allowed by ASC Topic 842:
|
• |
The Company chose not to separate nonlease components from lease components, accounting for lease components and nonlease components associated with a lease as a single lease component. More specifically, for theatre leases, the Company elected not to separate fixed common area maintenance costs from lease costs when calculating lease liabilities and assets. |
F-13
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
|
• |
The Company did not reassess whether existing contracts in effect as of the transition date of January 1, 2019 were, or contained, a lease. |
|
• |
The Company did not reassess the classification of existing leases as operating or finance as of the transition date. |
|
• |
The Company did not reassess whether any initial direct costs were incurred for any of its existing leases. |
|
• |
The Company did not elect to apply the recognition requirements of ASC 842 to short-term leases. |
The adoption of ASC Topic 842 included the following primary impacts:
|
1. |
The Company recorded a right-of-use asset and lease liability for all of its operating leases as required by the standard. The lease liability for each lease was determined based on the present value of lease payments. The right-of-use asset was based on the lease liability value, adjusted for offsets that existed as of adoption, including deferred rent liabilities of ($ |
|
2. |
Certain of the Company’s existing lease assets and liabilities, which were accounted for under prior sale-leaseback accounting guidance, were derecognized in accordance with ASC Topic 842 and reevaluated for classification per the new accounting guidance. Several of these leases have been reestablished as operating leases based on ASC Topic 842. |
|
a. |
For those leases that are now classified as operating leases in accordance with ASC Topic 842, approximately $ |
|
b. |
The Company recognized finance lease assets and liabilities in the amount of $ |
|
3. |
For the leases noted in item 2a above, the Company will now record the related operating lease payments as facility lease expense, compared to prior periods in which the capitalized asset was depreciated and lease payments were recorded as a reduction of a lease liability and interest expense. |
Real Estate Leases - The Company conducts a significant part of its theatre operations in leased properties under noncancelable operating and finance leases with terms generally ranging from
Equipment Leases - The Company has certain equipment operating leases primarily including projectors, trash compactors and various other equipment used in the day-to-day operation of the business. Certain of the leases require fixed lease payments to be made over the duration of the lease term, while others are variable in nature based on usage or sales. Certain of these leases are month-to-month, while others are noncancelable with terms generally ranging from
F-14
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
The following table represents the operating and finance right-of-use assets and lease liabilities as of December 31, 2019.
|
|
|
As of |
|
|
Leases |
Classification |
|
December 31, 2019 |
|
|
Assets (1) |
|
|
|
|
|
Operating lease assets |
Operating lease assets |
|
$ |
|
|
Finance lease assets |
Theatre properties and equipment, net of accumulated depreciation (2) |
|
|
|
|
Total lease assets |
|
|
$ |
|
|
|
|
|
|
|
|
Liabilities (1) |
|
|
|
|
|
Current |
|
|
|
|
|
Operating |
Current portion of operating lease obligations |
|
$ |
|
|
Finance |
Current portion of finance lease obligations |
|
|
|
|
Noncurrent |
|
|
|
|
|
Operating |
Operating lease obligations, less current portion |
|
|
|
|
Finance |
Finance lease obligations, less current portion |
|
|
|
|
Total lease liabilities |
|
|
$ |
|
|
(1) |
|
(2) |
|
As of December 31, 2019, the Company had signed lease agreements with total noncancelable lease payments of approximately $
The following table represents the Company’s aggregate lease costs, by lease classification, for the year ended December 31, 2019.
|
|
Year Ended |
|
|
Lease Cost |
Classification |
December 31, 2019 |
|
|
Operating lease costs |
|
|
|
|
Equipment (1) |
Utilities and other |
$ |
|
|
Real Estate (2)(3) |
Facility lease expense |
|
|
|
Total operating lease costs |
|
$ |
|
|
|
|
|
|
|
Finance lease costs |
|
|
|
|
Depreciation of leased assets |
Depreciation and amortization |
$ |
|
|
Interest on lease liabilities |
Interest expense |
|
|
|
Total finance lease costs |
|
$ |
|
|
(1) |
|
(2) |
|
(3) |
|
F-15
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
The following table represents the maturity of lease liabilities, by lease classification, as of December 31, 2019.
|
|
Operating |
|
Finance |
|
|
|
|
||
Years Ending |
|
Leases |
|
Leases |
|
Total |
|
|||
2020 |
|
$ |
|
|
$ |
|
|
$ |
|
|
2021 |
|
|
|
|
|
|
|
|
|
|
2022 |
|
|
|
|
|
|
|
|
|
|
2023 |
|
|
|
|
|
|
|
|
|
|
2024 |
|
|
|
|
|
|
|
|
|
|
After 2024 |
|
|
|
|
|
|
|
|
|
|
Total lease payments |
|
$ |
|
|
$ |
|
|
$ |
|
|
Less: Interest |
|
|
|
|
|
|
|
|
|
|
Present value of lease liabilities |
|
$ |
|
|
$ |
|
|
$ |
|
|
The following table represents future minimum lease payments under noncancelable operating and capital leases at December 31, 2018 as presented in the Company’s Annual Report on Form 10-K filed February 28, 2019:
|
|
Operating |
|
|
Capital |
|
||
Years Ending |
|
Leases |
|
|
Leases |
|
||
2019 |
|
$ |
|
|
|
$ |
|
|
2020 |
|
|
|
|
|
|
|
|
2021 |
|
|
|
|
|
|
|
|
2022 |
|
|
|
|
|
|
|
|
2023 |
|
|
|
|
|
|
|
|
Thereafter |
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
|
|
|
Amounts representing interest payments |
|
|
|
|
|
|
( |
) |
Present value of future minimum payments |
|
|
|
|
|
|
|
|
Current portion of capital lease obligations |
|
|
|
|
|
|
( |
) |
Capital lease obligations, less current portion |
|
|
|
|
|
$ |
|
|
The following table represents the weighted-average remaining lease term and discount rate, disaggregated by lease classification, as of December 31, 2019.
|
|
As of |
|
|
Lease Term and Discount Rate |
|
December 31, 2019 |
|
|
Weighted-average remaining lease term (years) (1) |
|
|
|
|
Operating leases - equipment |
|
|
|
|
Operating leases - real estate |
|
|
|
|
Finance leases - equipment |
|
|
|
|
Finance leases - real estate |
|
|
|
|
|
|
|
|
|
Weighted-average discount rate (2) |
|
|
|
|
Operating leases - equipment |
|
|
|
% |
Operating leases - real estate |
|
|
|
% |
Finance leases - equipment |
|
|
|
% |
Finance leases - real estate |
|
|
|
% |
|
(1) |
|
|
F-16
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
|
(2) |
|
|
The following table represents the minimum cash lease payments included in the measurement of lease liabilities and the non-cash addition of right-of-use assets for the twelve months ended December 31, 2019.
|
|
Year Ended |
|
|
Other Information |
|
December 31, 2019 |
|
|
Cash paid for amounts included in the measurement of lease liabilities |
|
|
|
|
Cash outflows for operating leases |
|
$ |
|
|
Cash outflows for finance leases - operating activities |
|
$ |
|
|
Cash outflows for finance leases - financing activities |
|
$ |
|
|
Non-cash amount of leased assets obtained in exchange for: |
|
|
|
|
Operating lease liabilities - real estate |
|
$ |
|
|
Operating lease liabilities - equipment |
|
$ |
|
|
Finance lease liabilities |
|
$ |
|
|
Lessor Arrangements
As noted above, the Company did not reassess whether existing contracts in effect as of the transition date of January 1, 2019 were, or contained, a lease. However, effective September 17, 2019, the Company amended its Exhibitor Services Agreement (“ESA”) with National CineMedia, LLC (“NCM”) and, as a result of this amendment, the Company reassessed the ESA under ASC Topic 842. The Company’s assessment resulted in the determination that the nonconsecutive periods of use of the theatre screens by NCM under the ESA qualify as a lease in accordance with ASC Topic 842. See further discussion in Note 7.
The Company rents its theatre auditoriums for corporate meetings, screenings, education and training sessions and other private events. These rentals, which are not significant to the Company, are generally one-time events and the related revenue is reflected as other revenue on the consolidated statement of income.
4. |
REVENUE RECOGNITION |
Revenue Recognition Policy
The Company’s patrons have the option to purchase movie tickets well in advance of a movie showtime or right before the movie showtime, or at any point in between those two timeframes depending on seat availability. The Company recognizes such admissions revenues when the showtime for a purchased movie ticket has passed. Concession revenues are recognized when products are sold to the consumer. Other revenues primarily consist of screen advertising and screen rental revenues, promotional income, studio trailer placements and transactional fees. The Company sells gift cards and discount ticket vouchers, the proceeds from which are recorded as deferred revenues. Deferred revenues for gift cards and discount ticket vouchers are recognized when they are redeemed for movie tickets or concession items. The Company offers a subscription program in the U.S. whereby patrons can pay a monthly fee to receive a monthly credit for use towards a future movie ticket purchase. The Company records the monthly subscription program fees as deferred revenues and record admissions revenues when the showtime for a movie ticket purchased with a credit has passed. The Company has loyalty programs in the U.S. and many of its international locations that either have a prepaid annual membership fee or award points to customers as purchases are made. For those loyalty programs that have an annual membership fee, the Company recognizes the fee collected as other revenues on a straight-line basis over the term of the membership. For those loyalty programs that award points to customers based on their purchases, the Company records a portion of the original transaction proceeds as deferred revenues based on the number of reward points issued to customers and recognizes the deferred revenues when the customer redeems such points. The value of loyalty points issued is based on the estimated fair value of the rewards offered. The Company records breakage revenue on gift cards and discount ticket vouchers generally based on redemption activity and historical experience with unused balances. The Company records breakage revenue upon the expiration of loyalty points and subscription credits. Breakage revenue is recorded as
F-17
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
other revenues on the consolidated income statements. Advances collected on concession and other contracts are deferred and recognized during the period in which we satisfy the related performance obligations, which may differ from the period in which the advances are collected. These advances are recognized on either a straight-line basis over the term of the contracts or as the Company meets its performance obligations in accordance with the terms of the contracts.
Screen advertising and screen rental revenues for the U.S. operating segment primarily relate to the ESA with NCM and the Company’s beverage concessionaire agreement. Prior to September 17, 2019, such screen advertising was accounted for under ASC Topic 606, Revenue from Contracts with Customers, and effective upon the amendment of the ESA, NCM screen advertising was accounted for under ASC Topic 842. See table at Note 7 for screen advertising revenues recorded in other revenue under ASC Topic 606 prior to the amendment of the ESA and screen rental revenues recorded in other revenue under ASC Topic 842 subsequent to the amendment of the ESA.
Accounts receivable as of December 31, 2019 included approximately $
Disaggregation of Revenue
The following table presents revenues for the periods indicated, disaggregated based on major type of good or service and by reportable operating segment.
|
|
Twelve Months Ended |
|
|
Twelve Months Ended |
|
||||||||||||||||||
|
|
December 31, 2018 |
|
|
December 31, 2019 |
|
||||||||||||||||||
|
|
U.S. |
|
|
International |
|
|
|
|
|
|
U.S. |
|
|
International |
|
|
|
|
|
||||
|
|
Operating |
|
|
Operating |
|
|
|
|
|
|
Operating |
|
|
Operating |
|
|
|
|
|
||||
Major Goods/Services |
|
Segment (1) |
|
|
Segment |
|
|
Consolidated |
|
|
Segment (1) |
|
|
Segment |
|
|
Consolidated |
|
||||||
Admissions revenues |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Concession revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Screen advertising, screen rental and promotional revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
(1) |
|
The following table presents revenues for the periods indicated, disaggregated based on timing of revenue recognition (as discussed above).
|
|
Twelve Months Ended |
|
|
Twelve Months Ended |
|
||||||||||||||||||
|
|
December 31, 2018 |
|
|
December 31, 2019 |
|
||||||||||||||||||
|
|
U.S. |
|
|
International |
|
|
|
|
|
|
U.S. |
|
|
International |
|
|
|
|
|
||||
|
|
Operating |
|
|
Operating |
|
|
|
|
|
|
Operating |
|
|
Operating |
|
|
|
|
|
||||
|
|
Segment (1) |
|
|
Segment |
|
|
Consolidated |
|
|
Segment (1) |
|
|
Segment |
|
|
Consolidated |
|
||||||
Goods and services transferred at a point in time |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Goods and services transferred over time |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
F-18
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
|
(1) |
U.S. segment revenues include eliminations of intercompany transactions with the international operating segment. See Note 20 for additional information on intercompany eliminations. |
Screen Advertising Advances and Other Deferred Revenues
The following table presents changes in the Company’s deferred revenues for the year ended December 31, 2019.
Deferred Revenues |
|
NCM Screen Advertising Advances (1) |
|
|
Other Deferred Revenues (2) |
|
|
Total |
|
|||
Balance at January 1, 2019 |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Amounts recognized as accounts receivable |
|
|
— |
|
|
|
|
|
|
|
|
|
Cash received from customers in advance |
|
|
— |
|
|
|
|
|
|
|
|
|
Common units received from NCM (see Note 7) |
|
|
|
|
|
|
— |
|
|
|
|
|
Interest accrued related to significant financing component |
|
|
|
|
|
|
— |
|
|
|
|
|
Revenue recognized during period |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Foreign currency translation adjustments |
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
Balance at December 31, 2019 |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
(1) |
|
|
(2) |
|
The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied as of December 31, 2019 and when the Company expects to recognize this revenue.
|
|
Twelve Months Ended December 31, |
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Remaining Performance Obligations |
|
2020 |
|
|
2021 |
|
|
2022 |
|
|
2023 |
|
|
2024 |
|
|
Thereafter |
|
|
Total |
|
|||||||
Deferred revenue - other |
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
$ |
|
|
Significant Financing Component
As discussed further in Note 7, in connection with the completion of the NCM, Inc. (“NCMI”) initial public offering, the Company amended and restated its ESA with NCM and received approximately $174,000 in cash consideration from NCM. The proceeds were recorded as deferred revenue and are being amortized over the term of the modified ESA, or through February 2041. In addition to the consideration received upon the ESA modification during 2007, the Company also receives consideration in the form of common units from NCM, at each annual common unit adjustment settlement, in exchange for exclusive access to the Company’s newly opened domestic screens under the ESA. See Note 7 for additional information regarding the common unit adjustment and related accounting. Due to the significant length of time between receiving the consideration from NCM and fulfillment of the related performance obligation, the ESA includes an implied significant financing component, as per the guidance in ASC Topic 606. The interest expense was calculated using the Company’s incremental borrowing rates at the time when the cash and each tranche of common units were received from NCM, which ranged from
5. |
EARNINGS PER SHARE |
The Company considers its unvested share based payment awards, which contain non-forfeitable rights to dividends, participating securities, and includes such participating securities in its computation of earnings per share pursuant to the two-class method. Basic earnings per share for the two classes of stock (common stock and unvested restricted stock) is calculated by dividing net income by the weighted average number of shares of common stock and unvested restricted stock outstanding during the reporting period. Diluted earnings per share is calculated using
F-19
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
the weighted average number of shares of common stock plus the potentially dilutive effect of common equivalent shares outstanding determined under both the two class method and the treasury stock method.
The following table presents computations of basic and diluted earnings per share under the two class method:
|
|
Year Ended |
|
|||||||||
|
|
December 31, |
|
|||||||||
|
|
2017 |
|
|
2018 |
|
|
2019 |
|
|||
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to Cinemark Holdings, Inc. |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Earnings allocated to participating share-based awards (1) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Net income attributable to common stockholders |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Denominator (shares in thousands): |
|
|
|
|
|
|
|
|
|
|
|
|
Basic weighted average shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
Common equivalent shares for restricted stock units |
|
|
|
|
|
|
|
|
|
|
|
|
Diluted weighted average shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per share attributable to common stockholders |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Diluted earnings per share attributable to common stockholders |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
(1) |
|
6. |
DIVIDENDS |
Below is a summary of dividends declared for the fiscal periods indicated.
|
|
|
|
|
|
Amount per Share of |
|
|
Total |
|
||
Declaration Date |
|
Record Date |
|
Payable Date |
|
Common Stock |
|
|
Dividends (1) |
|
||
|
|
|
|
|
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
|
|
(1) |
|
F-20
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
7. |
INVESTMENT IN NATIONAL CINEMEDIA LLC |
Summary of Activity with NCM
Below is a summary of activity with NCM included in the Company’s consolidated financial statements for the periods indicated. See Note 4 for discussion of the impact of the new revenue recognition accounting pronouncement.
|
|
Investment in NCM |
|
|
NCM Screen Advertising Advances |
|
|
Distributions from NCM |
|
|
Equity in Earnings |
|
|
Other Revenue |
|
|
Interest Expense - NCM (3) |
|
|
Cash Received |
|
|||||||
Balance as of January 1, 2017 |
|
$ |
|
|
|
$ |
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Receipt of common units due to annual common unit adjustment |
|
|
|
|
|
|
( |
) |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
Revenues earned under ESA (1) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
|
|
Receipt of excess cash distributions |
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
Receipt under tax receivable agreement |
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
Equity in earnings |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Amortization of screen advertising advances |
|
|
— |
|
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
Balance as of and for the twelve months ended December 31, 2017 |
|
$ |
|
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
— |
|
|
$ |
|
|
Impact of adoption of ASC Topic 606 (2) |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Receipt of common units due to annual common unit adjustment |
|
|
|
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Purchase of additional common units |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Revenues earned under ESA (1) (2) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
|
|
|
|
|
|
Receipt of excess cash distributions |
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
Receipt under tax receivable agreement |
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
Equity in earnings |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Amortization of screen advertising advances |
|
|
— |
|
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
Balance as of and for the twelve months ended December 31, 2018 |
|
$ |
|
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
|
|
|
$ |
|
|
Receipt of common units due to annual common unit adjustment |
|
|
|
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Revenues earned under ESA (1) (3) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
|
|
Interest accrued related to significant financing component (2) |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
— |
|
Receipt of excess cash distributions |
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
Receipt under tax receivable agreement |
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
Equity in earnings |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Amortization of screen advertising advances (2) |
|
|
— |
|
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
Balance as of and for the twelve months ended December 31, 2019 |
|
$ |
|
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
|
|
|
$ |
|
|
(1) |
|
(2) |
|
(3) |
|
F-21
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
In addition to the activity in the table above, the Company made payments to NCM of approximately $
Investment in National CineMedia
NCM operates a digital in-theatre network in the U.S. for providing cinema advertising. The Company entered into an Exhibitor Services Agreement with NCM (“ESA”), pursuant to which NCM primarily provides advertising to our theatres. As described in Note 6 to the Company’s financial statements as included in its 2018 Annual Report on Form 10-K, on February 13, 2007, National Cinemedia, Inc. (“NCMI”), an entity that serves as the sole manager of NCM, completed an initial public offering (“IPO”) of its common stock. In connection with the NCMI initial public offering, the Company amended its operating agreement and the ESA. At the time of the NCMI IPO and as a result of amending the ESA, the Company received approximately $
Common Unit Adjustments
In addition to the consideration received upon the NCMI IPO and ESA modification in 2007, the Company also periodically receives consideration in the form of common units from NCM. Pursuant to a Common Unit Adjustment Agreement dated as of February 13, 2007 between NCMI and the Company, annual adjustments to the common membership units are made primarily based on increases or decreases in the number of theatre screens operated and theatre attendance generated by each Founding Member. As discussed in Note 6 to the Company’s financial statements as included in its 2018 Annual Report on Form 10-K, the common units received (collectively referred to as the Company’s “Tranche 2 Investment”) are recorded at estimated fair value as an increase in the Company’s investment in NCM with an offset to deferred revenue or NCM screen advertising advances. The Company’s Tranche 2 Investment is accounted for following the equity method, with undistributed equity earnings related to its Tranche 2 Investment included as a component of earnings in equity in income of affiliates and distributions received related to its Tranche 2 Investment are recorded as a reduction of investment basis
During March 2019, NCM performed its annual common unit adjustment calculation under the Common Unit Adjustment Agreement. As a result of the calculation, on March 29, 2019, the Company received an additional
Below is a summary of common units received by the Company under the Common Unit Adjustment (“CUA”) Agreement during the years ended December 31, 2017, 2018 and 2019:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Event |
|
Date Common Units Received |
|
Number of Common Units Received |
|
|
Fair Value of Common Units Received |
|
||
2017 annual common unit adjustment |
|
|
|
|
|
|
|
$ |
|
|
2018 annual common unit adjustment |
|
|
|
|
|
|
|
$ |
|
|
2019 annual common unit adjustment |
|
|
|
|
|
|
|
$ |
|
|
F-22
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
Each common unit received by the Company is convertible into one share of NCMI common stock. The fair value of the common units received was estimated based on the market price of NCMI stock at the time that the common units were received, adjusted for volatility associated with the estimated period of time it would take to convert the common units and register the respective NCMI shares. The fair value measurement used for the common units falls under Level 2 of the U.S. GAAP fair value hierarchy as defined by ASC Topic 820-10-35. The Company records the additional common units it receives as part of its Tranche 2 Investment at estimated fair value with a corresponding adjustment to deferred revenue. The deferred revenue is amortized over the remaining term of the ESA.
Acquisition of Common Units
On July 5, 2018, the Company acquired
As of December 31, 2019, the Company owned a total of
Exhibitor Services Agreement
As previously discussed, our domestic theatres are part of the in-theatre digital network operated by NCM under the ESA. NCM provides advertising to our theatres through its branded “Noovie” pre-show entertainment program and also handles lobby promotions and displays for our theatres. We receive a monthly theatre access fee for participation in the NCM network and also earn screen advertising revenue on a per patron basis. Prior to September 17, 2019, the ESA was accounted for under ASC Topic 606, Revenue from Contracts with Customers. See Note 3 and Note 4. Effective September 17, 2019, the Company signed an amendment to the ESA, under which the Company will provide incremental advertising time to NCM and has extended the term through
The recognition of revenue related to the deferred revenue or NCM screen advertising advances will continue to be recorded on a straight-line basis over the new term of the amended ESA or February 2041.
|
|
Twelve Months Ended December 31, |
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Remaining Maturity |
|
2020 |
|
|
2021 |
|
|
2022 |
|
|
2023 |
|
|
2024 |
|
|
Thereafter |
|
|
Total |
|
|||||||
NCM screen advertising advances (1) |
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
|
(1) |
|
Significant Financing Component
Prior to the September 17, 2019 amendment of the ESA, the Company applied a significant financing component, as required by ASC Topic 606, due to the significant length of time between receiving the NCM screen advertising advances (the $
F-23
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
significant financing component guidance from ASC Topic 606 by analogy as the economic substance of the agreement represents a financing arrangement.
Subsequent to the issuance of the Company’s audited consolidated financial statements for the year ended December 31, 2018, the Company identified an error in the January 1, 2018 adoption of ASC Topic 606 specifically related to the significant financing component associated with the NCM ESA. The error impacted the cumulative effect of change in accounting principle for the adoption of ASC Topic 606 at January 1, 2018 and the recorded amounts of revenue and interest expense related to the amortization of NCM screen advertising advances associated with the significant financing component during 2018 and 2019. The Company evaluated the error and, based on an analysis of the relevant quantitative and qualitative factors, determined the impact was not material to the Company’s consolidated financial statements for any prior annual or interim period. The consolidated balance sheet, consolidated statement of equity, and corresponding notes to consolidated financial statements as of and for the year ended December 31, 2018 have been restated from the amounts previously reported to correct the cumulative effect of change in accounting principle for the adoption of ASC Topic 606. This resulted in a $
Summary Financial Information for NCM
The tables below present summary financial information for NCM for the periods indicated:
|
|
Year Ended |
|
|
Year Ended |
|
|
Year Ended |
|
|||
|
|
December 28, 2017 |
|
|
December 27, 2018 |
|
|
December 26, 2019 |
|
|||
Revenues |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Operating income |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Net income |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
|
As of |
|
|
As of |
|
||
|
|
December 27, 2018 |
|
|
December 26, 2019 |
|
||
Current assets |
|
$ |
|
|
|
$ |
|
|
Noncurrent assets |
|
$ |
|
|
|
$ |
|
|
Current liabilities |
|
$ |
|
|
|
$ |
|
|
Noncurrent liabilities |
|
$ |
|
|
|
$ |
|
|
Members' deficit |
|
$ |
( |
) |
|
$ |
( |
) |
F-24
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
8. |
OTHER INVESTMENTS |
Below is a summary of activity for each of the Company’s other investments for the periods indicated:
|
|
DCIP |
|
|
AC JV, LLC |
|
|
DCDC |
|
|
FE Concepts |
|
|
Other |
|
|
Total |
|
||||||
Balance at January 1, 2017 |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
— |
|
|
$ |
|
|
|
$ |
|
|
Cash contributions |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity in income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
|
Equity in comprehensive income |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
Cash distributions received |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
Other |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
Balance at December 31, 2017 |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Cash contributions |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
— |
|
|
|
|
|
Equity in income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
— |
|
|
|
|
|
Equity in comprehensive loss |
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
Cash distributions received |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
Other (1) |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Balance at December 31, 2018 |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Equity in income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
— |
|
|
|
|
|
Equity in comprehensive loss |
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
Cash distributions received |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
Other (2) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
Balance at December 31, 2019 |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
(1) |
|
|
(2) |
|
Digital Cinema Implementation Partners LLC (“DCIP”)
On February 12, 2007, the Company, AMC and Regal (the “Exhibitors”) entered into a joint venture known as DCIP to facilitate the implementation of digital cinema in the Company’s theatres and to establish agreements with major motion picture studios for the financing of digital cinema. On March 10, 2010, DCIP and its subsidiaries completed an initial financing transaction to enable the purchase, deployment and leasing of digital projection systems to the Exhibitors under equipment lease and installation agreements. On March 31, 2011, DCIP obtained incremental financing necessary to complete the deployment of digital projection systems. DCIP also entered into long-term Digital Cinema Deployment Agreements (“DCDAs”) with
As of December 31, 2019, the Company had a
Below is summary financial information for DCIP as of and for the years ended December 31, 2017, 2018 and 2019:
|
|
Year ended December 31, |
|
|||||||||
|
|
2017 |
|
|
2018 |
|
|
2019 |
|
|||
Revenues |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Operating income |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Net income |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
F-25
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
|
|
As of |
|
|||||
|
|
December 31, 2018 |
|
|
December 31, 2019 |
|
||
Current assets |
|
$ |
|
|
|
$ |
|
|
Noncurrent assets |
|
$ |
|
|
|
$ |
|
|
Current liabilities |
|
$ |
|
|
|
$ |
|
|
Noncurrent liabilities |
|
$ |
|
|
|
$ |
|
|
Members' equity |
|
$ |
|
|
|
$ |
|
|
As of December 31, 2019, the Company had
|
|
Year Ended December 31, |
|
|||||||||
|
|
2017 |
|
|
2018 |
|
|
2019 |
|
|||
Equipment lease payments |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Warranty reimbursements from DCIP |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
Management services fees |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
AC JV, LLC
During December 2013, the Company, Regal, AMC (the “AC Founding Members”) and NCM entered into a series of agreements that resulted in the formation of AC JV, LLC (“AC”), a joint venture that owns “Fathom Events” (consisting of Fathom Events and Fathom Consumer Events) formerly operated by NCM. The Fathom Events business focuses on the marketing and distribution of live and pre-recorded entertainment programming to various theatre operators to provide additional programs to augment their feature film schedule. The Company paid event fees to AC of $
Digital Cinema Distribution Coalition
The Company is a party to a joint venture with certain exhibitors and distributors called Digital Cinema Distribution Coalition (“DCDC”). DCDC operates a satellite distribution network that distributes all digital content to U.S. theatres via satellite. The Company has an approximate
FE Concepts, LLC
During April 2018, the Company, through its wholly-owned indirect subsidiary CNMK Texas Properties, LLC (“CNMK”), formed a joint venture, FE Concepts, LLC (“FE Concepts”) with AWSR Investments, LLC (“AWSR”), an entity owned by Lee Roy Mitchell and Tandy Mitchell. In December of 2019, FE Concepts opened a family entertainment center that offers bowling, gaming, movies and other amenities. The Company and AWSR each invested approximately $
F-26
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
9. |
GOODWILL AND OTHER INTANGIBLE ASSETS — NET |
The Company’s goodwill was as follows:
|
|
U.S. Operating Segment |
|
|
International Operating Segment |
|
|
Total |
|
|||
Balance at December 31, 2017 (1) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Acquisition of theatres (2) |
|
|
— |
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustments |
|
— |
|
|
|
( |
) |
|
|
( |
) |
|
Balance at December 31, 2018 (1) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Acquisition of theatres (3) |
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustments |
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
Balance at December 31, 2019 (1) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
(1) |
|
(2) |
|
(3) |
|
As of December 31, intangible assets-net, consisted of the following:
|
|
Balance at January 1, 2018 |
|
|
Additions (1) |
|
|
Amortization |
|
|
Other (2) |
|
|
Balance at December 31, 2018 |
|
|||||
Intangible assets with finite lives: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross carrying amount |
|
$ |
|
|
|
$ |
1,203 |
|
|
$ |
— |
|
|
$ |
( |
) |
|
$ |
|
|
Accumulated amortization |
|
|
( |
) |
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
( |
) |
Total net intangible assets with finite lives |
|
$ |
|
|
|
$ |
|
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
|
|
Intangible assets with indefinite lives: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tradename and other |
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
( |
) |
|
|
|
|
Total intangible assets — net |
|
$ |
|
|
|
$ |
2,056 |
|
|
$ |
(5,734 |
) |
|
$ |
( |
) |
|
$ |
|
|
|
|
Balance at January 1, 2019 |
|
|
Additions (3) |
|
|
Impact of ASC Topic 842 (4) |
|
|
Amortization |
|
|
Other (2) |
|
|
Balance at December 31, 2019 |
|
||||||
Intangible assets with finite lives: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross carrying amount |
|
$ |
|
|
|
$ |
(143 |
) |
|
$ |
( |
) |
|
$ |
— |
|
|
$ |
( |
) |
|
$ |
|
|
Accumulated amortization |
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
( |
) |
Total net intangible assets with finite lives |
|
$ |
|
|
|
$ |
( |
) |
|
$ |
|
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
|
|
Intangible assets with indefinite lives: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tradename and other |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
( |
) |
|
|
|
|
Total intangible assets — net |
|
$ |
|
|
|
$ |
349 |
|
|
$ |
|
|
|
$ |
(4,994 |
) |
|
$ |
( |
) |
|
$ |
|
|
(1) |
|
(2) |
|
(3) |
|
(4) |
|
F-27
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
Estimated aggregate future amortization expense for intangible assets is as follows:
For the year ended December 31, 2020 |
|
$ |
|
|
For the year ended December 31, 2021 |
|
|
|
|
For the year ended December 31, 2022 |
|
|
|
|
For the year ended December 31, 2023 |
|
|
|
|
For the year ended December 31, 2024 |
|
|
|
|
Thereafter |
|
|
|
|
Total |
|
$ |
|
|
10. |
IMPAIRMENT OF LONG-LIVED ASSETS |
The Company reviews long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. See Note 1 for discussion of the Company’s impairment policy.
The Company’s long-lived asset impairment losses are summarized in the following table:
|
|
Year Ended |
|
|||||||||
|
|
December 31, |
|
|||||||||
|
|
2017 |
|
|
2018 |
|
|
2019 |
|
|||
U.S. theatre properties |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
U.S. theatre operating lease right-of-use assets |
|
|
— |
|
|
|
— |
|
|
|
|
|
International theatre properties |
|
|
|
|
|
|
|
|
|
|
|
|
International theatre operating lease right-of-use assets |
|
|
— |
|
|
|
— |
|
|
|
|
|
Impairment of long-lived assets |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
The long-lived asset impairment charges recorded during each of the periods presented were for certain new concept theatres being developed and tested by the Company and other theatres that were individually impacted by increased competition, adverse changes in market demographics, or adverse changes in the development or the conditions of the areas surrounding the theatre. As of December 31, 2019, the estimated aggregate remaining fair value of the long-lived assets impaired during the year ended December 31, 2019 was approximately $
11. |
DEFERRED CHARGES AND OTHER ASSETS — NET |
As of December 31, deferred charges and other assets — net consisted of the following:
|
|
December 31, |
|
|||||
|
|
2018 |
|
|
2019 |
|
||
Long-term prepaid rents (1) |
|
$ |
|
|
|
$ |
— |
|
Construction and other deposits |
|
|
|
|
|
|
|
|
Equipment to be placed in service |
|
|
|
|
|
|
|
|
Other |
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
|
|
|
(1) |
|
|
F-28
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
12. |
LONG-TERM DEBT |
As of December 31, long-term debt consisted of the following:
|
|
December 31, |
|
|||||
|
|
2018 |
|
|
2019 |
|
||
Cinemark USA, Inc. term loan |
|
$ |
|
|
|
$ |
|
|
Cinemark USA, Inc. 5.125% senior notes due 2022 |
|
|
|
|
|
|
|
|
Cinemark USA, Inc. 4.875% senior notes due 2023 |
|
|
|
|
|
|
|
|
Other |
|
|
|
|
|
|
— |
|
Total long-term debt |
|
|
|
|
|
|
|
|
Less current portion |
|
|
|
|
|
|
|
|
Less debt issuance costs, net of accumulated amortization of $ |
|
|
|
|
|
|
|
|
Long-term debt, less current portion |
|
$ |
|
|
|
$ |
|
|
Senior Secured Credit Facility
Cinemark USA, Inc. has a senior secured credit facility that includes a $
Cinemark USA, Inc. made the following amendments to its Credit Agreement as follows during 2017 and 2018:
|
|
|
|
Debt Issue |
|
|
Loss on Debt |
|
||
Effective Date |
|
Nature of Amendment |
|
Costs Paid (1) |
|
|
Amendment (2) |
|
||
June 16, 2017 |
|
Reduced term loan interest rate by |
|
$ |
|
|
|
$ |
|
|
November 28, 2017 |
|
Extended maturity of revolving credit line to |
|
$ |
|
|
|
$ |
|
|
March 29, 2018 |
|
Extended maturity of term loan to |
|
$ |
|
|
|
$ |
|
|
(1) |
|
(2) |
|
Under the amended Credit Agreement, quarterly principal payments of $
Subsequent to the March 29, 2018 amendment noted in the table above, interest on the term loan accrues at Cinemark USA, Inc.’s option at: (A) the base rate equal to the greater of (1) the US “Prime Rate” as quoted in The Wall Street Journal or if no such rate is quoted therein, in a Federal Reserve Board statistical release, (2) the federal funds effective rate plus
F-29
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
the revolving credit line is determined by the consolidated net senior secured leverage ratio as defined in the Credit Agreement.
At December 31, 2019, there was $
Cinemark USA, Inc.’s obligations under the Credit Agreement are guaranteed by Cinemark Holdings, Inc. and certain of Cinemark USA, Inc.’s domestic subsidiaries and are secured by mortgages on certain fee and leasehold properties and security interests in substantially all of Cinemark USA, Inc.’s and the guarantors’ personal property, including, without limitation, pledges of all of Cinemark USA, Inc.’s capital stock, all of the capital stock of certain of Cinemark USA, Inc.’s domestic subsidiaries and
The Credit Agreement contains usual and customary negative covenants for agreements of this type, including, but not limited to, restrictions on Cinemark USA, Inc.’s ability, and in certain instances, its subsidiaries’ and our ability, to consolidate or merge or liquidate, wind up or dissolve; substantially change the nature of its business; sell, transfer or dispose of assets; create or incur indebtedness; create liens; pay dividends or repurchase stock; and make capital expenditures and investments. If Cinemark USA, Inc. has borrowings outstanding on the revolving credit line, it is required to keep a consolidated net senior secured leverage ratio, as defined in the Credit Agreement, not to exceed
The dividend restriction contained in the Credit Agreement prevents the Company and any of its subsidiaries from paying a dividend or otherwise distributing cash to its stockholders unless (1) the Company is not in default, and the distribution would not cause Cinemark USA, Inc. to be in default, under the Credit Agreement; and (2) the aggregate amount of certain dividends, distributions, investments, redemptions and capital expenditures made since December 18, 2012, including dividends declared by the board of directors, is less than the sum of (a) the aggregate amount of cash and cash equivalents received by Cinemark Holdings, Inc. or Cinemark USA, Inc. as common equity since December 18, 2012, (b) Cinemark USA, Inc.’s consolidated EBITDA minus
4.875% Senior Notes
On May 24, 2013, Cinemark USA, Inc. issued $
due 2023, at par value, (the “4.875% Senior Notes”). Interest on the 4.875% Senior Notes is payable on June 1 and December 1 of each year. The 4.875% Senior Notes mature on
On March 21, 2016, Cinemark USA, Inc. issued an additional $
The 4.875% Senior Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of Cinemark USA, Inc.’s subsidiaries that guarantee, assume or become liable with respect to any of Cinemark USA, Inc.’s or a guarantor’s debt. The 4.875% Senior Notes and the guarantees are senior unsecured obligations and rank equally in right of payment with all of Cinemark USA, Inc.’s and its guarantor’s existing and future senior unsecured debt and senior in right of payment to all of Cinemark USA, Inc.’s and its guarantor’s existing and future senior subordinated debt. The 4.875% Senior Notes and the guarantees are effectively subordinated to all of Cinemark USA, Inc.’s and its guarantor’s existing and future secured debt to the extent of the value of the assets securing such debt, including all borrowings under Cinemark USA, Inc.’s Credit Agreement. The
F-30
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
4.875% Senior Notes and the guarantees are structurally subordinated to all existing and future debt and other liabilities of Cinemark USA, Inc.’s subsidiaries that do not guarantee the 4.875% Senior Notes.
The indenture to the 4.875% Senior Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. As of December 31, 2019, Cinemark USA, Inc. could have distributed up to approximately $
Cinemark USA, Inc. may redeem the
5.125% Senior Notes
On December 18, 2012, Cinemark USA, Inc. issued $
The 5.125% Senior Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of Cinemark USA, Inc.’s subsidiaries that guarantee, assume or become liable with respect to any of Cinemark USA, Inc.’s or a guarantor’s debt. The 5.125% Senior Notes and the guarantees are senior unsecured obligations and rank equally in right of payment with all of Cinemark USA, Inc.’s and its guarantor’s existing and future senior unsecured debt and senior in right of payment to all of Cinemark USA, Inc.’s and its guarantor’s existing and future subordinated debt. The 5.125% Senior Notes and the guarantees are effectively subordinated to all of Cinemark USA, Inc.’s and its guarantor’s existing and future secured debt to the extent of the value of the assets securing such debt, including all borrowings under Cinemark USA, Inc.’s Credit Agreement. The 5.125% Senior Notes and the guarantees are structurally subordinated to all existing and future debt and other liabilities of Cinemark USA, Inc.’s subsidiaries that do not guarantee the 5.125% Senior Notes.
The indenture to the 5.125% Senior Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. As of December 31, 2019, Cinemark USA, Inc. could have distributed up to approximately $
F-31
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
Cinemark USA, Inc. may redeem the
Fair Value of Long Term Debt
The Company estimates the fair value of its long-term debt primarily using quoted market prices, which fall under Level 2 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35. The carrying value of the Company’s long term debt was $
Covenant Compliance and Debt Maturity
As of December 31, 2019, the Company believes it was in full financial compliance with all agreements, including related covenants, governing its outstanding debt.
The Company’s long-term debt, excluding unamortized debt issuance costs, at December 31, 2019 matures as follows:
2020 |
|
$ |
|
|
2021 |
|
|
|
|
2022 |
|
|
|
|
2023 |
|
|
|
|
2024 |
|
|
|
|
Thereafter |
|
|
|
|
Total |
|
$ |
|
|
Interest Rate Swap Agreements
The Company is currently a party to
The valuation technique used to determine fair value is the income approach and under this approach, the Company uses projected future interest rates as provided by counterparty to the interest rate swap agreement and the fixed rates that the Company is obligated to pay under the agreement. Therefore, the Company’s measurements use significant unobservable inputs, which fall in Level 3 of the U.S. GAAP hierarchy as defined by FASB ASC Topic 820-10-35. See Note 13 for a summary of unrealized gains or losses recorded in accumulated other comprehensive loss.
Below is a summary of the Company’s interest rate swap agreements designated as cash flow hedges as of December 31, 2019:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value at |
|
|
Notional |
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
||
Amount |
|
|
Effective Date |
|
Pay Rate |
|
|
Receive Rate |
|
Expiration Date |
|
2019 (1) |
|
|||
$ |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
(1) |
|
F-32
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
The total estimated fair value of the interest rate swaps of $
13. |
FAIR VALUE MEASUREMENTS |
The Company determines fair value measurements in accordance with FASB ASC Topic 820, which establishes a fair value hierarchy under which an asset or liability is categorized based on the lowest level of input significant to its fair value measurement. The levels of input defined by FASB ASC Topic 820 are as follows:
Level 1 – quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date;
Level 2 – other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and
Level 3 – unobservable and should be used to measure fair value to the extent that observable inputs are not available.
Below is a summary of liabilities measured at fair value on a recurring basis by the Company under FASB ASC Topic 820 as of December 31, 2019:
|
|
Carrying |
|
|
Fair Value |
|
||||||||||
Description |
|
Value |
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
||||
Interest rate swap liabilities |
|
$ |
( |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
( |
|
Below is a reconciliation of the beginning and ending balance for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3):
|
|
Liabilities (1) |
|
|
|
|
2019 |
|
|
Beginning balance - January 1 |
|
$ |
|
|
Total loss included in accumulated other comprehensive loss |
|
|
|
|
Settlements included in interest expense |
|
|
( |
) |
Ending balance - December 31 |
|
$ |
|
|
|
(1) |
|
The Company also uses the market approach for fair value measurements on a nonrecurring basis in the impairment evaluations of its long-lived assets (see Note 1 and Note 10). Additionally, the Company uses the market approach to estimate the fair value of its long-term debt (see Note 12). There were no changes in valuation techniques during the period. There were
14. |
FOREIGN CURRENCY TRANSLATION |
The accumulated other comprehensive loss account in stockholders’ equity of $
As of December 31, 2019, all foreign countries where the Company has operations, other than Argentina, are non-highly inflationary, and the local currency is the same as the functional currency in all of the locations. Thus, any fluctuation in the currency results in a cumulative foreign currency translation adjustment recorded to accumulated other comprehensive loss. The Company deemed Argentina to be highly inflationary beginning July 1, 2018. A highly inflationary economy is defined as an economy with a cumulative inflation rate of approximately
F-33
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
the reporting entity. The financial statements of the Company’s Argentina subsidiaries has been remeasured in U.S. dollars in accordance with ASC Topic 830, Foreign Currency Matters, effective beginning July 1, 2018.
Below is a summary of the impact of translating the financial statements of all of the Company’s international subsidiaries as of and for the years ended December 31, 2017, 2018 and 2019.
|
|
|
|
|
|
|
|
|
|
|
|
Other Comprehensive |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Income (Loss) |
|
|||||||||
|
|
Exchange Rate as of December 31, |
|
|
For the Year Ended December 31, |
|
||||||||||||||||
Country |
|
2017 |
|
2018 |
|
2019 |
|
|
2017 |
|
|
2018 (1) |
|
|
2019 (1) |
|
||||||
Brazil |
|
|
|
|
|
|
|
|
|
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
Argentina (1) |
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
Colombia |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
( |
) |
Chile |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
( |
) |
Peru |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|
All other |
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
(1) |
|
|
During the year ended December 31, 2017, the Company reclassified $
During the year ended December 31, 2018, the Company reclassified $
15. |
NONCONTROLLING INTERESTS IN SUBSIDIARIES |
Noncontrolling interests in subsidiaries of the Company were as follows at December 31:
|
|
December 31, |
|
|||||
|
|
2018 |
|
|
2019 |
|
||
Cinemark Partners II — |
|
$ |
|
|
|
$ |
|
|
Laredo Theatres – |
|
|
|
|
|
|
|
|
Greeley Ltd. — |
|
|
|
|
|
|
|
|
Other |
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
|
|
There were
16. |
CAPITAL STOCK |
Common Stock — Common stockholders are entitled to vote on all matters submitted to a vote of the Company’s stockholders. Subject to the rights of holders of any then outstanding shares of the Company’s preferred stock, the Company’s common stockholders are entitled to dividends declared by the board of directors. The shares of the Company’s common stock are not subject to any redemption provisions. The Company has
F-34
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
The Company’s ability to pay dividends is effectively limited by its status as a holding company and the terms of its subsidiary’s indentures and senior secured credit facility, which also significantly restricts the ability of certain of the Company’s subsidiaries to pay dividends directly or indirectly to the Company. See Note 12 for discussion of restrictions contained within the debt agreements of the Company’s subsidiaries.
Treasury Stock — Treasury stock represents shares of common stock repurchased by the Company and not yet retired. The Company has applied the cost method in recording its treasury shares.
Below is a summary of the Company’s treasury stock activity for the years ended December 31, 2017, 2018 and 2019.
|
Number of Treasury Shares |
|
|
Cost |
|
||
Balance at January 1, 2017 |
|
|
|
|
$ |
|
|
Restricted stock withholdings (1) |
|
|
|
|
|
|
|
Restricted stock forfeitures (2) |
|
|
|
|
|
|
|
Balance at December 31, 2017 |
|
|
|
|
$ |
|
|
Restricted stock withholdings (1) |
|
|
|
|
|
|
|
Restricted stock forfeitures (2) |
|
|
|
|
|
|
|
Balance at December 31, 2018 |
|
|
|
|
$ |
|
|
Restricted stock withholdings (1) |
|
|
|
|
|
|
|
Restricted stock forfeitures (2) |
|
|
|
|
|
|
|
Balance at December 31, 2019 |
|
|
|
|
$ |
|
|
(1) |
|
(2) |
|
As of December 31, 2019, the Company had no plans to retire any shares of its treasury stock.
Restricted Stock —
|
|
Year Ended |
|
|
Year Ended |
|
|
Year Ended |
|
|||||||||||||||
|
|
December 31, 2017 |
|
|
December 31, 2018 |
|
|
December 31, 2019 |
|
|||||||||||||||
|
|
Shares of Restricted Stock |
|
|
Weighted Average Grant Date Fair Value |
|
|
Shares of Restricted Stock |
|
|
Weighted Average Grant Date Fair Value |
|
|
Shares of Restricted Stock |
|
|
Weighted Average Grant Date Fair Value |
|
||||||
Outstanding at January 1 |
|
|
|
|
|
$ |
|
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
$ |
|
|
Granted |
|
|
|
|
|
$ |
|
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
$ |
|
|
Vested |
|
|
( |
) |
|
$ |
|
|
|
|
( |
) |
|
$ |
|
|
|
|
( |
) |
|
$ |
|
|
Forfeited |
|
|
( |
) |
|
$ |
|
|
|
|
( |
) |
|
$ |
|
|
|
|
( |
) |
|
$ |
|
|
Outstanding at December 31 |
|
|
|
|
|
$ |
|
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
$ |
|
|
During the year ended December 31, 2019, the Company granted
F-35
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
Below is a summary of restricted stock award activity recorded for the periods indicated.
|
|
Year Ended December 31, |
|
|||||||||
|
|
2017 |
|
|
2018 |
|
|
2019 |
|
|||
Compensation expense recognized during the period |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Fair value of restricted shares that vested during the period |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Income tax deduction upon vesting of restricted stock awards |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
As of December 31, 2019, the remaining unrecognized compensation expense related to these restricted stock awards was approximately $
Restricted Stock Units — During the years ended December 31, 2017, 2018 and 2019, the Company granted restricted stock units representing
At the time of each of the restricted stock unit grants, the Company assumes the IRR level to be reached for the defined measurement period will be the target IRR level in determining the amount of compensation expense to record for such grants. If and when additional information becomes available to indicate that something other than the target IRR level will be achieved, the Company adjusts compensation expense on a prospective basis over the remaining service period. The Company assumed forfeiture rates ranging from
Below is a table summarizing the potential number of units that could vest under restricted stock unit awards granted during the years ended December 31, 2017, 2018 and 2019 at each of the three levels of financial performance (excluding forfeitures):
|
|
Granted During the Year Ended December 31, |
|
|||||||||||||||||||||
|
|
2017 |
|
|
2018 |
|
|
2019 |
|
|||||||||||||||
|
|
Number of |
|
|
Value at |
|
|
Number of |
|
|
Value at |
|
|
Number of |
|
|
Value at |
|
||||||
|
|
Units |
|
|
Grant(1) |
|
|
Units |
|
|
Grant(1) |
|
|
Units |
|
|
Grant(1) |
|
||||||
at threshold IRR |
|
|
|
|
|
$ |
|
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
$ |
|
|
at target IRR |
|
|
|
|
|
$ |
|
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
$ |
|
|
at maximum IRR |
|
|
|
|
|
$ |
|
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
$ |
|
|
(1) |
|
F-36
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
Below is a summary of activity for restricted stock unit awards for the periods indicated:
|
|
Year Ended December 31, |
|
|||||||||
|
|
2017 |
|
|
2018 |
|
|
2019 |
|
|||
Number of restricted stock unit awards that vested during the period |
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of restricted stock unit awards that vested during the period |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Accumulated dividends paid upon vesting of restricted stock unit awards |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Compensation expense recognized during the period |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Income tax benefit recognized upon vesting of restricted stock unit awards |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
During the year ended December 31, 2019, the Company modified the performance target levels for the restricted stock unit awards granted during February 2017 and February 2018 for all participants other than certain executive officers. The modification adjusted the threshold, target and maximum IRR levels from
The current financial performance factors and respective vesting rates for each of the 2017, 2018 and 2019 grants are as follows:
|
|
Year Ended December 31, |
|
|
Percentage of Shares Vesting |
|
|||||||
|
|
2017 |
|
|
2018 |
|
|
2019 |
|
|
|
|
|
Threshold IRR |
|
|
|
|
|
|
|
|
|
|
|
|
|
Target IRR |
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum IRR |
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2019, the Company had restricted stock units outstanding that represented a total
As of December 31, 2019, the remaining unrecognized compensation expense related to the outstanding restricted stock unit awards was $
F-37
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
17. |
SUPPLEMENTAL CASH FLOW INFORMATION |
The following is provided as supplemental information to the consolidated statements of cash flows:
|
|
Year Ended December 31, |
|
|||||||||
|
|
2017 |
|
|
2018 |
|
|
2019 |
|
|||
Cash paid for interest |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Cash paid for income taxes, net of refunds received |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Noncash investing and financing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment (1) |
|
$ |
|
|
|
$ |
( |
) |
|
$ |
|
|
Theatre properties acquired under finance leases |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Investment in NCM – receipt of common units (see Note 7) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Interest expense - NCM (see Notes 4 and 7) |
|
$ |
— |
|
|
$ |
( |
) |
|
$ |
( |
) |
Dividends accrued on unvested restricted stock unit awards |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
(1) |
|
|
18. |
INCOME TAXES |
On December 22, 2017, the U.S. government enacted comprehensive tax legislation, the Tax Cuts and Jobs Act (the “Tax Act”). The Tax Act made changes to the U.S. tax code, which included (1) reduced U.S. corporate tax rate from
As of December 31, 2018, the amounts recorded for the Tax Act were final for the 2017 transition tax, the remeasurement of deferred taxes and the Company’s reassessment of valuation allowances.
The Company’s provision for federal and foreign income tax expense for continuing operations consisted of the following:
|
|
Year Ended December 31, |
|
|||||||||
|
|
2017 |
|
|
2018 |
|
|
2019 |
|
|||
Income before income taxes: |
|
|
|
|
|
|
|
|
|
|
|
|
U.S. |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Foreign |
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
F-38
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
Current and deferred income taxes were as follows:
|
|
Year Ended December 31, |
|
|||||||||
|
|
2017 |
|
|
2018 |
|
|
2019 |
|
|||
Current: |
|
|
|
|
|
|
|
|
|
|
|
|
Federal |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Foreign |
|
|
|
|
|
|
|
|
|
|
|
|
State |
|
|
|
|
|
|
|
|
|
|
|
|
Total current expense |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Deferred: |
|
|
|
|
|
|
|
|
|
|
|
|
Federal |
|
$ |
( |
) |
|
$ |
|
|
|
$ |
( |
) |
Foreign |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
State |
|
|
|
|
|
|
|
|
|
|
( |
) |
Total deferred taxes |
|
$ |
( |
) |
|
$ |
|
|
|
$ |
( |
) |
Income taxes |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
A reconciliation between income tax expense and taxes computed by applying the applicable statutory federal income tax rate to income before income taxes follows:
|
|
Year Ended December 31, |
|
|||||||||
|
|
2017 |
|
|
2018 |
|
|
2019 |
|
|||
Computed statutory tax expense |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
State and local income taxes, net of federal income tax impact |
|
|
|
|
|
|
|
|
|
|
|
|
Changes in valuation allowance |
|
|
|
|
|
|
|
|
|
|
||
Foreign tax rate differential |
|
|
( |
) |
|
|
|
|
|
|
|
|
Foreign dividends |
|
|
|
|
|
— |
|
|
— |
|
||
Foreign tax credits |
|
|
( |
) |
|
|
|
|
|
|
|
|
Impacts related to 2017 Tax Act (1)(2) |
|
|
( |
) |
|
|
|
|
|
— |
|
|
Changes in uncertain tax positions |
|
|
|
|
|
|
( |
) |
|
|
|
|
Other — net |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
Income taxes |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
(1) |
|
(2) |
|
As of December 31, 2019, the Company had approximately $
F-39
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
Deferred Income Taxes
The tax effects of significant temporary differences and tax loss and tax credit carryforwards comprising the net long-term deferred income tax liabilities as of December 31, 2018 and 2019 consisted of the following:
|
|
December 31, |
|
|||||
|
|
2018 |
|
|
2019 |
|
||
Deferred liabilities: |
|
|
|
|
|
|
|
|
Theatre properties and equipment |
|
$ |
|
|
|
$ |
|
|
Operating lease right-of-use assets |
|
|
— |
|
|
|
|
|
Intangible asset — other |
|
|
|
|
|
|
|
|
Intangible asset — tradenames |
|
|
|
|
|
|
|
|
Investment in partnerships |
|
|
|
|
|
|
|
|
Total deferred liabilities |
|
|
|
|
|
|
|
|
Deferred assets: |
|
|
|
|
|
|
|
|
Deferred lease expenses |
|
|
|
|
|
|
— |
|
Deferred revenue - NCM |
|
|
|
|
|
|
|
|
Deferred revenue - Other |
|
|
|
|
|
|
|
|
Gift Cards |
|
|
|
|
|
|
|
|
Operating lease obligations |
|
|
— |
|
|
|
|
|
Finance lease obligations |
|
|
|
|
|
|
|
|
Tax impact of items in accumulated other comprehensive income |
|
|
|
|
|
|
|
|
Other tax loss carryforwards |
|
|
|
|
|
|
|
|
Other tax credit carryforwards |
|
|
|
|
|
|
|
|
Other expenses, not currently deductible for tax purposes |
|
|
|
|
|
|
|
|
Total deferred assets |
|
|
|
|
|
|
|
|
Net deferred income tax liability before valuation allowance |
|
|
|
|
|
|
|
|
Valuation allowance against deferred assets – non-current |
|
|
|
|
|
|
|
|
Net deferred income tax liability |
|
$ |
|
|
|
$ |
|
|
Net deferred tax (asset) liability — Foreign |
|
$ |
( |
) |
|
$ |
( |
) |
Net deferred tax liability — U.S. |
|
|
|
|
|
|
|
|
Total |
|
$ |
131,252 |
|
|
$ |
132,467 |
|
A significant portion of our foreign tax credit carryforwards expire in
The Company’s valuation allowance changed from $
F-40
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
Uncertain Tax Positions
The following is a reconciliation of the total amounts of unrecognized tax benefits excluding interest and penalties, for the years ended December 31, 2017, 2018 and 2019:
|
|
Year Ended December 31, |
|
|||||||||
|
|
2017 |
|
|
2018 |
|
|
2019 |
|
|||
Balance at January 1, |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Gross increases - tax positions in prior periods |
|
|
|
|
|
— |
|
|
|
|
||
Gross decreases - tax positions in prior periods |
|
|
( |
) |
|
|
( |
) |
|
— |
|
|
Gross increases - current period tax positions |
|
|
|
|
|
|
|
|
|
|
|
|
Settlements |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Foreign currency translation adjustments |
|
|
|
|
|
|
( |
) |
|
|
( |
) |
Balance at December 31, |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
The Company had $
The Company and its subsidiaries file income tax returns in the U.S. federal jurisdiction and in certain state and foreign jurisdictions and are routinely under audit by many different tax authorities. The Company believes that its accrual for tax liabilities is adequate for all open audit years based on its assessment of many factors including past experience and interpretations of tax law. This assessment relies on estimates and assumptions and may involve a series of complex judgments about future events. The Company is no longer subject to income tax audits from the Internal Revenue Service for years before 2017. The Company is no longer subject to state income tax examinations by tax authorities in its major state jurisdictions for years before 2015. The Company is no longer subject to non-U.S. income tax examinations by tax authorities in its major non-U.S. tax jurisdictions for years before 2006.
The Company is currently under audit in the non-U.S. tax jurisdiction of Brazil.
19. |
COMMITMENTS AND CONTINGENCIES |
Employment Agreements — As of December 31, 2019, the Company had employment agreements with Lee Roy Mitchell, Mark Zoradi, Sean Gamble, Valmir Fernandes and Michael Cavalier. The employment agreements for Messrs. Mitchell, Gamble, Fernandes and Cavalier are subject to automatic extensions for a
Retirement Savings Plan — The Company has a 401(k) retirement savings plan (“401(k) Plan”) for the benefit of all eligible employees and makes matching contributions as determined annually in accordance with the 401(k) Plan. Employer matching contribution payments of $
Legal Proceedings
F-41
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
Intertrust Technologies Corporation (“Intertrust”) v. Cinemark Holdings, Inc., Regal, AMC, et al. This case was filed against the Company on August 7, 2019 in the Eastern District of Texas – Marshall Division alleging patent infringement. The Company firmly maintains that the contentions of the Plaintiff are without merit and will vigorously defend itself against the lawsuit. Although the Company does not believe that it has infringed on any of Intertrust’s patents, it cannot predict the outcome of this litigation.
Flagship Theatres of Palm Desert, LLC d/b/a Cinemas Palme D’Or v. Century Theatres, Inc., and Cinemark USA, Inc.; Superior Court of the State of California, County of Los Angeles. Plaintiff in this case alleges that the Company violated California antitrust and unfair competition laws by engaging in “circuit dealing” with various motion picture distributors and tortiously interfered with Plaintiff’s business relationships. Plaintiff seeks compensatory damages, trebling of those damages under California law, punitive damages, injunctive relief, attorneys’ fees, costs and interest. Plaintiff also alleges that the Company’s conduct ultimately resulted in closure of its theatre in June 2016. The Company denied the allegations. In 2008, the Company moved for summary judgment on Plaintiff’s claims, arguing primarily that clearances between the theatres at issue were lawful and that Plaintiff lacked proof sufficient to support certain technical elements of its antitrust claims. The trial court granted that motion and dismissed Plaintiff’s claims. Plaintiff appealed and, in 2011, the Court of Appeal reversed, holding, among other things, that Plaintiff’s claims were not about the illegality of clearances but were focused, instead, on “circuit dealing.” Having re-framed the claims in that manner, the Court of Appeal held that the trial court’s decision to limit discovery to the market where the theatres at issue operated was an error, as “circuit dealing” necessarily involves activities in different markets. Upon return to the trial court, the parties engaged in additional, broadened discovery related to Plaintiff’s “circuit dealing” claim. Thereafter, the Company moved again for summary judgment on all of Plaintiff’s claims. That new motion for summary judgment was pending when, on or about April 11, 2014, the trial court granted the Company’s motion for terminating sanctions and entered a judgment dismissing the case with prejudice. Plaintiff then appealed that second dismissal, seeking to have the judgment reversed and the case remanded to the trial court. The Court of Appeal issued a ruling on May 24, 2016, reversing the granting of terminating sanctions and instead imposed a lesser evidentiary and damages preclusion sanction. The case returned to the trial court on October 6, 2016. On May 10, 2018, after a five-week jury trial, the jury found no liability on one circuit dealing claim and awarded Plaintiff damages on the other claim, which are tripled for antitrust damage awards. Plaintiff would also be entitled to certain court costs and to seek at least some portion of its attorney’s fees. During 2018, the Company recorded a litigation reserve based on the jury award, court costs and attorney’s fees. The trial court denied a motion for a judgment notwithstanding the verdict and a motion for a new trial. The Company has appealed the judgment. Although the Company denies that it engaged in any form of circuit dealing, it cannot predict the outcome of its pending motions or future appeals.
Civil Investigative Demand. The Company received a Civil Investigative Demand (“CID”) from the Antitrust Division of the United States Department of Justice. The CID relates to an investigation under Sections 1 and 2 of the Sherman Act. The Company also received CIDs from the Antitrust Section of the Office of the Attorney General of the State of Ohio and later from other states regarding similar inquiries under state antitrust laws. The CIDs request the Company to answer interrogatories, and produce documents, or both, related to the investigation of matters including film clearances, potential coordination and/or communication with other major theatre circuits and related joint ventures. The Company intends to fully cooperate with all federal and state government agencies. Although the Company does not believe that it has violated any federal or state antitrust or competition laws, it cannot predict the ultimate scope, duration or outcome of these investigations.
From time to time, the Company is involved in other various legal proceedings arising from the ordinary course of its business operations, such as personal injury claims, employment matters, landlord-tenant disputes, patent claims and contractual disputes, some of which are covered by insurance or by indemnification from vendors. The Company believes its potential liability with respect to these types of proceedings currently pending is not material, individually or in the aggregate, to the Company’s financial position, results of operations and cash flows.
20. |
SEGMENTS |
The Company manages its international market and its U.S. market as separate reportable operating segments, with the international segment consisting of operations in Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay. Each segment’s revenue is derived from admissions and concession sales and other ancillary revenues. The Company uses Adjusted
F-42
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
EBITDA, as shown in the reconciliation table below, as the primary measure of segment profit and loss to evaluate performance and allocate its resources. The Company does not report asset information by segment because that information is not used to evaluate Company performance or allocate resources between segments.
Below is a breakdown of select financial information by reportable operating segment:
|
|
Year Ended December 31, |
|
|||||||||
|
|
2017 |
|
|
2018 |
|
|
2019 |
|
|||
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
U.S. |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
International |
|
|
|
|
|
|
|
|
|
|
|
|
Eliminations |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Total revenues |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Adjusted EBITDA (1) |
|
|
|
|
|
|
|
|
|
|
|
|
U.S. |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
International |
|
|
|
|
|
|
|
|
|
|
|
|
Total Adjusted EBITDA |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Capital expenditures |
|
|
|
|
|
|
|
|
|
|
|
|
U.S. |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
International |
|
|
|
|
|
|
|
|
|
|
|
|
Total capital expenditures |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
(1) |
|
The following table sets forth a reconciliation of net income to Adjusted EBITDA:
|
|
Year Ended December 31, |
|
|||||||||
|
|
2017 |
|
|
2018 |
|
|
2019 |
|
|||
Net income |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Add (deduct): |
|
|
|
|
|
|
|
|
|
|
|
|
Income taxes |
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense (1)(2) |
|
|
|
|
|
|
|
|
|
|
|
|
Loss on debt amendments and refinancing |
|
|
|
|
|
|
|
|
|
|
— |
|
Other income (3) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Distributions from DCIP (4) |
|
|
|
|
|
|
|
|
|
|
|
|
Other cash distributions from equity investees (5) |
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization (2) |
|
|
|
|
|
|
|
|
|
|
|
|
Impairment of long-lived assets |
|
|
|
|
|
|
|
|
|
|
|
|
Loss on disposal of assets and other |
|
|
|
|
|
|
|
|
|
|
|
|
Non-cash rent expense (6) |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
Deferred lease expenses (2) |
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
Amortization of long-term prepaid rents (2) |
|
|
|
|
|
|
|
|
|
|
— |
|
Share based awards compensation expense |
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA (2) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
(1) |
|
|
(2) |
|
|
(3) |
|
|
(4) |
|
|
(5) |
|
F-43
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
|
(6) |
|
Financial Information About Geographic Area
Below is a breakdown of select financial information by geographic area:
|
|
Year Ended December 31, |
|
|||||||||
|
|
2017 |
|
|
2018 |
|
|
2019 |
|
|||
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
U.S. |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Brazil |
|
|
|
|
|
|
|
|
|
|
|
|
Other international countries |
|
|
|
|
|
|
|
|
|
|
|
|
Eliminations |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Total |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
|
December 31, 2018 |
|
|
December 31, 2019 |
|
||
Theatre Properties and Equipment-net |
|
|
|
|
|
|
|
|
U.S. |
|
$ |
|
|
|
$ |
|
|
Brazil |
|
|
|
|
|
|
|
|
Other international countries |
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
|
|
21. |
RELATED PARTY TRANSACTIONS |
The Company manages theatres for Laredo Theatres, Ltd. (“Laredo”). The Company is the sole general partner and owns
The Company has an Aircraft Time Sharing Agreement with Copper Beech Capital, LLC to use, on occasion, a private aircraft owned by Copper Beech Capital, LLC. Copper Beech Capital, LLC is owned by Mr. Mitchell and his wife, Tandy Mitchell. The private aircraft is used by Mr. Mitchell and other executives who accompany Mr. Mitchell to business meetings for the Company. The Company reimburses Copper Beech Capital, LLC the actual costs of fuel usage and the expenses of the pilots, landing fees, storage fees and similar expenses incurred during the trip. For the years ended December 31, 2017, 2018 and 2019, the aggregate amounts paid to Copper Beech Capital, LLC for the use of the aircraft was approximately $
The Company holds events for its employees and their families at Pinstack, an entertainment facility, at various times throughout the year. Pinstack is majority-owned by Mr. Mitchell and his wife, Tandy Mitchell. In connection with these events, the Company paid Pinstack approximately $
F-44
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
The Company currently leases
The Company has a
22. |
VALUATION AND QUALIFYING ACCOUNTS |
The Company’s valuation allowance for deferred tax assets for the years ended December 31, 2017, 2018 and 2019 were as follows:
|
|
Valuation Allowance for Deferred Taxes |
|
|
Balance at January 1, 2017 |
|
$ |
|
|
Additions |
|
|
|
|
Deductions |
|
|
( |
) |
Balance at December 31, 2017 |
|
$ |
|
|
Additions |
|
|
|
|
Deductions |
|
|
( |
) |
Balance at December 31, 2018 |
|
$ |
|
|
Additions |
|
|
|
|
Deductions |
|
|
( |
) |
Balance at December 31, 2019 |
|
$ |
|
|
23. |
QUARTERLY FINANCIAL INFORMATION (UNAUDITED) |
|
|
2018 |
|
|||||||||||||||||
|
|
First Quarter |
|
|
Second Quarter |
|
|
Third Quarter |
|
|
Fourth Quarter |
|
|
Full Year |
|
|||||
Revenues |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Operating income |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Net income |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Net income attributable to Cinemark Holdings, Inc. |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Net income per share attributable to Cinemark Holdings, Inc.’s common stockholders: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Diluted |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
F-45
CINEMARK HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In thousands, except share and per share data
|
|
2019 (1) |
|
|||||||||||||||||
|
|
First Quarter |
|
|
Second Quarter |
|
|
Third Quarter |
|
|
Fourth Quarter |
|
|
Full Year |
|
|||||
Revenues |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Operating income |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Net income |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Net income attributable to Cinemark Holdings, Inc. |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Net income per share attributable to Cinemark Holdings, Inc.’s common stockholders: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Diluted |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
(1)
24. |
SUBSEQUENT EVENTS |
On
*****
F-46
SCHEDULE 1 - CONDENSED FINANCIAL INFORMATION OF REGISTRANT
CINEMARK HOLDINGS, INC.
PARENT COMPANY BALANCE SHEETS
(In thousands, except share data)
|
|
December 31, |
|
|
December 31, |
|
||
|
|
2018 |
|
|
2019 |
|
||
Assets |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
|
|
|
$ |
|
|
Prepaid assets and other |
|
|
|
|
|
|
— |
|
Investment in subsidiaries |
|
|
|
|
|
|
|
|
Total assets |
|
$ |
|
|
|
$ |
|
|
Liabilities and equity |
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
Accrued other current liabilities, including accounts payable to subsidiaries |
|
$ |
|
|
|
$ |
|
|
Other long-term liabilities |
|
|
|
|
|
|
|
|
Total liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies (see Note 6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
|
|
|
Common stock, $ |
|
|
|
|
|
|
|
|
Additional paid-in-capital |
|
|
|
|
|
|
|
|
Treasury stock, |
|
|
( |
) |
|
|
( |
) |
Retained earnings |
|
|
|
|
|
|
|
|
Accumulated other comprehensive loss |
|
|
( |
) |
|
|
( |
) |
Total equity |
|
|
|
|
|
|
|
|
Total liabilities and equity |
|
$ |
|
|
|
$ |
|
|
The accompanying notes are an integral part of the condensed financial information of the registrant.
S-1
CINEMARK HOLDINGS, INC.
PARENT COMPANY STATEMENTS OF INCOME
YEARS ENDED DECEMBER 31, 2017, 2018 and 2019
(in thousands)
|
|
2017 |
|
|
2018 |
|
|
2019 |
|
|||
Revenues |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
Cost of operations |
|
|
|
|
|
|
|
|
|
|
|
|
Operating loss |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Other income |
|
|
|
|
|
|
|
|
|
|
|
|
Loss before income taxes and equity in income of subsidiaries |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Income taxes |
|
|
|
|
|
|
|
|
|
|
|
|
Equity in income of subsidiaries, net of taxes |
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
The accompanying notes are an integral part of the condensed financial information of the registrant.
S-2
CINEMARK HOLDINGS, INC.
PARENT COMPANY STATEMENTS OF COMPREHENSIVE INCOME
YEARS ENDED DECEMBER 31, 2017, 2018 and 2019
(In thousands)
|
|
2017 |
|
|
2018 |
|
|
2019 |
|
|||
Net income |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Other comprehensive income (loss), net of tax |
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $ |
|
|
- |
|
|
|
( |
) |
|
|
( |
) |
Other comprehensive income (loss) in equity method investments |
|
|
|
|
|
( |
) |
|
|
( |
) |
|
Foreign currency translation adjustments |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Total other comprehensive loss, net of tax |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Comprehensive income attributable to Cinemark Holdings, Inc. |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
The accompanying notes are an integral part of the condensed financial information of the registrant.
S-3
CINEMARK HOLDINGS, INC.
PARENT COMPANY STATEMENTS OF CASH FLOWS
YEARS ENDED DECEMBER 31, 2017, 2018 and 2019
(in thousands)
|
|
2017 |
|
|
2018 |
|
|
2019 |
|
|||
Operating Activities |
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Adjustments to reconcile net income to cash provided by operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Share based awards compensation expense |
|
|
|
|
|
|
|
|
|
|
|
|
Equity in income of subsidiaries |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Changes in other assets and liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities |
|
|
|
|
|
|
|
|
|
|
|
|
Investing Activities |
|
|
|
|
|
|
|
|
|
|
|
|
Dividends received from subsidiaries |
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by investing activities |
|
|
|
|
|
|
|
|
|
|
|
|
Financing Activities |
|
|
|
|
|
|
|
|
|
|
|
|
Dividends paid to stockholders |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Payroll taxes paid as a result of noncash stock option exercises |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Net cash used for financing activities |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Increase (decrease) in cash and cash equivalents |
|
|
|
|
|
|
( |
) |
|
|
|
|
Cash and cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Beginning of period |
|
|
|
|
|
|
|
|
|
|
|
|
End of period |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
The accompanying notes are an integral part of the condensed financial information of the registrant.
S-4
CINEMARK HOLDINGS, INC.
NOTES TO PARENT COMPANY FINANCIAL STATEMENTS
In thousands, except share and per share data
1. |
BASIS OF PRESENTATION |
Cinemark Holdings, Inc. conducts substantially all of its operations through its subsidiaries. These statements should be read in conjunction with the Company’s consolidated financial statements and notes included elsewhere in this annual report on Form 10-K. There are significant restrictions over Cinemark Holdings, Inc.’s ability to obtain funds from its subsidiaries through dividends, loans or advances as contained in Cinemark USA, Inc.’s senior secured credit facility and the indentures to each of the
2. |
DIVIDEND PAYMENTS |
Below is a summary of dividends declared for the fiscal periods indicated.
|
|
|
|
|
|
Amount per Share of |
|
|
Total |
|
||
Declaration Date |
|
Record Date |
|
Payable Date |
|
Common Stock |
|
|
Dividends (1) |
|
||
|
|
|
|
|
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
|
|
(1) |
|
3. |
DIVIDENDS RECEIVED FROM SUBSIDIARIES |
During the years December 31, 2017, 2018 and 2019, Cinemark Holdings, Inc. received cash dividends of $
4. |
LONG-TERM DEBT |
Cinemark Holdings, Inc. has no direct outstanding debt obligations, but its subsidiaries do. For a discussion of the debt obligations of Cinemark Holdings, Inc.’s subsidiaries, see Note 12 to the Company’s consolidated financial statements included elsewhere in this annual report on Form 10-K.
S-5
CINEMARK HOLDINGS, INC.
NOTES TO PARENT COMPANY FINANCIAL STATEMENTS
In thousands, except share and per share data
5. |
CAPITAL STOCK |
Cinemark Holdings, Inc.’s capital stock along with its long-term incentive plan and related activity are discussed in Note 16 of the Company’s consolidated financial statements included elsewhere in this annual report on Form 10-K.
6. |
COMMITMENTS AND CONTINGENCIES |
Cinemark Holdings, Inc. has no direct commitments and contingencies, but its subsidiaries do. See Note 19 of the Company’s consolidated financial statements included elsewhere in this annual report on Form 10-K
*****
S-6